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Sickle cell disease (SCD) is marked by excruciating chronic pain, commonly known as 
pain crisis. SCD healthcare practitioners (HCPs) have been employing palliative care as a 
mainstream treatment option to manage SCD pain crises using mainly opioid analgesics 
for years. Due to the current opioid crisis, however, it has become imperative to explore 
alternative regimens to manage the pain and associated comorbidities of SCD. Thus, the 
goals of this study included exploring alternative treatment options for SCD pain crisis 
management with the intent of decreasing SCD patients’ dependency on opioid-based or 
related analgesics while reducing the frequency of pain crises as well as the number of 
hospitalizations all geared toward improving quality of life for SCD patients in terms of 
health status, living standards, and life expectancy. The study was also conducted to 
analyze and understand the participants’ experiences and perceptions of alternative 
treatment regimens, and is expected to offer a unique contribution to the literature.  
 The nature of this qualitative study was both descriptive and analytical, with a case study 
design. The frameworks used were the health belief model, biopsychosocial-spiritual 
model, and transtheoretical model. Data were collected from a sample of 11 participants, 
with interviews conducted by phone and email due to COVID-19. The code and coding 
technique was employed in data collection, processing, and analysis. The study findings 
would benefit SCD patients, HCPs and caretakers as they learned of these alternative 
regimens with the expectation of improving their pain management strategies. 
Nevertheless, Findings confirmed the need for further research on alternative treatments 
or interventions for SCD patients to prevent or reduce the frequency of pain crises and 
associated complications and thus increase quality of life and effect social change.  
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Chapter 1: Introduction to the Study 
Sickle cell disease (SCD), according to the Centers for Disease Control and 
Prevention (CDC, 2020b), is a group of inherited red blood cell disorders. SCD is marked 
with many pain episodes for patients, usually called pain crisis. Pain crises represent the 
main reason for frequent hospital visits and admissions among SCD patients, as well as 
the reason for SCD patients’ dependence on opioid analgesics for managing pain.  
SCD, at times referred to as the “forgotten disease,” is regarded as a neglected 
public health condition. Serjeant (1997) described SCD as the most common globin gene 
disorder, attributing it to a point mutation, GTG GAG, in the codon. The sixth amino acid 
of the standard beta chain of the hemoglobin has glutamic acid, while the sickle beta 
chain has valine (Serjeant, 1997). SCD is more prevalent among peoples whose ancestors 
came from sub-Saharan Africa; Spanish-speaking regions in the Western Hemisphere; 
Saudi Arabia; India; and Mediterranean countries such as Turkey, Greece, and Italy 
(CDC, n.d.).  
Pain crisis, one of the leading clinical hallmarks of SCD, generally occurs when 
hard, sickled, curved, or crescent-shaped red blood cells (RBC) clog small blood vessels 
(U.S. Department of Health and Human Services [USDHHS], 2020). This results in 
obstructing the smooth flow of blood and oxygen to specific organs, resulting in 
excruciating pain, especially in the joints, chest, and abdomen (USDHHS, 2020). Vaso-
occlusion (VOC) usually happens when blood circulation through the small blood vessels 
becomes blocked by sickled cells, leading to ischemic injuries with pain and irreversible 




that occurs when sickle-shaped RBCs occlude blood vessels (USDHHS, 2020).  
For years, the pain of SCD patients has been treated mainly with opioid analgesics 
and other prescription drugs. However, with the current opioid crisis, it has become 
crucial to research additional or new treatment options. Mahmood et al. (2020) declared 
how necessary it is for adjuvant nonopioid therapies that can improve pain control to be 
investigated, given the side effects of opioids. Thus, this study was conducted to explore 
the perceptions and experiences of SCD patients and parents/caretakers related to 
employing alternative treatment options for pain management. It was also conducted to 
explore treatments with the potential to reduce the frequency of pain crisis and eradicate 
dependency on prescription drugs or opioid-based substances. 
Background of the Study 
Naik and Haywood (2015) claimed that homozygous HbS was the first inherited 
condition identified at the molecular level in 1949. However, they noted that issues such 
as “hasty adoption of early mass screening programs for SCD, implementation of 
targeted screening mandates for SCT in athletics, and concerns about stigmatization all 
have led to the numerous controversies regarding research and policy decisions for SCT” 
(para. 1). Further, they stated that  
the historical background of SCD and SCT has contributed towards setting up the 
standards on how research should be conducted in the modern era. These are 
expected to help reduce stigmatization, ameliorate study conclusions, and inform 
genetic counseling and policy decisions for SCT. (para. 1) 




whereby GTG GAG in the codon switches with the sixth amino acid of hemoglobin, 
resulting in a single nucleotide substitution (A to T). This causes a glutamic acid codon 
(GAG) to convert to a valine codon [GTG] (Enwonwu, (1989).  
The mortality rate for the SCD community is generally high, and SCD patients’ 
life expectancy is generally low. In the past, it was common knowledge that SCD patients 
had short lifespans, with the notion that such patients could not live beyond the age of 20. 
However, Shet and Thein (2019) claimed that the survival rate of SCD patients in well-
resourced countries such as the United States has significantly improved in the past 60 
years, with many newborn SCD patients now expected to live to adulthood. Neville and 
Panepinto (2011) maintained that less than 30% of adults with SCD in the United States 
have a life expectancy not exceeding 70 years, with causes of death attributed to acute 
SCD-related complications such as pain, acute chest syndrome, stroke, pulmonary 
hypertension, renal failure, and infections. The mortality rate of children with SCD in 
developed countries, according to Neville and Panepinto, is as low as .5-1 per 100,000 
children. However, according to Shet and Thein (2019), with all the improvement in 
survival chances, the life expectancy of SCD patients still falls 20 to 30 years behind that 
of the general public.  
Excruciating pain crisis, the main reason for frequent hospital visits and 
widespread use of opioid-based analgesics among SCD patients, is a typical characteristic 
of SCD. As Matthie et al. (2019) asserted, acute, intermittent vaso-occlusive pain is the 
hallmark of SCD and is associated with substantial morbidity, impaired quality of life 




which have been the primary treatment option for managing these pains associated with 
SCD for years, Matte et al. (2019) proposed two new therapeutic strategies. These are 
pathophysiology-related new therapies and innovations in curative therapeutic options 
such as hematopoietic stem cell transplantation and gene therapy (Matte et al., 2019). 
These pathophysiology-related novel therapies have the potential to prevent sickling or 
sickle red cell dehydration; treat SCD vasculopathy and sickle cell-endothelial adhesive 
events; and promote antioxidant agents capable of reducing inflammatory responses to 
pathogens (Matte et al., 2019). Though in the past, there was a notion that there was no 
cure for SCD, all of these new therapies have proven to be promising. Yawn et al. (2014) 
also strongly recommended hydroxyurea and transfusion therapy for the SCD 
community. 
The use of “complementary and alternative medicine (CAM), which Thompson 
and Eriator (2014) defined as a group of diverse medical and health care systems, 
practices, and products that are not presently considered part of conventional medicine, 
has been on the rise in recent years. Examples of conventional CAM, according to 
Thompson and Eriator, are prayer, acupuncture, massage therapy, meditation, and 
relaxation techniques such as breathing exercises, guided imagery, and progressive 
muscle relaxation. However, SCD patients who attempt to use CAM encounter many 
challenges, such as lack of access to these methods, as well as to third parties or 
insurance to cover CAM costs (Thompson & Eriator, 2014). 
In the past, most of the therapy employed for SCD patients involved palliative 




treatment regimens such as self-care management and lifestyle modification. Matte et al. 
(2019) claimed that the major objectives of therapeutic strategies targeting sickle cell 
vasculopathy are to reduce or prevent vascular endothelial activation and damage. When 
conducting the data collection and analysis for the pretest trial, one of the themes that 
evolved was healthful eating, patients taking good care of themselves, and using dietary 
supplements such as folic acid daily. According to an SCD patient who participated in 
data collection for the current study by filling out a questionnaire and participating in an 
unstructured interview, the frequency of her pain crisis had decreased over the past 4 
years as she began eating a healthier diet (Hagan Asamoah, 2019). 
Problem Statement 
SCD is an inheritable blood disorder that mostly affects people of African, Asian, 
Indian, and South American descent, as well as people of Middle Eastern regions (CDC, 
2020b). SCD affects millions of people globally and about 70,000 to 80,000 individuals 
in the United States (USDHHS, 2020). The disorder has an estimated prevalence of 1 in 
every 500 African Americans and 1 in every 1,000 to 1,400 Hispanic Americans in the 
United States (USDHHS, 2020).  
Pain crisis can negatively impact the daily activities of SCD patients in diverse 
ways, such as missed school days and workdays, high hospital bills, fear, stress, 
depression, other mental disorders, and social isolation. The management of this chronic 
pain has been approached primarily with palliative treatment, using mainly opioid 
analgesics. Thus, Booker et al. (2006) posited that the nature of SCD pain is poorly 




have reported dissatisfaction with healthcare providers’ lack of empathy and inadequate 
management of chronic SCD pain (Booker et al., 2006). This dissatisfaction has led to 
mistrust toward physicians and hence patients’ unwillingness to communicate their true 
feelings due to fear of not receiving optimal treatment.  
With the current opioid crisis, it has become imperative to explore alternative 
regimens for managing SCD-related pain to decrease dependency on opioid analgesics. In 
the quest to explore alternative treatment options for pain relief, it is critical to gather 
information on the perspectives of members of the SCD community. The prescribing 
habits or attitudes and neglect of SCD patients by healthcare providers (HCPs) and the 
pharmaceutical industry, respectively, also need to be understood. It is also necessary to 
gain insight into why HCPs treating SCD patients select options such as opioid analgesics 
when there seem to be better treatments such as hydroxyurea, Endari, and acupuncture, 
among others. In this study, I sought to address these gaps in the literature. This study’s 
aim was to explore alternatives to orthodox opioid analgesics as therapies for SCD-
related pain, with a focus on therapies that have the potential to reduce the frequency of 
pain crisis and the number of hospitalizations.  
As Neville and Panepinto (2011) posited, there are few treatment options to 
prevent the development of most SCD symptoms, especially painful vaso-occlusive 
symptoms. These authors stated that for decades, the norm has been to manage SCD 
symptoms mainly with traditional supportive care measures such as aggressive hydration, 
anti-inflammatory medications, and narcotic analgesics. Matte et al. (2019) thus 




various pathophysiology’s associated with the disease. There is a need to explore both 
pharmaceutical treatments and nonpharmaceutical therapies/coping mechanisms such as 
acupuncture, nutrition, massage, prayer, hot pad treatments, music for distraction, 
hydroxyurea, Endari, and low-dose ketamine infusion. “According to Herman and 
Chaudhry (2010), hydroxyurea has the potential to increase the production of fetal 
hemoglobin and to help reduce the pain associated with the vaso-occlusive crisis" (para. 
6). Palm et al. (2018) also proposed low-dose ketamine infusion as an adjunct analgesic 
agent in patients with vaso-occlusive episodes, especially those who continuously report 
severe pain despite high-dose opioid therapy and experience opioid-induced adverse 
effects. The newly approved voxelotor (GBT-440) resembles an oral direct antisickling 
agent, which can be beneficial in SCD as it blocks HbS intermolecular contacts, 
preventing the generation of HbS fibers and red cell sickling (Matte et al., 2019). Vitamin 
D has the potential to reduce the number of pain days in SCD patients and enable them to 
achieve higher physical activity quality‐of‐life scores (Osunkwo et al., 2012).  
With all of these evidence-based alternative therapies available, it is somehow 
ironic that HCPs prescribing treatments for SCD pain limit their options mainly to opioid 
analgesics, irrespective of their adverse effects. Interestingly, the cost and side effects of 
these analgesics and hydroxyurea are almost the same. Most of the coping strategies that 
patients can use to address pain, such as mindfulness, distraction, massage, diet, and hot 
water pad treatment, do not necessarily incur costs. Therefore, there is a need to 
understand why SCD prescribers do not recommend or prescribe such strategies for their 




habits of their HCPs in managing pain and their knowledge of and interest in alternative 
therapies were of paramount importance in this study. Through this study, I sought to fill 
a gap in the literature by attempting to understand the prescribing habits of HCPs treating 
SCD patients, assess the awareness and experiences of SCD patients concerning the use 
of alternative regimens, and understand SCD patients’ perceptions of employing 
alternative regimens for pain relief. 
Purpose 
The primary purpose for undertaking this study was to explore pain management 
choices for SCD patients with the aim of creating awareness of and promoting alternative 
treatment regimens among SCD patients and their parents/caretakers. These alternative 
treatment options were explored with the intent of identifying and promoting therapies or 
strategies that have the potential to decrease SCD patients’ dependency on opioid-based 
analgesics. The focus was principally on therapies that are capable of reducing the 
intensity, frequency, and duration of pain crisis episodes; associated comorbidities; 
emergency room visitations; and hospitalizations.  
The study findings may help in gaining insight into the perceptions of SCD 
patients and their parents/caretakers on the prescribing habits or practices of SCD HCPs, 
as well as the challenges and experiences that SCD patients encounter as they seek pain 
relief. According to Shet and Thein (2019), gaps or lapses in providing resources and 
adequately equipping HCPs with the required skills lead to various challenges in 
providing effective management for the newly increased population of SCD patients. 




employ such natural approaches as heat, massage, or phytochemicals from vegetable and 
fruit juices, while others use alternative therapies due to fear of side effects associated 
with orthodox treatment.  
This study makes a unique contribution to the literature by promoting greater 
understanding of the prescribing habits of SCD HCPs, assessing SCD patients’ awareness 
of alternative therapies, analyzing the perceptions and experiences of patients regarding 
the use of alternative regimens, and educating patients about their right to request other 
treatment options from their HCPs. I used the qualitative method, employing interviews 
to understand the prescribing habits of SCD HCPs and explore the perceptions and 
experiences of SCD patients and their parents/caretakers on the use of alternative 
regimens. 
Significance 
Currently, the standard treatment option for SCD pain crisis is the use of opioid-
based analgesics, which can be very addictive. This approach is contrary to “the 
pharmaceutical companies’ reassurance in the 1990s to the medical community that 
patients would not become addicted to opioid pain relievers” (U.S. Department of Health 
and Human Services [USDHHS], n.d.). The HHS declared opioid use a public health 
emergency in 2017. A five-point strategy has been developed to combat the opioid 
epidemic, which makes it critical to explore and employ alternative treatment options for 
SCD patients (USDHHS, n.d.). This study may advance this effort by shedding more 
light on why SCD practitioners choose less effective opioid treatments when they have 




The study may also assist in examining SCD patients’ and their 
parents/caretakers’ awareness about the availability of other regimens, as well as in 
promoting these regimens and then empowering and educating patients about their right 
to request these alternative therapies during hospital visits. The findings of the study may 
be used to recommend appropriate strategies and alternative therapies for proper 
management of SCD pain crisis. Some of the social injustices and the racial and health 
disparities that SCD patients face as they seek treatment for pain were also investigated.  
This investigation was geared toward improving health status, living standards, 
and life expectancy (quality of life [QOL]) for SCD patients and their parents/caretakers. 
Consequently, the expected outcomes of the study were to effect positive social change 
by improving the living conditions of SCD patients through better pain management 
strategies, enhance SCD practitioners’ prescribing habits, and promote measures to 
prevent or reduce the frequency of pain episodes. The study findings showcase the 
prescribing habits of SCD HCPs and the perceptions of SCD patients and their 
parents/caretakers on the nature of pain relief strategies and alternative regimens for pain 
management. 
Framework (Conceptual or Theoretical) 
The health belief model (HBM), transtheoretical model (TTM), and 
biopsychosocial-spiritual model of chronic pain (BPS-Spiritual) were combined to form 
the theoretical/conceptual framework that guided this research. The HBM postulates that 
individuals will decide to do a health screening for a health condition if they are made 




risk of the condition, if they deem it beneficial to do the testing, and if the barriers to 
testing are low or manageable (Gustafson et al., 2007). HBM constructs may thus be 
applied in educating the SCD community about a patient’s perceived susceptibility to and 
the severity of prescription drug abuse or overdose, specifically regarding opioid 
analgesics with time and hence the need to explore alternative regimens emphasizing the 
effectiveness and benefits of these alternative therapies. Strategies to activate readiness 
and enhance the SCD community with self-efficacy to embrace alternative regimens such 
as coping strategies and disease-modifying agents (e.g., hydroxyurea and Endari) for 
better pain management may be explored and promoted using the HBM constructs.  
The TTM may also be employed to change patients’ perceptions about trying 
alternative regimens rather than orthodox prescribed analgesics that have traditionally 
been used. As Jensen et al. (2000) noted, “Patients’ readiness to adopt new beliefs and 
coping responses to pain may predict response to multidisciplinary or cognitive-
behavioral pain treatments that emphasize changes in beliefs and coping behaviors” 
(para. 1). TTM constructs may be used to empower SCD patients to adopt behavioral 
changes or lifestyle modifications, including specific diets (e.g., alkaline diets), healthy 
eating habits, coping strategies, self-care management, and self-awareness/mindfulness, 
among others. Such strategies are expected to help patients manage pain better. The BPS-
Spiritual model involves a holistic approach as it embraces the whole person, 
encompassing the biological, psychological, sociological, and spiritual aspects of the 
individual (Taylor et al., 2013). By integrating the constructs of the TTM, BPS-Spiritual, 





RQ1.  What are the experiences of the SCD patients or their parents/caretakers 
regarding the current prescribing habits of their HCPs to manage SCD 
pain, and how do they influence their choice of treatment? 
RQ2.  What are the experiences and attitudes of the SCD patients or their 
parents/caretakers toward alternative treatment methods, and how do they 
influence their choice of treatment? 
RQ3.  What is the stage of readiness for adopting alternative treatment methods 
for SCD patients or their parents/caretakers? 
RQ4.  How does disease perception among adult SCD patients or their 
parents/caretakers impact their willingness to try alternative treatment 
methods?  
Nature of the Study 
This study was qualitative, with a case study design using narrative accounts from 
interviews with participants. Patients were interviewed to assess their knowledge or 
awareness of alternative therapies and get their perceptions of using such therapies. 
Interviews were also used to understand and learn about the diverse strategies that SCD 
patients are using to cope with pain, especially as the first line of defense to manage pain 
even before they make it to a healthcare facility. Physicians were interviewed to find out 
whether they encouraged or recommended other coping strategies to their patients, 
especially self-care management, lifestyle modifications, and praying, and how effective 




were interviewed on what their general prescribing habits or choices were and why they 
adopted those habits or choices over others.  
Case studies may be used to compare the effectiveness of different treatment 
options by analyzing the experiences of participants who use alternative treatment 
options against those of patients who do not. Guided by the critical research questions, I 
used the qualitative approach in designing a thorough pain, psychological, and self-
management needs assessment for study participants to be administered through 
interviews and surveys. The study employed both descriptive and analytical processes, 
with interviews and questionnaires/surveys serving as data collection tools. Hence, the 
research design that was employed for this study was qualitative case study. According to 
Tetnowski (2015), a case study research design is a valuable tool for answering complex, 
real-world questions. This rendered it the appropriate design to use for this study in 
which I explored alternative treatment options, which can be deemed a “real-world” 
challenge for the SCD community. 
Possible Types and Sources of Data 
Both primary and secondary data sources were considered for this research study. 
Semistructured interviews (which were mainly phone interviews, given social distancing 
practices due to COVID-19) and surveys were administered with selected participants to 
determine the methods that they were currently employing for pain relief and their 
effectiveness based on members’ experiences. Secondary data from previous studies and 
other accredited organizations such as CDC and WHO, as well as online support group 




expectation that there might be live interviews and that human participants might thus be 
used in collecting data for this study, I contacted the Institutional Review Board (IRB) to 
determine essential procedures to be followed and the ethical considerations or 
requirements that must be met. A purposeful sampling technique was employed to recruit 
participants for the study.  
Definitions 
Gene mutation: “A permanent alteration in the DNA sequence that makes up a 
gene, such that the sequence differs from what is found in most people” (USDHHS, 
2020, p. xx).  
Point mutations: A broad category of mutations that describe a change in a single 
nucleotide of DNA, such that the “nucleotide is switched for another nucleotide. The 
nucleotide may also be deleted, or a single nucleotide is inserted into the DNA that 
causes that DNA to be different” from a typical or wild type gene sequence (National 
Human Genome Research Institute, n.d.). 
Pain crisis: An event in which the patient reports pain that is severe, uncontrolled, 
and causes distress for the patient, family members, or both” (Moryl et al., 2008). SCD 
pain crisis consists of chronic, intermittent, and unpredictable episodes of pain associated 
with the vaso-occlusive crisis (VOC) that usually sends SCD patients to the emergency 
room. Pain crisis may result in the interruption of blood flow to tissues due to clogging of 
blood vessels, leading to pain, acute chest syndrome, stroke, priapism, and chronic organ 
damage. 




sickled RBCs causing ischemic injury to the organ supplied, resulting in excruciating 
pain. 
Hydroxyurea: An inhibitor of DNA synthesis and an antimetabolite that is used to 
treat chronic and acute myelogenous leukemia and polycythemia vera, and that is used to 
increase the concentration of fetal hemoglobin in patients with SCD.  
SCD community: Consists of healthcare practitioners (physicians, nurses, 
dieticians, and other HCPs) of SCD patients, their parents/caregivers, and other 
stakeholders. 
Target/study population: Adult SCD patients and SCD patients’ 
parents/caregivers. 
Coping: A person’s cognitive and behavioral efforts in response to stressors that 
determine how those stressors will affect physical and emotional well-being (Lazarus & 
Folkman, 1984; Litt & Tennen, 2015). 
Coping strategies: Psychological patterns that individuals use to manage 
thoughts, feelings, and actions encountered during various stages of ill health. These may 
include information seeking, self-management, catastrophizing, and wishful thinking. 
Describe the extent to which individuals cope well with their pain, which may influence 
the quality of life.  
Self-management: The decisions and behaviors that patients with chronic illness 
engage in that affect their health, including the care and encouragement provided to 
people with chronic conditions and their families to help them understand their central 




behaviors (Group Health Research Institute, n.d).  
Spirituality/religiosity: Spirituality is a personal belief in God or a Higher Power, 
which may receive expression through individual prayer, meditation, and meaning in self. 
In contrast, religion is defined as involving organizational beliefs or adherence to 
institutionally based belief systems or dogma (Arrey et al., 2016, para. 6). 
Mindfulness: Described as a simple mental activity with the potential to reduce 
pain and the need for pain medication. It also increases the ability to regulate pain, 
emotion, and behavior mentally; alters the way in which the brain processes rewards; 
restores positive feelings; can be learned in a class or at home; and is an accessible 
alternative for managing pain (Voss et al., 2019). 
Pain management: A broad and multidisciplinary approach that addresses 
physical, psychosocial, and spiritual dimensions (Brennan et al., 2019).  
Opioid analgesics: Commonly referred to as prescription opioids, medications 
that have been used to treat moderate to severe pain in some patients. Examples are 
morphine, codeine, oxycodone, hydrocodone, tramadol, and fentanyl (CDC, 2021).  
Opioid crisis: Devastating consequence of the opioid epidemic, which has 
resulted in increases in opioid misuse and related overdoses (HHS, n.d.). 
Opioid dependence: Occurs when “the body adjusts its normal functioning around 
regular opioid use,” which may result in unpleasant physical symptoms when the 
medication is stopped (CDC, 2021, p. xx). 
Perceptions: Immediate or intuitive recognition or appreciation of moral, 




or consciousness; the process, act, or faculty of perceiving (Dictionary.com, 2020). 
Assumptions 
 There are a few assumptions that were addressed in this study. First, there was an 
assumption that SCD HCPs do not usually prescribe or recommend alternative therapies 
for their patients because of a lack of awareness and knowledge about the efficacy of 
these other therapies. Additionally, it was assumed that the SCD patients and their 
families would quickly embrace the concept of alternative treatment regimens for pain 
because of the current opioid crisis and all of the stigma and inconvenience associated 
with opioid analgesics. Moreover, I assumed that members of the SCD community would 
perceive exploring alternative treatment options as a step in the right direction. It was 
also assumed that patients and their families had substandard experiences with managing 
SCD-associated pains using the current treatment option, which justified the need to 
explore alternative options. 
Scope and Delimitations 
 The primary purpose of this study was to conduct research into alternative 
treatment options for SCD pain management and patients’ perceptions and experiences 
about such regimens. The scope of the study thus defined the parameters or boundaries 
under which the study was conducted, which implied taking into account the sample size, 
target population, time, and geographic area. For instance, I planned to recruit about 20-
25 study participants in order to attain saturation or gather enough information to be able 
to draw a valid conclusion after the collected data had been analyzed.  




and define the boundaries of a study, with examples being the choice of objectives, the 
research questions, variables of interest, theoretical perspectives that the researcher 
adopts, and target population. This study was delimited to SCD patients or their 
parents/caretakers who were at least 14 years of age and could easily communicate in 
English, preferably, or in Twi, an African dialect that I speak fluently. Delimitations also 
determine the criteria for participant recruitment, the profession or organizations to 
involve, unique characteristics of the sample/population, the philosophical framework, 
methodology, and variables in the study that set the boundary base on which the findings 
can be established (Simon, 2011). For instance, because of the specificity of the disease, 
only people who had knowledge of or experience with SCD or the subject matter were 
recruited to participate in the study.  
As this was a qualitative study, the initial data collection tools were going to be 
face-to-face interviews or a focus group. However, because of social and physical 
distancing regulations due to COVID-19, the data collection tools were delimited to 
mainly phone interviews, emails, video conferences or calls, texting, and messaging 
using various social media platforms. 
Limitations, Challenges, and/or Barriers 
Time management was a significant challenge, so strategies for effectively 
allotting specific and adequate time each day to work on the dissertation amidst other 
activities or responsibilities needed to be developed. I also anticipated that financial 
constraints would be encountered in covering all of the expenses that were accrued with 




other logistics necessary for the study.  
The stigmatization associated with the SCD condition and community in terms of 
longevity, morbidities, the claim of prescription drug abuse, restrictions in terms of 
partner choices, and other social limitations deters many SCD patients or their families 
from disclosing the condition. I expected that such stigma might serve as a significant 
barrier to the data collection process. Moreover, correctly transcribing the collected data 
might also pose a challenge, given that transcription is known to be time consuming and 
labor intensive. I anticipated that social and physical distancing measures due to COVID-
19 might place some restrictions on the data collection tools that could be used. 
Summary 
SCD is described as an inherited “blood disorder in which abnormal red blood 
cells damage the cerebrovascular system as well as organs such as the liver and spleen” 
(Scott & Scott, 1999, p. 1). The hemoglobin of SCD patients is defective, so red blood 
cells tend to cluster together and form long, rod-like structures that become stiff and 
assume sickle shape after they give up their oxygen (WHO, 2016). This is the reason for 
the excruciating pain, comorbidities or health complications, and numerous 
hospitalizations associated with the condition.  
In the United States, SCD affects around 72,000 people, most of whose ancestors 
came from Africa (WHO, 2016). SCD occurs in nearly 1 in every 500 African American 
births and 1 in every 1,000 to 1,400 Hispanic American births, while 1 in every 12 
African Americans carries the sickle cell allele (WHO, 2016). SCD has a 10% mortality 




SCD children averaged $11,702 dollars for those with Medicaid coverage and $14,772 
dollars for those with employer-sponsored insurance, with about 40% of both groups 
having at least one hospital stay that year (CDC, 2016). 
SCD is marked by frequent pain episodes and severe conditions such as chronic 
anemia, fatigue, anxiety, depression, pulmonary hypertension, respiratory infections, 
urinary tract infections, chronic arthritis, and necrosis, as well as neurophysiological 
conditions such as strokes, seizures, and cognitive and psychological problems. Hospital 
stays are frequent for SCD patients due to the severity of most of the health conditions 
associated with the disorder. SCD patients are at high risk of being misunderstood and 
misdiagnosed. SCD does not get the high-profile attention that other illnesses receive, 
even though it is a critical health condition. Scott and Scott (1999) thus suggested the 
need for continued research and public awareness on SCD. Pain crisis and VOC are the 
clinical hallmarks of SCD, and for years these pains have been managed through 
palliative care using mostly opioid analgesics. With the current opioid crisis, it has 





Chapter 2: Literature Review 
SCD is a genetic blood disorder that affects the hemoglobin (Hob) within red 
blood cells (RBCs; WHO, 2006). SCD is associated with recurrent pain and 
complications that are capable of interfering with many aspects of the patient’s life, 
including education, employment, and psychosocial development (WHO, 2006). People 
with SCD have RBCs containing an abnormal form of the oxygen-carrying protein 
hemoglobin S (WHO, 2006). As WHO (2006) explained, “Children who inherit the 
sickle-cell genes from both parents will develop the sickle-cell disease (SCD), while 
those who inherit the gene from only one parent will have the sickle-cell trait (SCT)” (p. 
1). CDC (2020) has characterized SCD as a significant public health concern and is 
working toward raising awareness about the disease. 
Neville and Panepinto (2011) noted that the incidence of SCD is higher than that 
of most other severe genetic disorders such as cystic fibrosis and hemophilia. Globally, 
there are approximately 300,000 SCD births annually, with about 10% to 40% of the 
population in most African countries carrying the sickle-cell gene, resulting in an 
estimated SCD prevalence of at least 2% (American Society of Hematology [ASH], 
2016). According to USDHHS (2020), most people with SCD are of African ancestry or 
identify themselves as Black. However, there are also many people with SCD who come 
from Hispanic, southern European, Middle Eastern, or Asian Indian backgrounds. 
USDHHS (2020) reported that there are about 100,000 Americans who have the disease, 
with about 1 in 13 Black or African American babies born with sickle cell trait (SCT) and 




among Hispanic American births is about 1 out of every 16,300 (CDC, 2020).  
Pain management is one of the major challenges for SCD patients. This case study 
was undertaken to explore alternative regimens that offer better pain management than 
traditional opioid treatment. In this chapter, I will present a thorough review of existing 
literature on such treatment options. This chapter includes a description of strategies 
employed to review the literature, a synopsis of the literature on the various treatment 
therapies investigated, a discussion of the conceptual and theoretical frameworks on 
which the study was grounded, and a summary of the findings of the literature review. 
Literature Search Strategy 
Relevant published articles were comprehensively searched for using Walden 
University Library’s electronic database. Several search engines were used to locate 
recently published articles on the research topic with interest in those published between 
2010 and 2020. However, it was necessary to make exceptions due to the scarcity of 
articles on the research topic, so the research was based on articles that dated as back as 
far as 1989, with most of the articles that contained information relevant to the research 
questions having been published beginning in the early 2000s. Search engines that were 
effective in retrieving appropriate articles were PubMed, Google Scholar, ProQuest, and 
ScienceDirect. Secondary source data—mainly statistical data and other demographic 
information for the study—were chiefly accessed from the websites of internationally 
acclaimed organizations such as WHO, NIH, ASH, NHLBI, and CDC. 
The key search terms that were used to locate relevant articles for the literature 




opioid analgesics, pain crises, vaso-occlusive events, self-care management, 
spirituality/religiosity perceptions, experiences, coping strategies, nutrition, 
micronutrients, prescribing habits, healthcare practitioners, theoretical framework, and 
qualitative research design. 
Etiology and Epidemiology 
SCD is a genetic disease caused by a gene mutation. Although the mutation is 
claimed to have originated from West Africa, it has become a global health concern due 
to migration or globalization and an increase in interracial marriages (Serjeant, 1997). As 
Serjeant (2013) wrote, “It is … speculated that the Hobs trait is a relatively new mutation 
limited to West Africa where it occurs at high frequencies (> 20%) especially in central 
Ghana and Burkina Faso, and only 2% in Nigeria” (para. 3). Frenette et al. (2019) 
reported that it has been suggested that 
SCD developed from a missense mutation within the β-globin gene leading to the 
substitution of valine for glutamic acid on the outer surface of the globin molecule 
rendering the sickle cell hemoglobin (“HbS”) less soluble and prone to 
polymerization upon deoxygenating. (para. 4) 
According to USDHHS (2020), mutations in the HBB gene, which provides 
instructions for making beta-globin, cause two of the subunits of hemoglobin to develop 
the various types of SCD. Sundd et al. (2019) hypothesized that a single amino acid 
substitution in the β-globin chain leads to polymerization of mutant hemoglobin S, 
impairing erythrocyte rheology and survival. As Manwani and Frenette (2013) noted, 




causes the encoding of the β-globin subunit leading to polymerization of deoxygenated 
sickle hemoglobin and decreased deformability of RBCs” (p. 1). Further, Manwani and 
Frenette explained, “There is a complex interplay of adhesive events among blood cells 
that can obstruct the vasculature, producing episodes of pain, hemolytic anemia, organ 
injury, and early mortality” (p. 1).  
SCD is inherited in an autosomal recessive pattern (USDHHS, 2020). Thus, both 
copies of the gene in each cell have mutations. This implies that the parents of an 
individual with the autosomal recessive condition must each carry one copy of the 
mutated gene, even though they may not show any signs or symptoms of the condition. 
As USDHHS (2020) explained, the abnormal versions of beta-globin can distort RBCs 
into a sickle shape, which can lead the cells to die prematurely, precipitating anemia. 
These inflexible, sickle-shaped cells can also get stuck or clogged in small blood vessels, 
which can result in serious medical complications (USDHHS, 2020), a typical example 
being the SCD pain crisis. USDHHS (2020) described the main types of SCD as 
hemoglobin Sβ0 thalassemia, Sβ+ thalassemia, SC, SD, SE, and SS. 
According to the USDHHS (2020) at least one of the two abnormal genes causes 
a person’s body to make hemoglobin S in each of the various types. The most common 
and severe type is sickle cell anemia, whereby the person has two hemoglobin S genes 
(i.e., hemoglobin SS; USDHHS, 2020.). The two other common types are the hemoglobin 
SC disease and hemoglobin Sβ thalassemia, with hemoglobin SD and hemoglobin SE 
being much less common (USDHHS, 2020). Other people, usually referred to as carriers, 




also have one normal gene, have normal RBCs. CDC (2020) asserted those with only one 
mutated gene, called the SCT, obtained one sickle cell gene (“S”) from one parent and 
one normal gene (“A”) from the other parent. These individuals usually do not exhibit 
any of the signs of the disease and live a healthy life, but they can pass the trait on to their 
children and may also have a few uncommon health problems that may be attributed to 
the SCT (CDC, 2020). 
According to CDC (2020), SCD patients usually start to have signs of the disease 
during the first year of life, usually around 5 months of age. Early signs and symptoms of 
SCD include swelling of the hands and feet, anemia, fatigue or extreme tiredness, 
jaundice, infections, and delayed growth, with episodes of pain crisis evolving with time 
(USDHHS, 2020). Karafin et al. (2019) claimed that chronic pain is prevalent in SCD, 
with 30% of patients experiencing daily pain while 50% meet the criteria for chronic pain 
syndrome. These researchers proposed that SCD patients have synaptic changes in the 
central nervous system (CNS) that may contribute to the pathogenesis of chronic pain 
based on their study findings (Karafin et al., 2019). The disease can also result in other 
complications affecting the patient’s spleen, brain, eyes, lungs, liver, heart, kidneys, 
penis, joints, bones, or skin as the years progress.  
SCD is claimed to be a lifelong illness, but the severity of the disease varies 
widely from person to person (USDHHS, 2020). Some patients may experience both 
acute and chronic signs, symptoms, and complications (USDHHS, 2020). The acute pain 
episodes or crises, which are described as sharp, intense, stabbing, or throbbing in their 




They can occur without warning when sickle cells block blood flow and decrease oxygen 
delivery (USDHHS, 2020). The pain crisis is one of the main reasons that SCD patients 
have frequent hospital visits or hospitalizations.  
Clinical Manifestations or Pathophysiology of Sickle Cell Disease 
SCD is associated with various complicated clinical manifestations. The ASH 
(2016) has stated that the severity of the numerous complications associated with SCD 
can render every stage of life extremely difficult and a challenge for patients. Shet and 
Thein (2019) asserted that in developed countries, the burden of disease has now shifted 
to adults with SCD as the disease has evolved into a debilitating condition with numerous 
complications associated with long-term chronic diseases coupled with all of the 
comorbidities that are attributed to aging. 
According to CDC (2020a), SCD patients usually start to exhibit signs of the 
disease during the first year of life, usually around 5 months of age, with the symptoms 
and complications of the disease being different for each person, ranging from mild to 
severe. CDC (2020) asserted that SCD infants do not show symptoms at birth because of 
how baby or fetal hemoglobin protects RBCs from sickling. This characteristic seems to 
degenerate when the infant is around 4 to 5 months of age, resulting in the baby or fetal 
hemoglobin being replaced by sickle hemoglobin, at which point the cells begin to sickle 
(CDC, 2020). Thus, SCD is described as a disease that worsens over time (CDC, 2020). 
The Physicians Committee for Responsible Medicine and Unbound Medicine (PCRM, 




weak linear growth, lean body mass, and reduced fat-free mass. Some of the common 
complications of SCD outlined by CDC (2020) are as follows:  
• Pain episode or crisis: The main reason that most SCD patients go to the 
emergency room or hospital. These pain crises occur when sickle cells 
traveling through small blood vessels get stuck and clog the blood flow. This 
results in pain that may range from mild to severe, which starts unexpectedly 
and can last for any length of time. According to the Sickle Cell Data 
Collection (SCDC, n.d.) program, in California, people with SCD seek care in 
the emergency department an average of 3 times per year from their late teens 
to their late 50s.  
• Hand-foot syndrome: An early symptom of SCD characterized by swelling in 
the hands and feet. May also present with a fever, which is claimed to be 
caused by the sickle cells getting stuck in the blood vessels and blocking the 
flow of blood in and out of the hands and feet. 
Painful vaso-occlusive events are the most common complication experienced by 
both children and adults with SCD. As Sundd et al. (2019) reported, “Erythrocyte 
abnormalities in SCD patients clinically manifest as hemolytic anemia, cycles of micro 
vascular vaso-occlusion leading to ischemia-reperfusion injury, infarction with VOC 
events and intravascular hemolysis promoting inflammation and redox instability” (para. 
1). Moreover, SCD may result in continuous small- and large-vessel vasculopathy and 
molecular, cellular, and biophysical processes that can cause acute and chronic pain and 




characterized “recurrent and unpredictable episodes of vaso-occlusion” as “the hallmark 
of SCD” (p. 1). HbS induces RBC membrane damage because of the cells’ deformed 
shape.  
This leads to calcium influx into the cell which may cause crosslinking of the 
membrane proteins activating channels that allow for the efflux of potassium and 
water from the cell thereby causing RBC dehydration worsening the sickling 
which may triggers VOC crisis. (Herman & Chaudhry, 2010, para. 2)  
Thus, obstruction of the RBCs may develop, reducing blood flow to the vital organs and 
triggering ischemia, necrosis, and pain (Herman & Chaudhry, 2010).  
Pain crisis is also claimed to result from damaged blood vessels, which become 
irritated, activating molecules in the blood called selectins, also known as “sticky factors” 
(Novartis Pharmaceuticals Corporation, 2019). These sticky factors are known to cause 
blood cells to stick to blood vessel walls and to each other (Novartis Pharmaceuticals 
Corporation, 2019). As more blood cells get sticky and adhere to each other and vessel 
walls, they form clusters in the bloodstream, in a process termed multicellular adhesion 
(Novartis Pharmaceuticals Corporation, 2019). These clusters build up and become 
blockages, making it difficult for blood and oxygen to flow generally in the vessels; this 
process is known as vaso-occlusion (Novartis Pharmaceuticals Corporation, 2019). When 
the blood cell clusters get more prominent, they result in episodes of sudden, 
unpredictable, and intense pain called pain crises or VOC (Novartis Pharmaceuticals 
Corporation, 2019). Bone infarction, necrosis, as well as bone marrow degeneration 




Herman and Chaudhry reported, it has been claimed that “pain episodes can affect any 
bone marrow-containing structure such as the ribs, sternum, vertebral bodies, and skull” 
(p. 2). The life-threatening complications of bone marrow infarction in SCD patients 
include pulmonary fat embolism and acute chest syndrome (ACS). 
Leger et al. (2018) pointed out that “SCD patients experience poor health-related 
quality of life (HRQOL), inadequate coping, and poor self-care management skills when 
compared to other chronic conditions that trigger episodic care leading to poor health 
outcomes” (p. 24). Further, Leger et al. noted, “SCD pains and other associated 
complications can negatively impact the physical, social, emotional, psychological, and 
spiritual domains as well as the level of self-efficacy, sufficiency, and sleep quality of 
affected patients and their family members” (p. 24). Other complications such as silent 
strokes can cause cognitive deficits, which can significantly impact the daily living 
activities of SCD patients, including disease management (Leger et al., 2018). According 
to Setty et al. (2003), nocturnal oxyhemoglobin desaturation contributes toward CNS 
complications associated with SCD and high rates of painful crises. “SCD is described as 
a hemoglobinopathy characterized by hemolytic anemia, increased susceptibility to 
infections, damages to organs and VOC” (Nur et al., 2011, p. 1). SCD leads to reduced 
QOL and life expectancy, with oxidative stress deemed responsible for most of these 
pathophysiologies (Nur et al., 2011). Other health challenges that SCD patients usually 
battle include fatigue, functional limitations, emotional effects, exhaustion from sleep 
deprivation, stress, and depression, which can affect their pain coping skills, self-care 




Encapsulated bacterial infections may present as splenic sequestration of sickle 
cells resulting in splenic congestion, as manifested by splenomegaly and reduced immune 
function (Herman & Chaudhry, 2010, para. 2). “SCD patients are thus more prone to 
getting bacteremia with pathogens like Streptococcus pneumonia, Haemophilus 
influenzae, and Neisseria meningitides which may result in life-threatening sepsis” 
(Herman & Chaudhry, para. 2). Pulmonary and cardiovascular complications are 
common health challenges in the SCD community. According to Herman and Chaudhry , 
neurological complications such as strokes and silent strokes are common with SCD-
VOC and ACS, which may present with fevers, infarction, pulmonary fat embolism, 
hypoxia, and chest pains. Myocardial infarction may also happen due to VOC of the 
coronary arteries, and occasionally right ventricular (RV) dysfunction may develop due 
to pulmonary arterial hypertension in SCD patients (Herman & Chaudhry, 2010, para.2). 
Hemolysis is also another common clinical complication associated with SCD because of 
how mechanically weak the sickle cells are, according to Herman and Chaudhry. These 
authors also declared that when inflexible cells are trapped in the spleen and get 
phagocytized by the reticuloendothelial system, extravascular hemolysis results, causing 
a reduction in the red cell survival time. Herman and Chaudhry posited that a normal 
RBC survives for an average of 90-120 days, whereas a sickle cell survives for only 10-
20 days. The sickle cell causes increased hemolysis complications as cholelithiasis due to 
excessive bilirubin production (Herman & Chaudhry, 2010). 
Amer et al. (2006) posited that oxidative stress also plays a significant role in 




bacterial infections, and VOC incidences in SCD. The oxidative stress of SCD‐RBC is 
attributed to the inherent instability of HbS and the high concentrations of iron and iron‐
containing compounds, such as haemin and Hob, in the plasma of the patients due to 
hemolysis and blood transfusions (Amer et al., 2006). According to Silva et al. (2013), 
sickle erythrocytes might be the trigger for multiple sources of reactive species, and SCD 
is intimately linked to chronic and systemic oxidative stress. These may require 
antioxidant therapies, which are deemed promising approaches for SCD treatment as they 
may constitute valuable means for preventing or delaying the development of organ 
complications. Edwards et al. (2005) also declared that the tissue damage associated with 
SCD increases patients’ risk for other medical complications such as delayed growth and 
sexual maturation, acute and chronic pulmonary dysfunction, stroke, aseptic necrosis of 
the hip and shoulders, retinopathy, dermal ulcers, and severe chronic pain. 
In general, SCD patients who transition from recurrent, acute pain to chronic, 
persistent pain may end up with more significant QOL impairment and higher rates of 
healthcare utilization (Matthie et al., 2019). Elander et al. (2003) observed that SCD 
patients with pain-related symptoms usually experience impaired activities and 
psychological disturbance than those with non-pain-related symptoms. Taylor et al. 
(2013) claimed the “BPS model of SCD pain can be used to hypothesized three 
categories of variables which are disease-related, psychosocial, a readiness that acts 
together overtime to explain the response to pain such as disability, distress, healthcare 
utilization in SCD" (Smith et al., 2005, para.9). These authors stated some of the disease-




complications and comorbidities, treatment variables (e.g., hydroxyurea, opiates, 
antidepressants), and pain location (Taylor et al., 2013). 
Conditions That Trigger Pain Crisis 
Examples of such conditions are extreme temperatures unusually cold and hot 
weather or conditions, high altitude, illness, physical and psychological stress, 
temperature changes, dehydration, or not drinking enough fluids, infections, pregnancy, 
alcohol, low oxygen tension, and extreme physical exercises or exertion. 
Impact of the Opioid Crisis on Sickle Cell Disease Patients 
The emerging opioid crisis has taken a significant toll on most people who suffer 
from chronic pain. However, the community most impacted by this crisis is SCD patients, 
thus making it necessary to employ alternative regimens. Ezenwa et al. (2016) claimed 
that SCD patients are also more likely to be accused of drug-seeking behavior and are 
directly or indirectly called drug addicts as compared to other populations with chronic 
pain. According to Su et al. (2019), opioids remained the most frequently prescribed 
medications for SCD, and there have been no significant changes over time in opioid 
prescribing. "Nevertheless, there is also evidence that SCD patients on chronic opioid 
therapy as a primary management strategy experience greater pain, poorer functional 
outcomes, and higher healthcare utilization than those who are not on opioids" (Matthie 
et al., 2019, p.1). Such patients also have a new challenge to deal with the increasing 
restrictions on opioid access due to the current opioid epidemic in the U.S. (Matthie et al., 
2019). Sinha et al. (2019) conducted a qualitative study using a semistructured interview 




opioid prescriptions had become more restrictive, more closely monitored, and 
increasingly challenging to fill in pharmacies of late (Sinha et al., 2019). The participants 
also reported increased stigmatization about opioid use and how their medical care was 
being affected by the physician's exclusive focus on reducing pain medication use (Sinha 
et al., 2019). Based on the experiences of the participants as deduced from the research 
findings, the opioid epidemic has negatively affected patients' care by increasing barriers 
to access to opioids and decreased opioid dosing. In contrast, they still have to deal with 
the challenge of the lack of access to alternative therapies (Sinha et al., 2019). The 
researchers observed an emerging interest among the patients to use alternative therapies 
such as marijuana to manage their pains (Sinha et al., 2019), confirming how critical it is 
to explore alternative therapies.  
Elander et al. (2003) posited that there is not enough evidence about substance 
dependence among SCD patients even though there are concerns about dependence on 
prescribed analgesia, which may compromise pain management. "Pain-related symptoms 
can be an indicator of how the pattern of frequent acute pain in SCD may make patients 
vulnerable to perceptions of drug dependence whereas non-pain-related symptoms depict 
more stringently defined dependence on analgesia with SCD" (Elander et al., 2003. para. 
1).  
Pharmacotherapy of Sickle Cell Disease 
For years, one of the primary pain management strategies that have been 
employed for SCD patients has been palliative care treatment. The WHO (2019) defined 




a life-threatening illness like SCD and their families. Palliative care involves employing 
strategies like prevention and relief of suffering using early detection of pain episodes, 
appropriately assessing and treating pain and other problems, as well as enhancing the 
physical, psychosocial, and spiritual aspects of patient care (WHO, 2019). Opioid 
analgesics have been the main pharmaceutical product that has been used in this case. 
Neville and Panepinto (2011) described SCD as a chronic, debilitating disorder with 
multiple symptoms rendering it difficult or challenging to treat. These authors elaborated 
on how there are few treatment options to prevent the development of most of these 
symptoms especially painful VOC. Neville and Panepinto (2011) claimed this is because 
most of these regimens are mainly managed with traditional supportive care measures 
like aggressive hydration, anti-inflammatory, and narcotic analgesics which have been 
the norm for decades. Palm et al. (2018) also confirmed that the primary treatment 
currently employed for these episodes is supportive, using fluids and intravenous opioid 
and anti-inflammatory medication.  
However, Manwani and Frenette (2013) proposed symptomatic management and 
prevention of painful VOC using the fetal hemoglobin–reactivating agent Hydroxyurea. 
This original non-opioid pharmaceutical product seems to have the potential to reduce the 
frequencies of VOC episodes. “It is also suggested that managing the VOC crisis with 
rehydration therapy to reverse the dehydration and hypoxia asserting that rehydration 
allows for increased RBC water and electrolyte uptake” (Herman & Chaudhry, 2010, 
para.6). “Hydroxyurea, which is capable of increasing the production of fetal 




gamma-globin chains reduces the pain associated with VOC as fetal hemoglobin carries 2 
alpha and 2 gamma-globin chains (Herman & Chaudhry, 2010, para.6). Su et al. (2019) 
proposed the need to increase the rate of prescribing of hydroxyurea for SCD children. Su 
et al. (2019) claimed there are safety and efficacy of starting Hydroxyurea in infancy and 
that the rate for prescribing Hydroxyurea for adults remains infrequent and considerably 
lower than opioids.  
Nevertheless, usually, acute SCD painful episodes are managed with morphine 
(an opioid), while the chronic pain is managed using NSAIDs {like Ibuprofen} (Herman 
& Chaudhry, 2010). Transfusions can prevent SCD-related strokes as it reduces sickled 
cells. Also, oral hydration therapy to hydrate RBCs and oral analgesics to manage pain is 
recommended for Priapism, according to Herman and Chaudhry. Palm et al. (2018) also 
proposed low-dose ketamine infusion as an adjunct analgesic agent in patients with VOC 
episodes especially those who continuously report severe pain despite high-dose opioid 
therapy and also experiences opioid-induced adverse effects. These researchers review a 
retrospective case series of five patients admitted to the intensive care unit (ICU) with 
prolonged VOC episodes who were treated with a continuous infusion of low-dose 
ketamine (5µg/kg/min) after insufficient pain control with opioid analgesic therapy (Palm 
et al., 2018). It was observed that these patients experienced a lower reported pain score, 
reduced opioid-induced adverse effects, and decreased opioid dosing requirements with a 
median reduction of 90mg morphine (Palm et al., 2018). Jennings et al. (2013) also 
attested that oral antagonist ketamine has analgesic properties.  




age of 17, or those with prior SCD related organ damage like stroke, acute chest 
syndrome, frequent painful episodes and multiple sites of osteonecrosis (Herman & 
Chaudhry, 2010). According to a randomized control trial conducted by Orringer et al. 
(2001), a Purified Poloxamer 188 used in concomitant with Hydroxyurea for the 
treatment of acute vaso-occlusive crisis resulted in a decrease in the duration of painful 
episodes. 
A newly approved pharmaceutical product, Voxelotor (GBT-440), has been 
developed to inhibit HbS Polymerization, enhance blood oxygen saturation and reduces 
hospitalization-induced VOC crisis (Nwabuko et al., 2019). Matte et al. (2019) also 
described Voxelotor (GBT-440) as an oral direct anti-sickling agent that can be beneficial 
in SCD as it blocks HbS intermolecular contacts, preventing the generation of HbS fibers 
and RBC sickling. Crizanlizumab, another new investigational biologic therapy 
manufactured by Novartis yet to be approved by the U.S. Food Drug Administration 
[FDA], is expected to help in the prevention of VOC or pain crisis (Nwabuko et al., 
2019). 
Physicians Committee for Responsible Medicine and Unbound Medicine, PCRM 
(2019) proposed some preventive strategies as comprehensive and multidisciplinary care 
that should incorporate education of both patient and family to help prevent 
complications of the disease. Other preventive strategies are regularly administering 
influenza, meningococcal and pneumococcal vaccines, and pneumococcal prophylaxis to 
children with SCD until age 5, especially those with a history of splenectomy or severe 




managing infections such as Pneumococcus and Meningococcus infections (Herman & 
Chaudhry, 2010) Also, a daily dose of 1mg Folic acid and an iron-free multivitamin to 
ensure adequate intake of nutrients that are usually deficient in SCD patients is 
recommended by PCRM (2019). Brousseau et al. (2004) observed decreases in the length 
of stay (LOS) during a pain crisis for 19 SCD children admitted at the hospital in a 
single-arm study conducted to determine the effect of intravenous (IV) magnesium 
sulfate on the LOS. 
Challenges That the Sickle Cell Disease Community Faces 
Cyril-Olutayo et al. (2019) proclaimed that the management of SCD had been a 
real challenge since its discovery in 1910 by Dr. Herrick. The CDC (2020) claimed that 
between1989 and 1993; there was an average of 75,000 hospitalizations due to SCD in 
the United States, costing approximately $475 million dollars. The CDC (2020) also 
reported that medical expenditures for children with SCD averaged $11,702 dollars for 
those with Medicaid coverage and $14,772 dollars for those with employer-sponsored 
insurance in 2005. About 40% of children from both groups had at least one hospital stay. 
The American Society of Hematology (ASH, 2016) also asserted on how SCD is 
associated with high treatment costs. An average person with SCD that lives to the age of 
45 may incur a total lifetime health care costs estimated to be about $1 million dollars, 
with annual costs ranging from over $10,000 dollars for children to over $30,000 dollars 
for adults (ASH, 2016). The Agency for Healthcare Research and Quality in 2004 
reported that 83,149 adults were hospitalized for SCD with approximately $488 million 




susceptible or at high risk of having SCD, these costs are a challenge or burden 
considering the financial or socio-economic status of most of these families dealing with 
the SCD condition. 
Multiple follow up and specialty clinic appointments coupled with pain episodes 
which constantly interrupt life activities are the main reasons for stress that leads to more 
absences from work, school, and fear of job loss or class placement is also another major 
challenge (Leger et al., 2018). Most SCD patients may also not have a primary care 
provider or individual health care plan, a cause of depression for them that can affect 
their pain coping skills, self-care management, and quality of life (Leger et al., 2018). 
Preoccupation with their illness may also cause the SCD patient to have poor health 
outcomes from negative medical experience (Leger et al., 2018).  
Patients in some low or middle-income countries or communities may not have 
access to some vital health services like penicillin prophylaxis, broad-spectrum 
antibiotics, healthcare facilities, practitioners, and health insurances (Leger et al., 2018). 
SCD patients also have to deal with the stigma associated with the condition in terms of 
longevity, all the morbidities, the claim of prescription drug abuse, restrictions in terms of 
partner choice, and other social limitations. 
Shet and Thein (2019) asserted that the gaps or lapses in providing resources and 
adequately equipping SCD healthcare practitioners with the required skills lead to various 
challenges in providing effective management for the newly increased population of SCD 
patients. Taylor et al. (2013) claimed that there is a lack of research on the occurrence 




maintained that barriers in access to specialist care remain a challenge for SCD patients. 
Adherence to medication or treatment regimen can be a significant challenge for many 
SCD patients, especially the children. According to Modi et al. (2009), forgetfulness was 
the primary barrier to adherence, and caregiver reminders were the primary strategies 
identified by both caregivers and adolescents, with the adolescents reporting significantly 
more barriers for pain management. Modi et al. (2009) recommended multidisciplinary 
treatment teams to facilitate dialogue with patients and their families about adherence 
barriers and strategies, which is necessary because both caregivers and adolescents seem 
to experience similar barriers and strategies across multiple components of the SCD 
treatment regimen. 
Issues of Healthcare Disparities and Social Justice That Impact the Sickle Cell 
Disease Patient: Understanding Practitioners’ Prescribing Habits 
For years, SCD patients has had limited options for a treatment regimen for the 
management of SCD-related chronic excruciating pains. The mainstream treatment for 
these pains has been with opioid analgesics. Even though there are both pharmaceutical 
and non-pharmaceutical products that SCD-HCPs could have explored for their patients, 
their prescribing habits have been mainly for these opioids- related analgesics 
irrespective of all the stigmas that are associated with them. For instance, hydroxyurea, a 
pharmaceutical product that claims to have the potential to reduce the frequency of these 
pain episodes and its consequent hospitalizations, is rarely prescribed for SCD patients 
even though it has been in the market for more than twenty years. Aside from these 




companies seemed to have neglected the SCD community for so many years and have 
barely been manufacturing any products for this community. For instance, hydroxyurea 
has been the only pharmaceutical product manufactured or approved for SCD for about 
20 years. Stone (2015) asserted that no drugs were approved between 2010 and 2013 for 
the treatment of SCD pain, while five new ones became approved for cystic fibrosis. 
Nwabuko et al. (2019) described SCD as one of the diseases of public health importance 
that requires political, legislative, and cultural attention. These authors asserted that 
legislation on SCD prevention would enable proper auditing, surveillance of the blood 
types of the population for precise mapping, budgeting, and allocation of resources.  
Currently, there is a shortage of SCD practitioners, and there are few 
Oncologists/Hematologist who goes out of their way to show interest in the SCD patient. 
The situation is so bad that for a big metropolis like Dallas/Fort Worth foe instance, it 
takes six months to get an appointment for an SCD patient to see a physician. When a 
patient misses an appointment, it takes another six months to reschedule or get another 
appointment. Su et al. (2019) maintained, however, that hematologists/oncologists 
accounted for a higher proportion of visits by children than adults, while emergency 
medicine visits were higher in adults than children. CDC (2020) affirmed that the SCD 
patient has limited access to comprehensive team care than other people with genetic 
disorders like hemophilia and cystic fibrosis. Ironically, most SCD departments are 
attached to oncology/hematology departments in most major healthcare facilities, with 
most of the practitioners being oncologists/hematologists, which indicates awareness of 




attention or assistance their counterparts are receiving. With the current statistics or 
prevalence of the disease globally and the annual expenses per each case, SCD should be 
deemed as a major public health concern (CDC, 2020) and thus warrant recognition. 
However, Suzette Oyeku, a sickle cell expert at The Children's Hospital at 
Montefiore/Albert Einstein College of Medicine maintained that "there is shockingly 
little data on sickle cell epidemiology in the United States due to the limited national 
surveillance data on the condition" (Stone, 2015, para. 18). Stone asserted that “the 
difference in access to care and research dollars for SCD might be due to racism and 
economic differences claiming that there are several sources for disparities in funding and 
treatment of SCD as compared to other diseases” (paras. 15 &18). Meanwhile, Strouse, a 
researcher from Johns Hopkins, who made this observation, did not attribute these 
differences to racism or social justice issues, but instead to media savvy (Stone, 2015). 
Booker et al. (2006) posited that the nature of SCD pain is poorly understood and 
is often sub-optimally managed. Stone (2015) also maintained that health care workers 
are prone to underestimate the patients' pains and most often treat patients as drug 
seekers. There are also now the humiliating drug screens by feds with the claim of 
ensuring that patients are taking the narcotics and not selling those (Stone, 2015). Leger 
et al. (2018) asserted that there is a lack of provider knowledge or irrational fear of 
"addiction" that leads to improper triage or inadequate pain management. Stone declared 
that the pain crises associated with SCD remain undertreated, which may reflect racial 
and gender biases. Taylor et al. (2013) proclaimed that SCD patients that experience 




in increased healthcare costs associated with emergency room visits, hospitalizations, and 
lost work productivity. 
According to Leger et al. (2018), there is enough evidence that there is a 
significant delay in average time to administer initial analgesia in the ED compared to the 
recommended 15–20 minutes; and only a few patients received the recommended pain 
relief agents at the recommended dose and routes. Ezenwa et al. (2016) also declared that 
SCD patients usually receive inadequate and untimely treatment for pain control. They 
are also more likely to be accused of drug-seeking behavior and labeled as drug addicts 
as compared to other populations with chronic pain (Ezenwa et al., 2016). It is a norm for 
SCD patients to receive their first pain medication 30 minutes later than others like renal 
colic patients presenting with similar symptoms in the ER, increasing the tendencies for 
such inequities to result in health disparities with time (Ezenwa et al., 2016). Lee et al. 
(2012) asserted that "ER healthcare providers often respond with inadequate pain control 
because of overestimating drug dependence and their perceptions of drug-seeking 
behaviors by patients' with SCD" (para. 5). Furthermore, these authors added that 
"misconceptions by ED providers, combined with lack of a regular primary care provider 
and poor self-care management of SCD, are factors contributing to the patient's repeated 
use of the ED for pain management (Lee et al., 2012, para. 5). There is also a stigma from 
society, including even among healthcare professionals that SCD patients are more prone 
to develop opioid-based analgesia addictions than other diseases with similar symptoms 
(Booker et al., 2006). This stigma influences prescribing and nursing behaviors and has 




patients' willingness to communicate their true feelings for fear of not receiving optimal 
treatment (Booker et al., 2006). Elander et al. (2004) also affirmed how the treatment of 
painful episodes in SCD could result in disputes between patients and HCP. This raises 
concerns about patient behaviors with the suspicion of either drug-seeking due to 
analgesic dependence and misuse or pseudo-addiction caused by under- treatment of pain 
(Elander et al., 2004). 
According to Adegbola et al. (2012), the perceived disrespect from HCPs 
increased emotional pain and worsened the physical pain for the SCD patient. Patients 
also reported dissatisfaction with HCPs lack of empathy and inadequate management of 
the chronic SCD-related pain, resulting in non-therapeutic patient-HCP relationships 
(Booker et al., 2006).  Ratanawongsa et al. (2009), however, claimed that the negative 
perception of SCD patients on provider attitudes affects the quality of patient-provider 
communication and care during VOCs. Thomas and Cohn (2006) also declared that the 
poor communication between SCD patients and their HCPs causes suspicion and mistrust 
and results in most patients feeling labeled negatively by the healthcare system and thus 
skeptical of opening themselves to an unsympathetic system. These researchers organized 
pilot courses on communication skills and cultural awareness strategies for HCPs to use 
in challenging situations such as patients acting hostile and aggressive towards them. It 
occurred that the training had a positive and enduring impact on practitioners' perceived 
ability and confidence in communicating with their patients (Thomas & Cohn, 2006). The 
authors thus concluded that the training model employed might help reduce mistrust and 





Nutrition as an Alternative Treatment Option in Sickle Cell Disease Pain 
Management: Nutrients, Herbs, Fruits, and Veggies With Analgesics, Anti-
Inflammatory, and Vasodilation Potentials 
The position of nutrition in SCD pain management can be a beneficial alternative 
treatment regimen that needs critical investigation. Thompson and Eriator (2014) asserted 
that the majority of SCD patients live with chronic pains, which has resulted in many of 
them resorting to the use of complementary and alternative medicine (CAM). PCRM 
(2019) posits that SCD patients’ have more significant than average requirements for 
both calories and micronutrients, but most patients are deficient in essential 
micronutrients. According to Hyacinth et al. (2010), because of the challenge in finding a 
cure for SCD after 100 years of its discovery, there has been a growing interest in the 
nutritional problems of the disease resulting in many researchers seeking nutritional 
alternatives as a means of decreasing morbidity and improving quality of life for SCD 
patients. These authors claimed that the SCD patient usually does not meet or fulfill the 
recommended dietary allowances (RDAs) when compared to the general population, 
irrespective of the fact that efficacy of macronutrient supplementation proved to be 
evidence-based (Hyacinth et al., 2010). Likewise, micronutrients occur to be insufficient 
among the SCD community, according to Hyacinth et al., (2010). These authors thus 
recommended the need to establish specific RDAs for SCD patients, much like the 
specific RDAs developed for pregnancy and growth within the general population SCD 




vegetables, whole grains, and legumes (plant foods) have the potential to provide a higher 
proportion of essential nutrients than a typical Western diet, and have the appropriate 
supplementation to prevent deficiency and decreases disease exacerbation. Hyacinth et al. 
(2010) cited, for example, that recent findings of vitamin D deficiency among the SCD 
community may attribute to incomplete ossification and bone disease, one of the 
significant complications of SCD. According to PCRM (2019), iron overload and 
oxidative stress may cause the depletion of antioxidant vitamins.  
Most of the herbs, fruits, and veggies that we use daily possess analgesics, anti-
inflammatory, and vasodilation potentials that can play significant roles in managing the 
pains associated with SCD pains. Cyril-Olutayo et al. (2019) commented on how 
medicinal plants have been used traditionally in Africa for the management of SCD, 
whose treatment has been mainly palliative. These authors claimed that the following 
herbs or medicinal plants Zanthoxyllum xanthoxyloides, cajanus cajan, carica papaya, 
cnidoscolus aconitifolius have ant sickling effects which can prevent and reverse sickling 
of RBC (Cyril-Olutayo et al., 2019). These researchers conducted a study on the 
medicinal plant, Telfairia occidentalis (fluted gourd or pumpkin), a nutritious vegetable 
rich in vitamins, proteins, antioxidants. It was observed that this herb could treat SCD as 
it is capable of preventing and reversing the sickling of RBC, stabilizes the RBC 
membrane, reduces HbS red cell density, increases their PCV, prevents and alleviate 
SCD crisis in infants and adults (Cyril-Olutayo et al., 2019).  
Osunkwo et al. (2012) conducted a pilot study where SCD patients who were 




experienced fewer pain days per week and had higher physical activity quality‐of‐life 
scores. Based on these findings, researchers suggested that vitamin D possesses the 
potential to reduce the number of pain days in SCD patients (Osunkwo et al., 2012). 
Amer et al. (2006) claimed that exposing or treating SCD patients with antioxidants such 
as N‐acetyl‐cysteine, vitamins C and E, decreased their oxidative stress or damage to 
RBC and platelets, thereby alleviating symptoms associated with their pathology. 
PCRM (2019) recommended the importance of staying hydrated or drinking 
enough fluid during strenuous exercises as sickling of erythrocytes increases in SCD 
patients who exercise in the heat without consuming fluids, compared with those who 
stay well-hydrated. Omega-3 fatty acid (n-3FAs) supplements are recommended for the 
SCD-child patient as they are low or deficient on alpha-linolenic acid and the long-chain 
omega-3 polyunsaturated fatty acids (eicosapentaenoic acid [EPA] and docosahexaenoic 
acid [DHA]) according to this committee.  
ω-3 FAs have the potential to increase the fluidity of RBC membranes, which 
may prevent sickle cell crises. Both EPA and DHA are known to have significant 
therapeutic benefits of reducing severe anemia (PCRM, 2019). Based on a double-
blinded, olive oil-controlled clinical trial Tomer et al. (2001) conducted, it was observed 
that treatment with dietary ω-3 FAs for one year reduced the frequency of pain episodes 
that requires hospital visits from 7.8 events during the preceding year to 3.8 events per 
year as they reduce prothrombotic activity in SCD. Matte et al. (2019) also maintained 
that a phase II multicenter randomized, double-blinded placebo-controlled study in SCD 





Franceschi (2000) speculated that dietary magnesium (Mg) pidolate 
(pyroglutamic acid) supplementation has the potential to inhibit K–Cl co‐transport and 
reduce dehydration. Franceschi (2000) claimed that blocking the transport pathways that 
promote loss of potassium (K) is a potential therapeutic strategy for SCD as it prevents 
erythrocyte dehydration, one of the causes of pain crisis. Prasad et al. (1999) claimed that 
frequent hemolysis in SCD could attribute to zinc deficiencies in these patients. Zinc 
deficiency is known to impact T‐helper1 (TH1) functions adversely, cell-mediated 
immunity, and causes decreased interleukin (IL)‐2 production (Prasad et al., 1999). These 
researchers proposed that zinc supplementation has the potential to improve the T‐helper 
function and decrease the incidence of infections in patients with SCD (Prasad et al., 
1999). Datta et al. (2019) also maintained that there is evidence that zinc supplementation 
may be beneficial in reducing the risk of infections and the painful VOC in SCD patients. 
According to Nwabuko et al. (2019), folic acid supplementation, L- Glutamine, 
Glutathione oxidase inhibitor, Thiocyanate-containing foods, Vitamin B containing diet, 
seaweeds, and other food supplements are recommended, since they are rich in 
antioxidants. Matte et al. (2019) asserted that a “multicenter, randomize, placebo-
controlled double-blind phase III clinical trial with L-glutamine (0.3g/Kg twice a day) 
supplementation reduced the mean number and length of hospitalization, associated with 
the increased median time to the first crisis” (p. ). Agbai (1986) claimed that the 
prevalence of SCD is relatively rare in Africans than in the African-American population 




three times more common among indigenous Africans than in African-Americans. The 
ratio of SCD to SCT is 1 out of 50 for African-Americans and less than 1 out of 1,000 for 
tropical Africans, according to Agbai (1986). This researcher attributed this etiological 
disparity to an anti-sickling agent, thiocyanate (SCN-) found abundantly in staple African 
foods, such as the African yam and cassava (Agbai, 1986). The author claims that staple 
American foods have negligible SCN-concentrations. In contrast, non-staple foods in the 
American diet, such as carrots, cabbage, and radishes, have SCN- levels far below the 
African yam and cassava (Agbai, 1986). SCD remains regarded as congenital deficiency 
anemia that can be improved by prophylactic diets with high SCN- contents (Agbai, 
1986). The researcher thus concluded that “thiocyanate deficiency anemia” is a 
nutritionally correct clinical status for those born with the homozygous sickle 
hemoglobin genome and that subjects become more susceptible if they subsist on SCN-
deficient food contents (Agbai, 1986). However, other thiocyanate rich foods that may 
easily be located in the US include turnips, broccoli, Brussels sprouts, and cauliflower.  
According to Al‐Momen (1995), most of the patients that have severe SCD may 
suffer from unrecognized vitamin B12 deficiency. Ohnishi et al. (2000) posited that dense 
RBCs in SCD patients tend to adhere to neutrophils, platelets, and vascular endothelial 
cells, which could trigger VOC and thus subsequent painful crisis. Nutritional antioxidant 
supplements, hydroxyl radical scavengers, and iron-binding agents could inhibit the 
formation of such dense cells (Ohnishi et al., 2000). Some of the nutritional supplements 
found to be capable of inhibiting dense cell formation by 50% aged garlic extract, black 




carotene (Ohnishi et al., 2000). Grapefruits, for instance, are high in potassium content 
rendering them useful vasodilators that contribute to the widening of blood vessels and 
the relaxation of smooth muscles in the cells enabling smooth flow of blood in the 
vessels.  
Coping Mechanisms/Strategies, Lifestyle Modifications, and Sickle Cell Disease Pain 
Management 
Employing coping strategies that may range from simple strategies like hot pad 
massaging, relaxation, and prayers to more sophisticated ones like self-
awareness/mindfulness, healthful eating habits Acupuncture, among others. These can be 
effective approaches to dealing with the SCD pain. Neville and Panepinto (2011) 
proposed that “even though there is the need for new treatments for SCD, especially for 
disease-modifying agents, it is also imperative to explore new approaches for improving 
treatment with the existing modalities”(p. 11) 
Dampier (2019) posited that because of the multifactorial nature of both pain and 
VOC, it is imperative to explore simultaneously targeting multiple mechanisms, which 
may be the optimal approach for effective preventive therapies. Lee et al. (2012) 
proposed the coordination of interdisciplinary health team members to reduce pain 
episodes and any associated catastrophic complications like renal failure, pulmonary 
disease, and cardiovascular events. “Because of the complexity of chronic pain in SCD 
patients, a multidimensional perspective is needed which embraces the whole person by 
focusing on biological, psychological, sociological, and spiritual factors” (Taylor et al., 




in an interdisciplinary treatment program such as physiotherapy, psychotherapy, part of a 
coping pain group, acquire information and education about the pathophysiology of 
disabling pain mechanisms and management, regular medical consultations, and drug 
therapy reported decreases in mean pain severity. They also depicted improvement in 
social functioning compared to patients receiving standard care as inpatient rehabilitation 
and drug therapy (Angst et al., 2009). Williams and Tanabe (2016) suggested that 
patients should be able to use non-pharmacological interventions to alleviate pain with 
some degree of success. These researchers also claimed three categories of non-
pharmacological therapies, which are peer-support groups, educational/psycho-
educational, and skill-based (Williams & Tanabe, 2016). Adebowale (2014) asserted that 
though there is no cure for SCD, there are cost-effective treatment options for the pain 
and other aspects of the disease, such as early intervention with analgesics, antibiotics, 
rest, proper nutrition, folic acid, high fluid intake and supplementation. Elander et al. 
(2003) observed that SCD patients with pain-related symptoms that impaired activities 
sought a more typical lifestyle. According to Lim et al. (2019), interventions should 
emphasize the negative impacts of emotion-focused avoidance coping and integrate other 
empirically supported coping strategies to improve HRQOL for SCD children presenting 
with high intensity of pain. Elander et al. (2019) posited the need for a brief measure of 
patient satisfaction with treatment for pain to help improve the treatment of painful 
episodes caused by SCD, especially during and after the transition from pediatric to adult 
care. 




employ to help better manage pain episodes. According to Matthie et al. (2019), self-
management is vital to SCD management even though its role in chronic pain 
management is not proven and thus proposed the need to develop and implement 
effective strategies for the prevention and management of chronic pain. Edwin et al. 
(2011) recommended the critical importance of self-management, especially self-
awareness, to enhance the quality of life for the SCD community as they are cost-
effective, and consistent with sound ethical principles and good conscience. Tam et al. 
(2019) designed an electronic teaching module (ETM) for educating adult patients on 
VOC self-management and treatment options for SCD. Tam et al. (2019) claimed the 
ETM increased the knowledge of patients in SCD. The educational ETM has the potential 
to provide an immediate impact on health literacy for an underserved patient population 
and potentially improve disease management and disease-specific outcomes (Tam et al., 
2019). Jenerette and Murdaugh (2008) proposed that vulnerability factors, such as socio-
demographics, negatively affect health care outcomes. These authors suggested the use of 
interventions to increase self-care management resources to improve the health care 
outcomes of SCD patients. Examples of such self-care management resources, according 
to the authors, are assertiveness, self-efficacy, coping behaviors, social support, self-care 
ability, self-care actions, and communication skills. Jenerette and Murdaugh also asserted 
that because of the high cost involved in medical interventions for SCD patients, self-care 
management is critical and may be the best alternative option to decrease the health care 
costs as well as improve the health status and quality of life for persons living with SCD. 




Sickle Cell Disease Association of America with seven adult SCD patients as 
participants. Some of the themes that emerged were self-awareness, emotional support, 
career selection, and success factors, nourishment, advocacy, knowledge, physical, and 
complementary and alternative medicine (Tanabe et al., 2010). The most common 
reported self-management strategy was self-awareness, with emphasis on journaling and 
body awareness (Tanabe et al., 2010). Additionally, spiritual support, friends, family, and 
professional counseling continued to be forms of emotional support, and another reported 
the best self-management practice (Tanabe et al., 2010). 
Matthie et al. (2015) maintained that home self-care contributes to proper pain 
management, prevent pain crisis. Matthie et al. (2015) suggested that empowering health 
care providers (HCP) with a better understanding of self-care would enable them to 
provide or equip patients with the resources and skills they required to be able to 
participate in their disease management. Some of the benefits that SCD patients may 
acquire from self-care interventions are social support, SCD self-efficacy, and access to 
education (Matthie et al., 2015). According to Masuda et al. (2011), acceptance and 
commitment therapy (ACT) promotes acceptance of severe sensations, emotions, and 
thoughts, which enhances functioning and quality of life for SCD adolescents and their 
parents. “These authors proposed that ACT interventions can be useful conceptual and 
therapeutic additions to the treatment of pediatric patients with SCD and the family” 
(Masuda et al., 2011, p. 9). According to Simmons et al. (2019), mindfulness-based 
intervention (MBI) is feasible and acceptable for persons with SCD experiencing chronic 




pharmacologic, behavioral pain management options for practitioners that care for SCD 
patients and chronic pain. 
Spirituality has been one of the coping mechanisms that have been employed by 
the SCD community to manage pain. According to Wachholtz and Pearce (2009), chronic 
pain is a sophisticated experience that results from the interrelationship between 
biological, psychological, social, and spiritual factors. These authors affirmed that many 
patients that experience chronic pain uses various religious/spiritual forms of copying, 
such as prayer and spiritual support, to manage their pain. Wachholtz and Pearce (2009) 
proposed that health care professionals should participate in the exploration of spiritual 
matters that may contribute to the pain experience of their patients. Taylor et al. (2013) 
also posits that because spirituality/religion is central to the SCD community, they can be 
incorporated to any model of chronic pain as it is proven that spirituality/religiosity is 
associated with decreased pain intensity in patients. “It was concluded from a study 
findings that adopting positive religious strategies are associated with significantly fewer 
hospital admissions after adjusting for other demographic and diagnostic variables” 
(Bediako et al., 2011, p.1). Cotton et al. (2009) claimed that patients who engage in 
higher levels of religion and spirituality recover from illness more quickly, are less 
depressed and enjoy better HRQOL. In a study conducted by these researchers, most 
SCD adolescents described employing a “collaborative” religion and spirituality coping 
style (Cotton et al., 2009). They reported depending on God for support and on prayer for 
symptom relief, believing in God to “strengthen” them in such situations with those who 




who attend religious services are also found to be less likely to engage in risky health 
behaviors and have better mental health outcomes thus less depression and anxiety 
(Cotton et al., 2009). 
Acupuncture has been one of the coping strategies or non-pharmaceutical therapy 
that has been used for pain relief and can be explored for SCD pain management. Tsai et 
al. (2015) proposed Acupuncture has the potential to decrease pain and anxiety as well as 
reduced PED visits and hospitalizations for SCD pain when used to treat the acute and 
chronic SCD pains of a child patient. Based on a retrospective study they conducted, Lu 
et al. (2014) concluded that the physical insertion of the needle during the administration 
of Acupuncture might be useful in alleviating pain and proposed the possibility of using it 
as an adjuvant for pain management for the SCD population. According to Wick, (2019) 
complementary and integrative therapies (CIM) or complementary and alternative 
medicines (CAM) such as vitamins, minerals, homeopathy, meditation, 
acupuncture/acupressure, or deep breathing techniques involves a holistic, patient-
focused approach to health care in managing pain and anxiety. 
Other non-pharmacologic therapies or approaches such as massaging and relaxing 
can be an effective alternative regimen for SCD pain management. Bodhise et al. (2004) 
asserted that deep tissue/pressure massage therapy technique, including neuromuscular 
trigger point treatment with acupressure for SCD patients, has sound effects on pain relief 
and quality of life. Rees et al. (2003) proposed that because a majority of painful episodes 
are managed at home, SCD patients and parents should be educated as to when to seek 




necessary because most patients only go to a hospital only when oral analgesia is 
insufficient, or symptoms suggest a severe complication (Rees et al., 2003). Furthermore, 
educating SCD patients would help prevent or combat most of the complications 
associated with VOC or pain crisis. 
Exploring Preventative Measures to Combat Sickle Cell Disease 
Incidence/Prevalence 
SCD prevalence continues to be increasing recently and becoming more 
widespread globally due to globalization and an increase in migration. It has resulted in 
interracial marriages rendering it a significant public health concern even though it has 
not received much recognition as other health conditions. In the quest of controlling its 
incidences and hence prevalence, countries like Ghana with a high prevalence of one in 
every three Ghanaians having the hemoglobin S or C gene has proposed such extreme 
preventative strategies like prenatal diagnosis (PND) and selective abortion which 
presents with a whole lot of ethical concerns (Edwin et al., 2011). Other standard 
preventative measures that are employed globally to control SCD incidences are genetic 
counseling and testing, as well as new-born screenings. Edwin et al. (2011), for instance, 
proposed preconception genetic testing and strategic reproductive choices, PND and 
education for carrier parents, and holistic management for the SCD community in Ghana. 
Nwabuko et al. (2019) recommended the need to put in place proper documentation, 
which may ultimately lead to the establishment of local and national Surveillance 
Epidemiological End-Result (SEER) statistics for SCD. These authors claimed SEER 




epidemiology, incidence rate, prevalence, birth rate, mortality rates, and the ABO Rhesus 
blood types for SCD patients. Nwabuko et al. (2019) maintains this could be life-saving 
as it promises to reduce the protocols of blood grouping required for emergency medical 
interventions, especially in cases of severe anemia due to road traffic accidents, medical 
and surgical conditions that would require urgent blood transfusions. Rees et al. (2003) 
also proposed the following guidelines to be adopted for rapid admission to hospitals, 
which include "a written protocol for quick assessment of pain and rapid, safe 
administration of analgesia and personalized care plans made available to on‐call medical 
staff. These authors also suggested that patients should be able to carry 
hemoglobinopathy cards that state their diagnosis and baseline hematological data. This 
would make it possible to initiate an analgesia therapy within 30 minutes of arrival in 
hospital after a rapid initial assessment and to enable the pain to be brought under control 
within 60 minutes of starting analgesia (Nwabuko et al., 2019). 
As part of the measure to combat SCD, Nwabuko et al. (2019) also proposed the 
need for a Public Health awareness campaign on SCD and campaign language should be 
culturally friendly, relevant, and understandable to mitigate the challenges of health 
literacy and culture barriers. The authors made use of mass media (radio, TV adverts), 
social media (i.e., Facebook, Whatsapp, Blog, Flicker, Twitter and Instagram, etcetera) as 
the vehicles for disseminating information. Radio and TV adverts are imperative, but they 
are non-existent. There is hardly anything like commercials on any radio or TV station on 
any aspect of the disease, not even to promote an SCD medication, unlike other chronic 




claimed there is an increase in the percentage of carriers and the high possibility of a 
continuous increase in number if not controlled. This author thus proposed incorporating 
social welfare counseling in social, religious, health and educational sectors and other 
techniques when educating carriers especially individuals yet to get married, towards the 
prevention and eradication of the disease (Adebowale (2014). Because of "the huge 
burden of SCD coupled with the associated high morbidity and mortality rates globally, it 
is imperative to invest more in ways of reducing the prevalence of the disorder" (Aneke 
& Okocha, 2016, para.1).  
Unaddressed Aspects of Sickle Cell Disease Pain Management: Impact on 
Psychological and Mental Health 
A significant effect of pain crises on SCD patients, especially the children and 
their HRQOL that is usually overlooked and not addressed, is on their mental health. The 
impact of pain crisis on the psychological or mental health of SCD patients and their 
caregivers is a critical aspect of the disease phase that is most often not taken into 
consideration by SCD health practitioners. Anie et al. (2010) described SCD as a global 
health problem with psychosocial implications. “Chronic pain in adults with SCD is 
described as a complex multidimensional experience that includes biologic, psychologic, 
sociologic, and spiritual factors” (Taylor et al., 2013, p.1). These authors gave some of 
the psychosocial variables like stress, mental health status, coping behaviors, social 
interactions, cognitive dysfunction, functional and socioeconomic status. 
The pain crisis has the potential of inducing extreme stress and depression on both 




suffer a lot of psychological and emotional distress due to the isolated lifestyle they tend 
to adopt due to all the health challenges they go through. Most of them complain about 
how they are the ones who are always sick and have to stay away from school as 
compared to their colleagues and why they cannot do most of the things that other kids do 
like playing outside, running, playing in the snow among others. One patient retorted, 
“this disease is severe and can be very depressing at times” after recounting her 
challenges with SCD. The stigma from society and the healthcare sector towards the SCD 
community can also be another source of stress and psychological distress for many SCD 
patients and their families. Elander et al. (2003) declared psychological disturbance as a 
theme associated with non-pain-related symptoms. Edwards et al. (2005) asserted that 
because of the chronicity of SCD with its frequent hospitalizations for pain and other 
medical management, it has the potential to significantly impair psychosocial 
functioning, alter intra- and interpersonal relationships, and reduced QOL for the patient. 
Thus these authors concluded that due to this significant role of psychosocial issues in the 
trajectory and management of SCD, understanding the pathophysiology of SCD without 
thoroughly understanding the equally important psychosocial influences is 
misunderstanding SCD (Edwards et al., 2005). According to Taylor et al. (2013), factors 
other than biological factors, such as psychological and sociological factors examples 
being SCD genotype, HbF levels, comorbidities, depression, stress, mental health status, 
coping behaviors, social interactions, cognitive dysfunction, and functional and 
socioeconomic status are common among SCD adults with chronic pain. Reader et al. 




frequency, intensity, duration, impairment, coping, and emotional functioning in children 
with SCD. The researchers observed a strong relationship between increased pain 
frequency and higher depressive and anxiety symptoms, moderate-to-strong associations 
between pain-related impairment and depressive symptoms, small-to-strong associations 
between pain-related impairment and anxiety with pain-coping strategies, and 
maladaptive cognitive strategies depicting the strongest association with emotional 
functioning. Mackey (2019) declared how stressful it could be for an SCD caregiver 
without any coping strategies. Wang et al. (2011) asserted that coping strategies provide a 
protective role in mitigating caregiving stress (Mackey (2019). “Interventions for 
children with SCD reporting high pain intensity should put more emphasis on negative 
impacts of emotion-focused avoidance coping and integrate other empirically supported 
coping strategies to improve HRQOL” (Lim et al., 2019, para.1).  
With HBM, Pantaleao et al. (2019) hypothesized that cues to action and perceived 
pain burden enhances the relationships between psychosocial factors such as stress that 
caregivers experience communicating about SCD to their child or HCPs during ER visits. 
“These authors thus suggested that caregivers of children with SCD could benefit from 
interventions that enhance stress-management and communication skills with their child 
and HCPs” (Pantaleao et al., 2019, para. 1). Sadeghloo et al. (2019) maintained that 
positive thinking training could be an effective strategy for improving the quality of life 
of parents with ill children. Pecker and Darbari (2019) asserted that psychosocial and 
affective comorbidities are common and can impact disease outcomes in SCD. Pecker 




integral part of the management of SCD. According to Da Silva et al. (2019), the 
treatment of chronic pain, including pharmacological and non-pharmacological 
treatments, can have an impact on brain function. Though these researchers asserted that 
this trend is not well established with SCD patients, however, neuroimaging evidence 
indicated abnormal neural processing related to chronic pain and psychosocial 
comorbidities in SCD beyond ischemic stroke and cerebral hemorrhage (Da Silva et al., 
2019). Consequently, the authors proposed behavior therapy as a mechanism to improve 
psychological symptoms as well as chronic pain and quality of life for the SCD 
community (Da Silva et al., 2019). Connolly et al. (2019) also claimed that SCD youth 
that battles persistent pain are at risk for psychosocial and neurocognitive impairments as 
the persistent pain may tend to be an important indicator of disease burden. Therefore, 
these authors suggested that disease management may be enhanced by assessing 
cognitive and psychosocial functioning by incorporating interdisciplinary treatments to 
address any impairments associated with persistent pain (Connolly et al., 2019). 
Perceptions and Experiences of the Sickle Cell Disease Community Regarding 
Alternative Treatment Options for Pain Management 
There is a gap in the perceptions and experiences of the sickle cell disease 
community on alternative treatment options for pain management that is the focus for this 
study. Few studies have attempted to address the perceptions and experiences of parents 
and patients and even other stakeholders of the SCD community on alternative treatment 
options. "Parents perspectives on care and the relationships between coping, family 




literature neither has much attention being given to pediatric sickle cell intervention 
efforts" (Mitchell et al., 2007, p.8). Atorkey (2015) also declared that the literature is 
insufficient on SCD patients' perceptions and beliefs and their impact on patients' 
treatment compliance. Smith et al. (2018) also maintained that there is little is known 
about parent perceptions of managing SCD pain episodes in young children. 
Theoretical Foundations: Health Belief Model, Transtheoretical Model, and 
Biopsychosocial-Spiritual Model of Chronic Pain 
 "The theoretical framework is described as the foundation from which all 
knowledge is constructed both metaphorically and literally for a research study" (Osanloo 
& Grant, 2016, p. 1). "According to these authors, the theoretical framework serves as the 
structure and support for the rationale for the study, the problem statement, the purpose, 
the significance, and the research questions and provides a grounding base for the 
literature review, the methods and analysis" (Osanloo & Grant, 2016, p. 1). The Health 
Belief Model (HBM), Biopsychosocial-Spiritual Model of Chronic Pain, and the 
Transtheoretical Model (TTM) would form the theoretical foundations for this study.  
Taylor et al. (2013) described three models of pain associated with SCD: 
biomedical model, the bio- psychosocial model for SCD pain, and the Health Beliefs 
Model. The constructs of HBM would thus be employed to assess and enhance the SCD 
community, especially patients' and parents' experiences and perceptions on exploring 
alternative treatment regimens in place of opioid analgesics through interviews. 
According to Gustafson et al. (2007), health screening behavior is usually influenced by 




seriousness of the disease, perceived benefit of the specific action, and barriers to the 
behavior. Hence, the construct perceived susceptibility can be used to provide 
information on the mode of operation of these opioids, that they are purposely for 
maintenance, relieve SCD chronic pains associated and help patients to deal with it 
without really doing anything to change the disease state. Perceived severity would be 
used to determine the target audience's experiences and perceptions of the seriousness or 
consequences of prescription drug abuse or overdose and consequences such as the 
possibility of addiction and side effects. Perceived benefits could be employed to 
promote alternative regimens like some of the disease-modifying agents such as 
hydroxyurea and endari, which are claimed to have the potential to reduce the frequencies 
of pain episodes. Perceived barriers would be used to analyze the target audiences' 
experiences with and perceptions of tangible and psychological costs to trying alternative 
treatment regimens and other health disparities like unequal distribution of social and 
health resources such as inadequate healthcare facilities, practitioners and services. With 
cues to action, the community's awareness of SCD symptoms and approach to pain 
management can be assessed base on which appropriate strategies to motivate the 
community to embrace an alternative regimen could be proposed. Self-efficacy could 
contribute towards evaluating patient's abilities to confidently manage pain episodes by 
employing coping strategies like self-awareness for early detection of pains and 
symptoms of associated comorbidities like stroke, infections of organs in the body, and 
mindfulness for better pain management. Taylor et al. (2013) referred to an individual's 




of healthcare and perceived benefits and barriers to healthcare utilization as readiness 
variables.  
The constructs of TTM can be employed to investigate patients' opinions and 
experiences with their HCPs prescribing habits and then the possible strategies to 
empower them to enforce changes where necessary. Prochaska and Velicer (1997) 
asserted that the Trans-theoretical model health behavior change involves progress 
through six stages of change: pre-contemplation, contemplation, preparation, action, 
maintenance, and termination. At this pre-contemplation stage, SCD patients/parents may 
have no intention of taking action, thus adopting any of alternative treatment options or 
coping mechanisms like self-care management practices as they may doubt their 
effectiveness. By creating awareness, SCD patients/caretakers may contemplate trying 
some of these alternative treatment practices soon. SCD patients/patients may prepare to 
try some of these alternative treatment practices. SCD patients may need to take action 
through empowerment to request for their HCP to prescribe other regimens aside from 
opioid analgesics and also try self-care management practices for a short period. SCD 
patients/prescribers adopt alternative treatment regimens or practices and continue to be 
maintained for the long-term, depending less on opioids for pain management. Finally, 
SCD patients/prescribers might decide to rely more on alternative treatment regimens or 
practices. It may require further studies to accomplish these behavioral changes in the 
SCD community, ultimately. 
Taylor et al. (2013) developed the Bio-psychosocial-Spiritual Model of Chronic 




approach previously developed by Turk and Gatchel ((2018) purposely for SCD patients 
who deemed spirituality/religiosity as an essential aspect of chronic pain management. 
Taylor et al. (2013) proposed the BPS-Spiritual model for adults with chronic pain from 
SCD since it embraces the whole person. The model accommodates the biological, 
psychological, sociological, and spiritual factors relevant to adults with SCD (Taylor et 
al., 2013). 
Use of the Biopsychosocial-Spiritual Model of Chronic Pain for Sickle Cell Disease 
Pain Management 
 According to Taylor et al. (2013), the BPS model has been used effectively in 
other chronic pain populations and interdisciplinary treatment programs like 
physiotherapy, psychotherapy, and coping pain support groups. It has also been used to 
provide information and education about the pathophysiology of pain mechanisms and 
management of chronic disabling pain, regular medical consultations and drug therapy. 
Taylor et al. (2013) claimed there were decreases in mean pain severity and improvement 
in social functioning compared to patients receiving standard care like inpatient 
rehabilitation and drug therapy. These researchers also asserted that because 
spirituality/religion plays a critical role in the SCD community, it is necessary to 
incorporate an aspect of this dimension to any model of chronic pain in adults with SCD 
as spirituality/religiosity has been associated with decreased pain intensity (Taylor et al., 
2013). They are promoting the BPS-Spiritual model because of its holistic approach since 
it embraces the whole person, thus the biological, psychological, sociological, and 




the overall goal of the BPS model of chronic pain is to help the patient become an active 
participant in life management skills and learn new ways of thinking about and coping 




CDC (2020b) claimed that there are millions of people with the SCD condition 
globally and more prevalent among people with ancestors or background from sub-
Saharan Africa; Spanish-speaking regions in the Western Hemisphere such as South 
America, the Caribbean, Central America; India; and Mediterranean countries such as 
Saudi Arabia, Turkey, Greece, and Italy. SCD is also common in areas where the 
prevalence of malaria is high and is claimed that people who carry the sickle cell trait are 
less likely to have severe forms of malaria (CDC, 2020b). 
According to a study that Mitchell et al. (2007) conducted, employing both 
quantitative and qualitative methods with 53 parents of SCD children confirmed that 
positive patient coping was related to positive family functioning and lower health 
utilization. The study participants, however, requested the need for comprehensive health 
care approaches that meet the physical and psychological needs of patients and families 
(Mitchell et al., 2007). The participants of an exploratory study conducted by Anie et al. 
(2010) claimed that society, in general, had a negative image of SCD, and reported 
negative perceptions and attitudes. “These researchers concluded that employing 
psychosocial interventions in SCD would help to reduce negative thoughts and feelings 




(Anie et al., 2010. p. 5). Based on the findings of a survey conducted by Smith et al. 
(2018) on 51 parents of 2- to-6-year-olds SCD patients, 82% of the parents who reported 
using medications to manage their children’s pains claimed moderate satisfaction with 
current management strategies and resources. However, they expressed interest in 






Chapter 3: Research Method 
Introduction 
The purpose of this study was to qualitatively explore the perceptions and 
experiences of the SCD community on the use of alternative treatment options for pain 
management instead of opioid analgesics. The findings contribute insight into the 
prescription habits of SCD practitioners and variables (such as cost, availability of/access 
to alternative regimens and other health services, knowledge, and more) that influence 
patients’ and HCPs’ choices of treatment options. It also throws light on how patients’ 
experiences and perceptions impact their choice of treatment regimens. The case study 
approach was employed to address these issues of interest in the study. The subsections 
within this chapter address the research design and rationale, participants, my role as the 
researcher, methodology, data collection, instrumentation, validity, ethical procedures, 
and trustworthiness. 
Research Design and Rationale 
One of the significant purposes of this study was to assess the experiences and 
perceptions of alternative treatment options for pain management, employing a 
qualitative approach. Astalin (2013) characterized qualitative research as “a systematic 
scientific inquiry that seeks to build a holistic, largely narrative, description to inform the 
researcher’s understanding of a social or cultural phenomenon” (p. 1). With SCD being a 
genetically inheritable disease that affects a specific population in society, there are 
certain cultural norms and practices that may influence the perceptions of members of the 




qualitative research the appropriate approach to use to execute this study.  
  "Creswell (2015) declared that the real beauty of qualitative research is that the 
possibilities for data collection are very extensive, noting that sources may include open-
ended interviews, open-ended observations, and public and private documents such as 
private diaries, newspaper articles, and meeting minutes”. Astalin (2013) also affirmed 
that qualitative research can be conducted with a combination of observations, 
interviews, and document review. The specific qualitative research design used for this 
study was the case study design, which can be carried out using various data collection 
tools. As Alpi and Evans (2019) explained,  
Case study research is a qualitative approach where the investigator explores a 
real-life, contemporary bounded (a case) or multiple bounded systems (cases) 
over time, through detailed, in-depth data collection involving multiple sources of 
information reports a case description and case themes. (p. 2) 
A case study has also been described as “an intensive, holistic description and analysis of 
a bounded phenomenon such as a program, an institution, a person, a process, or a social 
unit” (Yazan, 2015, p. 6). Astalin (2013) also asserted that case studies can be used to 
holistically analyze people, events, decisions, periods, projects, policies, institutions, and 
other systems by one or more methods. Given the diverse nature of the study population 
in terms of geographic location, educational level, and disease type, among other 
characteristics, I reasoned that it might not be realistic to adopt a specific tool or source 
of information; rather, several tools and sources might be needed for data collection. For 




This type of qualitative approach is accredited with certain distinctive attributes 
which are particularistic which implies it focuses on a particular situation, event, 
program, or phenomenon; descriptive because it yields detailed, thick description 
of the phenomenon under study and Heuristic as it illuminates the reader's 
understanding of the phenomenon under study”. (p. 6) 
Alpi and Evans (2019) claimed that rigor in case studies depends on the research 
design and its components, which include the study questions, propositions, unit of 
analysis, logic linking the data to propositions, and criteria for interpreting the findings 
(Yin, 2017). Other features of case studies include the use of multiple sources of data, a 
case study database, and a transparent chain of evidence linking the questions asked, the 
data collected, and the conclusions drawn, according to Yin (2017). Common sources for 
data for case studies include interviews, documentation, archival records, direct 
observations, participant observation, and physical artifacts (Alpi & Evans, 2019). 
Nevertheless, this study might be considered a microcase or microlevel case study 
because it was conducted within a brief time frame; it was expected to be simple and 
straightforward; it described an apparent problem of interest; and the study findings or 
reporting were expected to be very brief and focused on specific points to depict the 
clarity of the “lesson” inherent in the case (Alpi & Evans, 2019). 
Research Questions 
RQ1.  What are the experiences of the SCD patients or their parents/caretakers 
regarding the current prescribing habits of their HCPs to manage SCD 




RQ2.  What are the experiences and attitudes of the SCD patients or their 
parents/caretakers toward alternative treatment methods, and how do they 
influence their choice of treatment? 
RQ3.  What is the stage of readiness for adopting alternative treatment methods 
for SCD patients or their parents/caretakers? 
RQ4.  How does disease perception among SCD patients or their 
parents/caretakers impact their willingness to try alternative treatment 
methods? 
As is the norm with case study research designs, multiple data sources were 
employed in addressing the research questions. These included phone interviews, video 
conferences, emails, and shared or archived stories of patients. As noted earlier, face-to-
face interviews and focus group methods were not possible in this study because of social 
and physical distancing restrictions due to COVID-19. 
Role of the Researcher 
According to Sutton and Austin (2015), qualitative research studies enable 
researchers to access the thoughts and feelings of research participants, making it 
possible to gain a better understanding of the meaning that people ascribe to their 
experiences. I have been personally involved with SCD communities for about 19 years, 
and one of my initial significant concerns for the community was the prescribing habits 
of its HCPs. I have never been comfortable with or approving of the choice of 
pharmaceutical products, especially opioid analgesics, for pain management, especially 




Professionally, I have had the privilege to work in specialty pharmacies for the 
past 14 years, where terminal or extreme diseases and health conditions such as cancers, 
autoimmune and genetic diseases, and skin conditions are the principal focus. However, 
SCD was never considered or included in these categories of health conditions. As I 
became more aware of how ineffective some of the pharmaceutical treatments for SCD 
patients can be and of the adverse or side effects and other complications associated with 
them, my concern heightened. Another interesting observation I made was that as more 
and newer medications were continually being developed and approved for other 
conditions, there were barely any for SCD. Stone (2015) affirmed that no drugs were 
approved between 2010 and 2013 for the treatment of SCD, whereas five new 
medications were approved for cystic fibrosis. As I switched to the public health sector 
professionally, my interest in alternative treatment options for SCD evolved into seeking 
more preventative measures employing natural products such as nutrients and other 
mechanisms that may be deemed more efficacious in pain management.  
With all of these factors at play, there was a possibility that I would influence the 
data collection process in a way that might threaten the quality of the data and introduce 
bias. However, it was my responsibility as the researcher to ensure that the quality of the 
study met the required standard and that bias was avoided or limited as much as possible. 
According to Greenbank (2003), a researcher’s morals, competency, and personal and 
social values have an essential influence on the research process. As such, Greenbank 
maintained that it is imperative for researchers to describe relevant aspects of themselves, 




research. As Sutton and Austin (2015) asserted, qualitative study requires reflection on 
the part of researchers, both before and during the research process, purposely for 
providing context and understanding for readers. Sutton and Austin stated that to remain 
reflexive, researchers should not be ignorant or avoid the possibility of their own biases, 
as reflexivity requires researchers to reflect upon and clearly articulate their positions and 
subjectivities in terms of worldview, perspective, and biases. With such information, 
readers can have a better understanding of the filters through which questions were asked, 
data were gathered and analyzed, and findings were reported (Sutton & Austin, 2015).  
Greenbank (2003) posited that researchers should provide rational explanations 
for their actions to justify their research methods. Greenbank also proposed that 
researchers should adopt a participatory strategy or approach to research that involves 
conducting a pilot study and feeding back preliminary findings to research participants 
for comment and modification. I conducted a pilot study and received great feedback 
from the participants, some of which I incorporated into the design of the instrument that 
I used to collect data.  
Methodology 
Target Population 
The population of interest for this research was SCD patients, as well as parents 
and caregivers of younger SCD patients. SCD, a genetic disorder, is known to be more 
prevalent among minority populations of African, Hispanic, Middle Eastern, and Asian 
descent. Study participants varied in gender, ethnicity, race, age, socioeconomic status 




particular type of SCD (SS, SC, beta thalassemia, etc.), which might influence the type of 
treatment regimen that best suits each patient. According to Asiamah et al. (2017), it is 
necessary for a researcher to provide a proper definition or specification of a population 
of interest because this guides others in appraising the credibility of the sample, sampling 
technique(s), and outcomes of the research. Asiamah et al. also asserted that because the 
study population forms the primary source of data, they can influence the research 
credibility based on the researcher’s understanding, definition, and choice of it. 
Inclusion Criteria 
To be selected to participate in this study, individuals needed to meet the 
following conditions:  
• knowledgeable in or experienced with SCD or the subject, specifically SCD 
patients and parents/caregivers 
• interested in being interviewed or ready to be interviewed to share their 
story/experiences and express their views 
• able to speak, read, and write in English or the Twi language of the Akan 
people of Ghana, West Africa, in which I can easily communicate 
• 14 years of age or older 
• stakeholder in the SCD community 
Exclusion Criteria 
The following groups were excluded from participating in the study: 




• non-English-speaking community members who did not speak the Twi 
language of the Akan people of Ghana, West Africa 
Sampling Procedures 
I performed sampling to select a portion of the SCD community to participate in 
the study. However, because of social and physical distancing restrictions due to COVID-
19, this study was not limited to a specific location, given that interviews could be 
conducted by phone or through online/social media platforms and tools such as email, 
Skype, and WhatsApp. Marshall (1996) stated that it is necessary to choose a study 
sample for any research project because it is impractical, inefficient, or unethical to study 
whole populations, noting that the purpose of a study determines the sampling method 
selected.  
I used purposeful sampling, a very strategic sampling technique, for this study. 
Purposeful sampling was deemed an appropriate sampling technique because of the 
characteristics of the study population, the purpose of the study, and the need to be 
tactful, judgmental, and specific in selecting participants for the study. The participants 
who were included in the study were those who had experience with alternative treatment 
options and were intellectually capable of constructively expressing their views. 
Participants included parents/caregivers and patients, whom I contacted by email, text, 
messaging, and social media. According to Palinkas et al. (2015), purposeful sampling is 
widely used in qualitative research for the identification and selection of information-rich 
cases when resources are limited. It is appropriate for identifying and selecting 




interest (Creswell & Plano Clark, 2011; Patton, 2002).  
Purposeful sampling was also consistent with the case study design. According to 
Seawright and Gerring (2008),  
case selection should be a primary role of the case study researcher as in so doing 
it also sets out an agenda for studying those cases which implies case selection 
and case analysis are intertwined to a much greater extent in case study research. 
(p. 2).  
“However,” Seawright and Gerring wrote, “to prevent the dangers of selection bias 
introduced whenever researchers choose their cases in a purposive fashion … perhaps 
case study researchers should choose cases randomly” (p. 3). 
Sample Size 
Onwuegbuzie and Leech (2007) asserted that selecting sample size in qualitative 
studies requires careful deliberation, as it determines the extent to which the researcher 
can make each of the four types of generalizations, irrespective of a small sample size. 
While Onwuegbuzie and Leech posited that sample sizes in qualitative research should 
not be so large that they render it difficult to extract thick, rich data, other authors have 
postulated that sample sizes should not be so small that it becomes difficult to achieve 
data saturation (Flick, 1998; Onwuegbuzie & Leech, 2007). Mason (2010) for instance, 
affirmed that qualitative samples must be large enough to assure that almost all relevant 
perceptions are captured, noting that if a sample is too large, the data become repetitive 
and superfluous. Mason cautioned that even though the guiding principle for sample size 




a point of diminishing return to a qualitative sample so adding more data does not 
necessarily lead to more information. (p. 1). Mason added that sample sizes for 
qualitative studies are generally much smaller than those in quantitative research. 
Because qualitative research designs are very labor intensive, it can be time consuming 
and impractical to analyze large samples (Mason, 2010). Based on the findings of the 560 
studies whose contents were analyzed for their sample sizes, it was deduced that the 
mean sample size was 31. Taking all of these factors into consideration, I determined that 
the sample size for this study would be between 20 and 25 participants. 
Instrumentation 
Salkind (2010) described instrumentation as the tools or means with which 
researchers attempt to measure variables or items of interest in the data collection 
process; an instrument is a device used by investigators for collecting data. For this study, 
instruments that I used in the data collection process included phone and face-to-face 
interviews, videotape, audiotape, email, texting, and archived data review, among others. 
Salkind (2010) also asserted that instrumentation incorporates construction and 
assessment as well as conditions under which the designated instruments are 
administered.  
Acharya et al. (2009) designed a questionnaire to explore knowledge, attitudes, 
and beliefs about SCT and SCD, and this is one of the instruments that was adopted for 
this study. Al-Azri et al. (2016) also developed an instrument to test knowledge and 
health beliefs regarding SCD, and it might also be emulated. Other researchers such as 




consultations, focus group discussions, and construct validation of questionnaires through 
cognitive testing and assessment of construct validity by a nationwide pilot survey, which 
were also used. Sample questionnaires that have been used by reputable entities such as 
the U.S. Food and Drug Administration (FDA, 2014) and the Thalassemia International 
Federation via Survey Monkey were also used for data collection. Because of the 
geographical distribution of the study population and COVID-19, all data were collected 
remotely online, by phone, by email, by text, or through social media tools such as 
Facebook Messenger, among others. 
Procedures for Pilot Studies 
In (2017) claimed a pilot study is executed to test all the procedures of the main 
study and validates the feasibility of the study by assessing the inclusion and exclusion 
criteria, data collection methods, storage and testing of the instruments for measurements 
in the study, and the training of researchers and research assistants. A mock pilot study 
has already been done when taken course RSCH - 8450H. Three participants, an SCD 
patient, a parent, and a pharmacist, were selected for the pilot study. A questionnaire was 
administered to them, followed by a semi-structured face-to-face interview with the 
patient and pharmacist. Fortunately, one participant is a sickle cell anemia disease (S.C.) 
patient and the father of the patient, so their responses were based on first-hand 
experiences, and their responses can be deemed to be valid and reliable. The other has no 
SCD or any relatives who have the condition, so basically did not have much experience 
in SCD, which impacted her responses and even her interest and approach to answering 




interviews and a questionnaire composed of twenty-three questions, some of which were 
prepared by me, and others were sample questions from some renowned establishments 
like the U.S. Food and Drug Administration (FDA, 2014) and The Thalassemia 
International Federation on survey monkey. Perfect responses, feedback, and suggestions 
were received from them, which helped to decide on the topics or subsections to include 
in the literature review. The pharmacist reviewed the questionnaire with me, and we went 
through the questions together. The necessary modifications suggested or realized would 
be incorporated into the interview questions or questionnaires for the final study.  
Procedure for Recruitment and Participation 
Various strategies to recruit study participants were considered. Local SCD health 
facilities especially those I am already acquainted with example, UT Southwestern 
health, the Texas Oncology's SCD departments and The Sickle Cell Association of Texas 
Marc Thomas Foundation (SCATMTF) among others were contacted. Permission was 
sought from the administration and leaders, respectively from those that were interested 
and also in a good position to participate due to COVID to recruit study participants. 
Working group members or leaders of online SCD communities and platforms like 
Generation S, oneSCDvoice, Raremark and others were also approached for permission 
and help to recruit members to participate in the research. Other social media platforms 
like Facebook, and others were also used to recruit study participants. Last but not least, 
acquaintances known to have the disease or relatives with SCD were contacted for 





Since most of these communities are remote, most of the contact were done 
through emails, text messages and phone calls. Monetary gifts were used to motivate 
participants where necessary. A letter of consent was designed and issued to participants 
to explain to them the study procedures, their roles to get their agreement or approval to 
participate. The Walden Institutional Review Board (IRB) approval was obtained before 
participants were recruited and allowed to participate. 
Data Collection Method 
Emails, text messages, and phone calls were sent out to the participants that were 
purposively selected to participate in the data collection. Different categories of 
participants were anticipated based on the geographic distribution of the SCD 
community, and due to COVID, the data collection was conducted mainly through phone 
interviews, by emails, and other social media platforms using questionnaires. Most of 
interviews conducted, lasted between 40 to 90 minutes. A consent form was issued to 
participants to explain the terms and conditions of the whole process, what their role in 
the study is, that it is a voluntary process, how their information would be protected and 
used, among others. Thus, it was used to explain to the participants as much as possible 
the intent of the study. Participants were made to sign the consent form electronically by 
emailing back “I Consent” before they were allowed to participate in the study. The data 
was collected solely by me. The entire data collection process lasted for about a month 
and half. At the end of the data collection, the responses of some selected study 
participants especially the adult SCD patients were reviewed with them to guarantee that 




attained with the 11 study participants, it was no longer necessary to gather any more  
information from archived data and patients shared stories from online SCD communities 
or groups such as Generation S sponsored by Novartis Pharmaceuticals Corporation, 
oneSCDvoice, Raremark. 
Data Analysis Plan 
Several strategies were employed in the processing and analysis of the data that 
were collected. An example is a content analysis, which, according to Bengtsson (2016), 
is purposely for organizing and obtaining meaning from the data collected in order to 
draw realistic conclusions from it. The principles of content analysis was used to seek out 
individual words, code them and developed themes from the data through which the 
necessary interpretations and inferences were made when all participants’ responses and, 
audio-recordings collected and taken were studied and analyzed (Hagan Asamoah, 2018). 
Another strategy that was used for the data analysis is a narrative analysis whereby 
participants responses were used to retell or reformulate participant's stories to be able to 
give a better presentation of their perceptions and present the findings in a format that 
meet the expected requirements and expectation of a doctoral dissertation (Hagan 
Asamoah, 2018). Manual transcription was employed in transcribing and coding of all the 
enormous amount of data that were collected during the research using Microsoft Word 
Processing and Excel to aid in the process.  
Issues of Trustworthiness 
"Trustworthiness depicts how a research study has been conducted competently 




worth and that the results are credible and good to guide further research and practice" 
(Rallis & Rossman, 2009, p. 281). Guaranteeing the trustworthiness of the data collected 
is a vital aspect of the research process. Some of the ways the issues with trustworthiness 
were handled are by letting the dissertation chair and committee member review the 
questionnaire and the interview questions and also conducted a pilot study to test their 
efficacy and quality. The trustworthiness of the study implies how best the data collected 
or the findings can be trusted. Another way to ensure trustworthiness was establishing a 
rapport with the study participants and thus gained their trust and confidence which 
guaranteed reliable responses. "To guarantee trustworthiness, qualitative researchers must 
demonstrate that their data analysis has been conducted in a precise, consistent, and 
exhaustive manner through recording, systematizing, and disclosing the methods of 
analysis with enough detail to enable the reader to determine whether the process is 
credible" (Nowell et al., 2017, p. 1). Shenton (2004) claimed that the trustworthiness of 
qualitative research is often questioned by positivists because their concepts of validity 
and reliability cannot be addressed in the same way in naturalistic work" (p. 1). 
Employing the Guba constructs, Shenton (2004) proposed four criteria to address 
trustworthiness, which are credibility/ internal validity, transferability/external 
validity/generalizability, dependability /reliability and conformability/objectivity. 
Credibility/Internal Validity 
Shenton (2004) declared to resolve credibility; researchers need to demonstrate 
that a true picture of the phenomenon under scrutiny is being presented. Triangulation 




to different study participants, collect the data from different sources using different 
methods affirming case study as appropriate for the study. Member checks was also 
employed by letting participants review their responses to interviews or questionnaires 
for correctness. I had the responsibility to provide detailed descriptions of the 
participants' standpoints or perceptions as honestly and thoroughly as possible, that my 
viewpoint was integral reflecting in the report (Rallis & Rossman, 2009). These authors 
suggest that this can be achieved by designing the study in such a way that the data are 
gathered over a significant time, or, very intensively if over a short period of time and to 
triangulate using employing different data collection methods such as interviewing, 
observing, and document review (Rallis & Rossman, 2009). I also documented the 
process of gathering, analyzing and interpreting the data by keeping a log or journal and 
writing analytic memos, recording the intellectual journey of my study and thus proving 
to my readers and users of my findings that it was carefully and thoughtfully conducted 
(Rallis & Rossman, 2009). 
Transferability/External Validity/Generalizability 
It was expected that enough detail of the context of the fieldwork for the findings 
should be provided to be deemed justifiably to be able to apply it to other settings 
(Shenton, 2004). My findings in this study were presented in such a way that they could 
be used or applied in other settings. To achieve or guarantee the transferability of my 
study findings, Rallis and Rossman (2009) proposed complete descriptions of the 
conceptual framework that were used, the design of the study, the data collection 




interpretations and conclusions. I used a common coding scheme, The Code and Coding 
Technique, to ensure and compare my findings with conflicting and similar literature 
(Sinkovics et al., 2008). I also tested the equivalence of the research topic example by 
pre-testing the definition of the concept (Sinkovics et al., 2008). A full description was 
adopted by giving detailed descriptions and interpretations of the data that were collected 
and any other situations that were observed during the study. I saw to it that the study is 
reproducible so that other researchers can duplicate or repeat it later. 
Dependability/Reliability 
Data auditing was done to enhance the dependability of the data. According to 
Silverman (2003), reliability can be ensured by using standardized methods to write filed 
notes and proper transcripts for interviews and textual studies and by comparing the 
analysis of the same data by several observers. Thus the responses of different 
participants were compared to check for consistency. The research report should be 
logical, transparent, and consistent and allows for replication (Sinkovics et al., 2008).  
Confirmability/Objectivity 
I had the responsibility to take the necessary steps to demonstrate that the findings 
were really from the data collected and not my views or proclivity to avoid bias. 
Objectivity was achieved by making use of an external audit, such as allowing 
participants to review and react to data and my interpretations (Sinkovics et al., 2008). I 
was alert and coherent of my background assumptions, the definition of behaviors, in the 
literature review in order not to over-represent the problem (Sinkovics et al., 2008). 




still was detached enough which enabled me to make good observations (Sinkovics et al., 
2008). I was conscious of my actions, perceptions, and thoughts so as not to influence the 
outcome of the study to avoid bias.  
Ethical Procedures 
Rallis and Rossman (2009) claimed that an unethical study is not a trustworthy 
study (Rallis & Rossman, 2009). Thus, I had the responsibility of conducting the study 
ethically, with deep sensitivity to the needs and interests of the study participants (Rallis 
& Rossman, 2009). This was achieved by employing vigilance and thoughtfulness 
throughout the entire research, which included an approach to critical gatekeepers, 
selecting study ethically by using Walden's and other professional codes of ethics or 
standards for conduct that are based on moral principles (Rallis & Rossman, 2009). 
Ethical principles were used to guide the research in addressing any issues that rose from 
the study in order to meet the goals of the research as well as to maintain the rights of the 
research participants (Orb et al., 2001). Because the data were collected remotely or 
digitally and considering the vulnerability of the study population, sensitivity was a 
priority based on how private, sacred, or stressful the management of SCD is, how much 
potential there is for stigmatization, and how politically controversial the issues (opioid 
crisis and prescription drug abuse) are (Tiidenberg, 2020). Hence, the possible 
consequences from participating in the study to both me and the study participants were 
taken into account (Tiidenberg, 2020). 
Summary 




sections were addressed or defined, such as the study design and the rationale, who the 
study population or target audience were, method that was employed to select 
participants, thus the sampling population using purposive sampling while employing tact 
in order to prevent bias and also snowballing sampling was also incorporated due to 
COVID-19. The data collection and analysis processes that were used, considering the 
study design were also discussed. Also, the necessary procedures and steps that need to 
be followed to ensure the study's trustworthiness and that the appropriate ethical 





Chapter 4: Results 
Introduction 
 This case study research was undertaken to investigate SCD patients’ and their 
parents/caretakers’ experiences and perceptions about employing alternative treatment 
options (both pharmaceutical and nonpharmaceutical products) in lieu of opioid 
analgesics for pain management. The study was built on the premise by such researchers 
as Majumdar et al. (2013) that CAM is effective in controlling SCD pains. Poor 
management of these pains usually results in poor QOL for patients and their families, as 
it usually impacts the psychological, sociological, physical, and spiritual aspects of the 
individual’s life. It renders basic daily activities such as working and attending school 
very difficult to do and results in frequent hospital visits or hospitalizations, which may 
be associated with high hospital costs and hence financial burdens. Jalalian and 
Anokwuru (2017) suggested the need to provide healthcare plans for SCD patients to 
reduce hospital admission costs for patients who stay in the hospital for extended periods 
of time and promote more preventive therapies such as bone marrow transplantation 
(BMT), use of traditional medicine, and use of community care. It was based on some of 
these presumptions that I conducted this study. 
The primary data collection instrument for the study was semi-structured 
interviews supplemented by reviewing patients’ or family members’ shared stories. The 
subtopics treated in this chapter include the pilot study, setting, demographics, data 
collection, data analysis, evidence of the trustworthiness of the data, and study results. 




The study was guided by these research questions: 
RQ1.  What are the experiences of the SCD patients or their parents/caretakers 
regarding the current prescribing habits of their HCPs to manage SCD 
pain, and how do they influence their choice of treatment? 
RQ2.  What are the experiences and attitudes of the SCD patients or their 
parents/caretakers toward alternative treatment methods, and how do they 
influence their choice of treatment? 
RQ3.  What is the stage of readiness for adopting alternative treatment methods 
for SCD patients or their parents/caretakers? 
RQ4.  How does disease perception among adult SCD patients or their 
parents/caretakers impact their willingness to try alternative treatment 
methods?  
Pilot Studies 
After receiving IRB approval, I performed a pilot study with two participants, a 
57-year-old parent and an 18-year-old patient. I conducted semi-structured face-to-face 
interviews at their home as practice, as well as to gain logistical insights and test the 
effectiveness or correctness of the data collection instrument. Malmqvist et al. (2019) 
proposed three aims of a pilot study: (a) to gather data to provide guidance for a 
substantive study adapted to modify research procedures and instruments, (b) to help 
researchers effectively utilize observational and video-recorded data, and (c) to test a 
theoretical model as a tool of analysis. These authors also emphasized that the importance 




interviews are used, is to enable researchers to be better informed (especially for novice 
researchers; Malmqvist et al., 2019). Pilot studies also help researchers to prepare to face 
the challenges that are likely to arise in their substantive studies and to gain more 
confidence in the instruments to be used for data collection (Malmqvist et al., 2019). 
Malmqvist et al. added that proper analysis of the procedures and results from a pilot 
study helps to identify any weaknesses of the instrument so that they can be corrected. 
Thus, a carefully organized and managed pilot study has the potential to increase the 
quality of research, as the results can inform subsequent parts of the research process 
(Malmqvist et al., 2019). Accordingly, I conducted this pilot study to evaluate the 
effectiveness or appropriateness of the interview questions, any anticipated challenges, 
and mistakes that needed to be corrected before administering the instrument to the main 
study participants. 
Setting 
Due to COVID-19, data collection was conducted virtually, mainly through phone 
calls, employing semi-structured interview techniques. Additionally, some of the 
interview questionnaires were administered through email or text, based on participants’ 
choices. Thus, the study settings were the homes or residences and offices of the study 
participants, as well as my home. The semi-structured interviews were therefore 
conducted under very comfortable conditions. The participants were assured of the 





The target population for this study consisted of patients, parents, and caretakers 
in the SCD community. A recruitment flyer was posted on popular social media 
platforms such as Facebook, as well as on the social media sites of partner organizations 
such as SCATMTF and Raremark. Through Raremark, I also got linked to the Living 
with Sickle Cell, Inc organization, where some of the study participants were recruited. I 
also sent the recruitment flyer to all of my contacts using WhatsApp, Messenger on 
Facebook, LinkedIn, and email.  
Snowball sampling had to be employed in recruiting participants as the pandemic 
made it difficult to find potential participants. The recruitment of study participants was 
done basically virtually due to COVID-19; hence, I had to also depend on some of the 
study participants to recruit other participants. Several people or support groups 
expressed interest after randomly posting on the social media of some online SCD 
support groups, with some of the leaders promising to assist in recruiting members from 
their groups. Initially, there were about 35 leads or potential participants expressing 
interest when the recruitment flyer ad was launched.  
Employing the techniques of purposive and snowball sampling, I selected 11 
individuals to participate in the study based on their experiences, availability, time 
constraints, time zone, financial constraints, and location (some of the groups that I 
contacted were international groups). All of the participants who were purposively 
selected to take part in the study were located in the United States, but they were located 




It seemed that the state in which a participant was located played a major role in 
their ability and confidence in managing their pain and disease based on the health 
services and the support systems of the state. For instance, one participant who relocated 
from Virginia to South Carolina stated that “in South Carolina the hospitals do not know 
sickle cell disorder well and the doctors … do not treat the disease well, so they always 
sent her child home after an ER visit or hospitalization with fever and pain”. She claimed 
that in Virginia, health services or doctors were more knowledgeable, so the recovery 
time for her child during crisis tended to be a lot shorter. She also maintained that her 
relationships with HCPs in South Carolina were not as good as they had been Virginia. 
She expressed the view that HCPs in South Carolina just do not care but rather they treat 
cancer patients, way more than they do with SCD patients. Another participant from 
Virginia claimed to have a very good relationship and rapport with their HCPS and noted 
that a support group based there had lobbied with the government for SCD patients to be 
treated the same as cancer patients. This participant’s main complaint was about the fact 
that Virginia HCPs treated all SCD patients the same way and did not try to tailor 
treatment plans based on the type of SCD or conditions of the patient. Further, the 
participant observed that because of trust issues between HCPs and patients, patients 
preferred to rely on support groups for emotional support. 
All participants were African or African American; no patient from any other race 
responded to the recruitment ad posted on social media. This was consistent with SCD’s 
higher prevalence among Black people or people of African descent. Of the 11 




were 12 patients altogether, as one mother who took part in the study had two SCD 
patients. Among the patients, seven were males and five were females. The SS type 
(70%) was predominant and these participants with the SS-type seemed to have a good 
understanding of the condition possibly because they seemed to have frequent pain 
episodes and the associated complications. The ages of the study participants ranged from 
23 to 70 years. However, the SCD patients’ ages, based on information provided by 
patients or their parents, ranged from 6 to 70 years. Four of the study participants were 
patients, and seven were parents/guardians of SCD patients under the age of 18. All of 
the seven parents/caretakers who participated in the study were females or mothers, 
suggesting that mothers are more involved in taking care of their sick children and 
managing their pain. Most of the participants had some form of education; seven of them 
claimed to have some graduate degrees three had a college degree, and one had a 
vocational/trade school diploma. The income level of almost all of the participants fell 
below the middle-class level and may be considered low or even very low income; only 
three of the participants could be categorized as coming from a middle-class family.  
Saturation was reached at about the 10th participant, but to avoid sampling bias 
and skewed data, I decided to recruit an extra participant, specifically one with a type of 
SCD (SC) other than SS, as 70% of the study participants were SS patients and only 30% 
were SC patients at the point of saturation. There were no participants representing the 

















































SP3 Parent 12 Female Female $5,001– 
10,000 




SP4 Parent 9 Female Male $70,001– 
100,000 




SP5 Patient 28 Male N/A $5,001– 
10,000 
Graduate Low Black/ 
African 
SS 
SP6 Parent 6 Female Female $40,001– 
50,000 












SP8 Patient 70 Male N/A $10,001– 
20,000 
Graduate Low Black/ 
African 
SC 
SP9 Parent 19 Female Female More 
than 
$100,000 
Graduate High Black/ 
African 
SC 








SP11 Parent 13, 
17 














Employing virtual techniques and tools, data collection was conducted using 
open-ended semi-structured interview questions. The design of the interview instrument 
was guided by an instrument used by the U.S. FDA at a public meeting conducted by the 
agency to hear perspectives from SCD caretakers and other patient representatives on the 
most significant effects of their disease and available therapies. The interviews were 
conducted virtually from the comfort of my and the participants’ residences using phone 
or video calls, texting, and email. I audio-recorded the phone interviews and reviewed the 
recordings to capture any information missed during interview transcription.  
Data Analysis 
Bernard (2011) described data analysis as the search for patterns in data and for 
ideas that help explain why those patterns are there in the first place. As proposed, 
content analysis was employed alongside other feasible methods for data analysis. Babbie 
(2001) also described content analysis as the as a means to examine recorded human 
communications, characterizing it as essentially a coding operation, with coding being 
the process of transforming raw data into a standardized form. Ryan and Bernard (2000) 
also asserted that content analysis is one of the major coding traditions whereby the 
researcher produces a matrix by applying a set of codes to a set of qualitative data (e.g., 
written texts, etc.), with the assumption that the codes of interest have already been 
discovered and described beforehand. Though the codes used were not previously 
described as proposed by these researchers, they were developed based on the interview 




Thus, the code and coding technique was employed in data collection, processing, 
and analysis. According to Strauss (1987), any researcher who wishes to become an 
expert at doing qualitative analysis must learn to code well and easily, as the excellence 
of a research study rests in large part on the excellence of the coding. The code and 
coding technique was deemed appropriate for this study because it makes it easy to link 
the data back to the research questions and propositions, rendering the interpretation of 
the output from a case study subtler and easier to understand (Miles & Huberman, 1994). 
According to these researchers, the code and coding technique uses the case-oriented 
approach strategy referred to as “partial ordered displays” to analyze a case study, which 
allows for the quick identification of segments relating to the research questions and any 
potential themes (Miles & Huberman, 1994).  
Coding the data was imperative because, as Miles and Huberman (1994) put it, 
codes were used as labels to assign symbolic meaning to the descriptive or inferential 
information compiled during the study. Atkinson (2002) described coding as assigning 
“tags” or “labels” to the data collected, by which the data are organized and managed. 
Richards and Morse (2007) also asserted that coding is a key part of a qualitative data 
analysis, and at times is considered to be synonymous with the analysis or an early form 
of analysis, as it serves as an interpretive process of moving from the data to the idea, and 
from the idea to all the data pertaining to that idea.  
The coding of the data was done concurrently with the data collection, which 
helped to speed up the process. Hartley (2004) asserted that when the data collection and 




study. Miles and Huberman (1994) also argued that it enables the researcher to go back 
and forth between thinking about the existing data and generating strategies for collecting 
better data and also makes analysis an ongoing, lively enterprise that contributes to the 
energizing process of the research.  
According to Kohlbacher (2006), the analysis of case study data requires a careful 
description of the data and the development of categories in which to place behaviors or 
processes. The data should be organized around certain topics, key themes, or central 
questions and then examined to see how well they fit or fail to fit the expected categories 
(Kohlbacher, 2006). Yin (2003) also claimed that data analysis consists of examining, 
categorizing, tabulating, testing, to address the initial propositions of a study, while 
Neuman (1997) argued that data analysis entails a search for patterns in data, which, once 
identified, are interpreted in terms of a social theory or the setting in which they occur, 
resulting in a more general interpretation of their meaning. 
Yin (2003) proposed three general analytic strategies for analyzing case study 
evidence: relying on theoretical propositions, thinking about rival explanations, and 
developing a case description. With any of these strategies, these five specific techniques 
for analyzing case studies can be practiced that include: (a) pattern matching, (b) 
explanation building, (c) time-series analysis, (d) logic models, and (e) cross-case 
synthesis (Yin, 2003). Thus, I executed the following steps to analyze the data. 
Step 1: Data Processing 
Each study participant’s responses or data were carefully processed before being 




were converted into expanded write-ups as proposed by Miles and Huberman (1994), 
with data entry using Microsoft Word and then data organization and analysis using 
Microsoft Excel. According to Miles and Huberman, a write-up is an intelligible product 
that anyone can read, edit for accuracy, comment on, code, and analyze using several 
methods.  
After the write-ups, codes were generated based on the research questions. A code 
is defined as “a word or short phrase that symbolically assigns a summative, salient, 
essence-capturing, and/or evocative attribute for a portion of language-based or visual 
data” (Saldaña, 2015). According to Atkinson (2002), a code might be used to identify a 
word, a phrase, a sentence, or a paragraph important to the research from which meanings 
are ascribe to the chunks of data of a research (Miles & Huberman, 1994). Hedlund-de 
Witt (2013) also described a code as a lower level of data analysis on the way to labels, 
categories, themes, and theory. Hedlund-de Witt (2013) asserted that the act of coding 
requires that the researcher wears an analytic lens that is based on perception and 
interpretation of what is happening in the data. Saldaña (2013) asserted that the level of 
personal involvement of a researcher as a participant observer either as a peripheral, 
active, or complete member during fieldwork filters how he perceives, document, and 
thus code his data which depends on the types of questions that are asked as well as the 
types of responses that were received during the interviews.  
Once the initial codes were generated, the actual coding process began which 
involved examining chunks or segments of data from the case studies and associating 




cycles of coding were employed for this study that included a first and second cycles 
coding. Microsoft Excel was also used to code and analyze the data. 
Step 2: The First Cycle of Coding 
Basically, it is the initial coding process of the interview transcripts. 
Saldaña (2013) described the first cycle coding methods as codes initially 
assigned to the data chunks and involves applying provisional and tentative codes. 
Hedlund-de Witt (2013) asserted that the magnitude of the data coded during the 
first cycle coding can range from a single word to a full sentence, an entire page 
of text, or a stream of moving images which can be repeated numerous times 
before the second cycle coding.  
A combination of descriptive and in vivo coding strategies were employed 
in this initial coding cycle. According to Miles and Huberman (1994), a 
descriptive code assigns labels, most often nouns to data to summarize it in a 
word or short phrase that serves as the basic topic of a data-passage. Hedlund-de 
Witt (2013) also claimed that descriptive coding summarizes the primary topic of 
the excerpt/datum. It serves as the first step of the data analysis. Thus, some of the 
descriptive codes created during this stage were role, gender of child, household 
income, educational level, SES, coping strategies, support systems among others. 
In vivo coding was used to code significant or outstanding statements by 
participants. According to Hedlund-de Witt (2013), in vivo coding occurs when a 
code is taken verbatim directly from the data and placed in quotation marks and is 




word coding of participants usually placed in quotation marks. Examples are 
opioids treat or help with the pain faster: “fast acting” and religion: “prayers have 
powers”.  
Step 3: The Second Cycle of Coding 
A second cycle coding was conducted to reorganize, classify, prioritize, integrate, 
synthesize, consolidate and conceptualize the huge data and codes compiled during the 
first cycle coding as proposed by Onwuegbuzie et al. (2016). Hedlund-de Witt (2013) 
asserted that second cycle coding methods are basically for reorganizing and reanalyzing 
the data coded through first cycle methods. They are used to explore the 
interrelationships across multiple codes and categories in order to develop a sense of 
thematic, conceptual, and/or theoretical organization and coherence from the first cycle 
codes (Hedlund-de Witt, 2013). 
The principle of focused coding was applied in the second cycle coding. Adu 
(2016) claimed that focused coding helps in identifying “the most frequent or significant 
initial codes” by looking for: (a) code frequencies, (b) codes relationships, (c) central 
codes, and (d) building categories around them. According to Hedlund-de Witt (2013), 
focused coding is usually executed subsequent to initial coding, and it searches for the 
most frequent or significant initial codes to develop the categories or themes that would 
be considered to be more important. Patel (2014) also asserted that focused coding 
categorizes coded data based on thematic or conceptual similarity. Thus, using focused 
coding, the significant codes derived from the first cycle coding were categorized based 




developed by Taylor et al. (2013). Pattern coding was also employed to group the codes 
into a smaller number of categories, themes, and then constructs/concepts After the 
second cycle coding, a code-weave was conducted where the primary codes, categories, 
themes, and/or concepts were compiled into a few sentences. The results are illustrated in 
Table 2. 
Step 4: Codes to Categories 
After the two levels of coding, several major categories emerged from the coded 
data. As Dey (1999) declared, the codes formed are used to compute the categories from 
which meanings were imputed to the data. Saldaña (2013) asserted that when codes are 
clustered together according to similarity and regularity, they actively facilitate the 
development of categories and thus analysis of their connections. Thus, the coding 
enabled me to organize and group similarly coded data into categories or “families” 
because they share some characteristic. Some categories contained clusters of coded data 
which were refined into subcategories as suggested by Saldaña (2013). Hence, about 40 
major categories/subcategories were clustered together under about 15 major cluster of 
themes. An example from the original code, Pain Management, emerged various 
categories/subcategories such as Medications and Coping Strategies.  
Category: Medications 
Subcategory 1: Pharmaceuticals 
CODE: Prescribed 
CODE: Over the Counter 






Step 5: Emergence of Themes 
According to Saldaña (2013), a theme is an “outcome of coding, categorization, 
and analytic reflection, not something that is, in itself, coded” (p. 13). Rallis and 
Rossman  (2003) also described a category as a word or phrase describing some segment 
of the data that is explicit, whereas a theme is a phrase or sentence describing more subtle 
and tacit processes. Using Microsoft Word and Excel, similar statements or responses by 
participants were organized to clusters of categories from which 15 major themes were 
developed. Examples of the clusters of categories formed are pain management, coping 
strategies, religion, ideal treatment, knowledge of symptoms, effectiveness, support 
system, abuse of prescribed medications, participants experience and perceptions. Table 3 
depicts some of the clusters of categories, themes developed and associated research 






























Most of the participants reported of 
decreased frequency in pain crisis most of 
them attributing it to enhanced awareness of 
symptoms, increased in self-confidence and 
improved knowledge on signs and symptoms 
as well as the proper management of pains. 
Most of the participants reported only 1 – 2 
times hospitalization per year with only one 
patient reporting more than 10 times of 
hospitalization and another one 3-5 times. 
The oldest participant, a 70-year old SC 
patient reported his last crisis related 
hospitalization was in 1994 attributing this to 
increased awareness and proper management 
of symptoms and so was a similar story of 
another SC patient. This also depicts how the 
pain crisis and associated complications are 
tied to the type of SCD a patient has. Almost 
all participants reported how pain crisis 
usually results in them either not going to 
school, work and limiting their social 
activities and impact them psychologically 
and financially.  
 
RQ 4 Biopsychological 
Pain 
management 
First line of defense 
maintenance 
Almost all the participants employ some 
form of homecare/selfcare as simple as hot 
baths/pads and pain killers as first line 
defense for pain management especially 
before they head to the hospital during a 
crisis. Most use these also on daily bases for 
managing pains. Most of the participants 
declared they uses natural products like fruits 
and veggies, herbal products like shea butter, 
chlorophyll and nutraceuticals like vitamins 
and pharmaceutical products like 
Hydroxyurea and painkillers daily for 
prevention and maintenance of pains.  
 
RQ 4  Biopsychological 




Abuse of medical 
prescription drugs 





Patients uses both pharmaceutical/ 
nonpharmaceutical 
Prescribed/OTC products; mostly prescribed 
for the management/prevention of pain crisis. 
Most of the participants did not think SCD 
patients abuse prescription medications but 
rather there was this notion by some few 
participants that some patients are compelled 
to take more of their prescribed medications 
because SCD HCPs seemed not to really 
understand the caliber of the SCD-related 
pains, they tend to under-prescribe for their 
patients confirming what previous studies by 
Booker et al. (2016) and others proposed. 
Most of the participants also think HCPs still 
chooses to prescribe opioid analgesics over 
other potential medications because they are 






























the pain quicker. Most of the patients are 
also taking Hydroxyurea for prevention or to 
reduce the frequency of pain crisis and 
attribute the reduction in their pain episodes 
to it. However, one patient who claimed has 
being using it for 4 years; said Hydroxyurea 
increases the chances of getting infections; 
and because it is supposed to be a 
chemotherapy it is affecting his hair growth; 
and also reduces his appetite. Another parent 
claimed it rather helps to prevent infections. 
Overall, there was no serious side effects 
reported for any of the other medications 
nevertheless the possibilities of side effects 
were the main reason most of the participants 
were skeptical in trying other or new 












Participants gave various coping strategies 
they have been employing to manage their 
pains. This ranges from natural products,  
self-care management and self-
awareness/mindedness. Most common 
strategies mentioned were keeping hydrated 
by drinking more water, taking hot showers 
or using hot pads, eating healthy, doing or 
managing stress, distraction, rest, massaging, 
prayers. Unique or new strategies learned 
were aromatherapy, shea-butter because of 
its anti-inflammatory properties, chlorophyll, 













Participants have had diverse experiences 
with their pain management but overall.it 
seems they have had success stories. Most of 
them have already tried alternative regimens 
and there was a split. Whilst some feel they 
are very effective and even though they have 
contributed towards the reduction in the 
frequency of their pain crisis episodes, others 
thought they were not that effective as the 
orthodox ones (opioid analgesics) they have 
been using. Almost all of them are open to 
exploring alternative regimen but few 
thought there is no need for change or try 
new treatments if what they are already using 










All of the participants claimed to pray and 
also rely on others praying for/with them 
especially during crisis. Whilst some of them 
put more energy or focus on them because 
they deemed it effective, others however 
claimed they are not that effective as one of 
them put it because prayers do not actually 
take the pains away. Another patient rather 
maintained or insisted on the effectiveness or 
the role prayers played in managing his pains 
declared that he prays a lot and think that if 
not for God have been dead a long time ago. 
He claimed prayers help a lot to soothe the 
pains especially during hospitalizations 
before the analgesics administered to him 


























start to work on him, he depends on prayers 
to help him stay calm and comfortable. He 
said there are always a hospital chaplain and 
a sister who usually prays with him during 
such times and it has been very effective. 
Others also attest to how helpful prayers 
have been to them. 
Few uses other religious activities like 












Most of the participants belong to support 
group or have a form of a support system 
especially family members and 
religious/spiritual leaders/members that they 
lean on especially during crisis and also 
information and resources. One parent stated 
that she used to feel very lonely and unsure 
of herself but since she joined a support 
group she does not feel like that anymore and 
she now feel more confident especially in 
managing her son’s pains and in handling 
other related issues . Another parent who 
happened to be a leader of a support group 
also claimed that when it comes to emotional 
or psychological issues related to SCD, most 
patients prefer to turn to their support group 
for help instead of their HCP team. However, 
one patient stated that he does not like 
joining support groups hearing and being 
around other SCD patients negatively 
impacts him: it usually make him more 
depressed. 
 
RQ 2 Sociological 
Psychological 




Various views were given concerning what 
an ideal treatment should be but most wanted 
treatments that are safe, capable of 
preventing or eliminating pain crisis, easy to 
administer or use, less invasive on organs; no 






Financial SES  
Insurance policy/coverage 
Aside from a couple of the participants can 
be classified as from middle class families, 
almost all of the participants were of low 
SES, with average annual income of $20,000 
to $300,000 dollars which can be a strong 
determining factor in the choice of treatment 
options, health services to engage in etc. One 
of the major triggers of pain crisis and with 
such low SES or income levels stress and 
their associated health issues are inevitable 
among SCD patients and their families. 
Participants had varied educational levels 
with some of them even at the graduate level. 
It was observed that participants with higher 
educational levels have better control of the 
disease as they use more sophisticated or 
better management strategies than those with 
low educational level. Actually, the oldest 
patient/participant, a 70 year old SC patient 
nicknamed “the model patient” used to be a 
Language Professor at Harvard University 















hospitalization was in 1994 attributes his 
current good health status to healthy eating 
habits. He claimed his pain crisis frequency 
reduced drastically when he learned of the 
importance of taking folic acid daily, eating 
healthy and drinking alkaline water which he 







Categories, Emerged Themes, and Research Questions 
 
Categories Emerged themes Research questions 
Knowledge Knowledge about other treatment 
options 
RQ 1 
Knowledge Knowledge on SCD RQ 1 
Effectiveness Effectiveness of the medication RQ 1 
Perceptions Personal reasons such as lack of 
concern/care and benefits 
RQ 1 
Experiences Participants’ experiences RQ 2 






Pain management Type: Coping strategies/other 
regimens 
RQ 2 
Perceptions Participants’ perceptions RQ 3 
Alternative treatment 
options 
Resistance to change RQ 3 
Pain management Ideal treatment 
Research 
RQ 4 









This study was conducted purposely to investigate and analyze various alternate 
treatment options study participants have been using, how effective and safe they have 
been, and if they can be applied or recommended for others. Hence, the experiences and 
perceptions of participants on alternative treatment options were explored as well as other 
related issues like practitioners prescribing habits, access to health services, challenges 
among others. About 15 themes evolved during the data processing and analysis which 
were aligned with the research questions.  
Research Question 1 
By addressing RQ1: What are the experiences of the SCD patients or 
parents/caretakers regarding the current prescribing habits of their HCPs to managing the 
SCD pain, and how does this influence their choice of treatment; participants gave 
diverse views on why their HCPs prescribe certain type of medication and why they 
mostly chooses to go with whatever their HCPs prescribe or recommend for them. Some 
of the themes that emerged under this question were:  
▪ effectiveness of the medication 
▪ knowledge about other treatment options 
▪ knowledge on SCD 
▪ personal reasons such as lack of concern/care and benefits 
Theme 1: Effectiveness of the Medication 
Participants claimed their HCPs are accustomed to prescribing certain 




especially choose to prescribe opioid analgesics over others because they “help with the 
pain faster”; thus they are fast-acting. SP7 also affirmed that opioids are very effective 
which makes HCPs opt to prescribe it more. SP6 also asserted that HCPs prescribed 
opioids especially because they know how quick the opioids will help to alleviate the 
pain. SP2 claimed HCPs are open to prescribe varied medications, but they prescribed 
mainly opioid analgesics because pains are the main issue or challenge with SCD; it is 
also based on the type of the disease a patient has which determines the type of 
medication that may need to be prescribed for the patient. SP3 also maintained that HCPs 
prescribed specific medications based on the condition the patient is going through and 
employ different medications too with that effect.  
Theme 2: Knowledge/Awareness About Other Treatment Options 
Most of the participants confirmed that their HCPs are aware of other treatments 
and may occasionally discuss with and recommend some of these treatments to them. 
However, they are mostly pharmaceuticals. SP2 stated that HCPs at times expressed 
concern about polypharmacy because of the various medications they keep prescribing, 
but they still just keep switching (prescribing) to new medications without doing anything 
about it. Thus most of the medications prescribed are not that effective so they keep 
prescribing and trying new medications. SP2 happened to be one of the patients whose 
condition is still on the worse side and still gets frequent pain crisis (more than 10 times 
in a year), more hospitalizations, and associated complications. SP3 also asserted that 
HCPs choose to prescribe specific medications because of insurance issues. SP3 stated, “I 




However, some of the participants believed their HCPs are not really aware or 
have little knowledge of other treatments, their mode of operation, and their 
effectiveness. According to Sohail Rana of the Center for SCD Howard University, 
misinformation abounds concerning Hydroxyurea so many physicians do not prescribe it 
or do not provide adequate information about it. SP4 declared, “HCPs have less 
awareness of other meds and are misrepresented.” According to SP11, the HCPs are only 
interested in bone marrow, stem cell therapies, or clinical trials, but patients are not given 
much information to help them to understand the role of these therapies in their pain 
management. 
Theme 3: Knowledge on SCD 
Most of the participants stated that their HCPs do not really have enough 
knowledge or really understand the caliber of the SCD pain thus tend to under prescribe 
in terms of dosage and strength of medications as well as influencing their choice of 
medications to prescribe. According to SP4, “HCPs knowledge on SCD is about a level 
of 7; they treat all SCD cases or patients the same way. They don’t try to tailor treatment 
plan based on the type or conditions of the patient.” According to SP11, HCPs prescribe 
only specific medications because of lack of knowledge in the disease and in other 
medications all because of a lack of education and recommended strongly that SCD 
HCPs need to be educated more on the disease itself and on alternative treatments. SP11 
added how some Caucasian SCD patient acquaintances are being constantly denied SCD 
related health care or services specifically medications or treatment because HCPs do not 




Black people or people of Africa descent and other minorities.” This attests to the 
observation or notion made in the literature review regarding globalization and interracial 
marriages. SCD is no longer an “only Black people disease” but it now transcends races 
and has now become a global issue hence the need for the public health sector to give 
more attention to it. According to the WHO (2020), approximately 5% of the world’s 
population carries trait genes for hemoglobin disorders, mainly sickle-cell disease and 
thalassemia. It is speculated that currently, nearly 90% of the world's sickle cell disease 
population lives in these three countries: India, Democratic Republic of Congo, and 
Nigeria with the prevalence of cases higher in India confirming that SCD is no longer a 
Black only disease.  
Theme 4: Personal Reasons Such as Lack of Concern/Care and Benefits 
Some participants also maintained that their HCPs prescribed specific 
medications because of personal reasons such as lack of empathy and benefits. SP3 
claimed HCPs know about other treatments but being African American and poor makes 
them choose specific medication for her child. SP3 stated, “Also, they ask about 
participants concerns but you can tell they do not care.” Thus, financial status of the 
participant plays a major role in this. Eight out of the 11 (73%) considered to be of low 
SES and the remaining three, middle class or SES, this may help to highlight the trend of 
HCPs’ prescribing habits or choice of medications especially when it comes to the newly 
approved SCD medications as cost may play a major role in this. For instance, SP11 
maintained that their family cannot afford the new medications especially endari. The 




insisted that the SCD patients still need their opioid analgesics. The new medication, 
adakveo, for instance costs between $7,000 and $9,500 dollars per month but is claimed 
to be covered under the medical benefit and so is oxbryta which costs] $10,417 dollars a 
month. It is estimated that the average sickle cell disease patient is estimated to face 
nearly $1 million dollars in total lifetime health care costs with annual costs of more than 
$30,000 dollars for adult patients (Novartis International, 2019). Nevertheless, SP10 also 
argued that “HCPs choose to prescribe certain meds because they may receive additional 
money (kickbacks) from the drug maker to promote those medicines versus other 
therapies.” 
Research Question 2 
In response to RQ2: What is the experience and attitude of the SCD patients or 
parents/caretakers toward alternative treatment methods, and how does this influence 
their choice of treatment? Participants have had diverse experiences with their pain 
management using alternative treatment methods but overall, it seems they have had 
success stories. Most of them have already tried alternative regimens, and there was a 
split. Whilst some feel they are very effective and even have contributed toward the 
reduction in the frequency of their pain crisis episodes, others thought they were not that 
effective as the orthodox ones (opioid analgesics) they have been using. Themes that 
were developed included: 
• accommodating attitude 
• participants’ experiences/perceptions 




• effectiveness/efficacy, safety/side effects, cost/affordability 
Theme 1: Accommodating Attitude 
Most of the participants claimed they are open to try other regimens. SP1 stated 
that being open to other options and would like her daughter to try them to see which one 
helps better. SP1 also felt alternative regimens are necessary so that patients would have 
a lot of options to choose from. SP4 was open to any evidence-based treatments and 
thought they should be incorporated into SCD treatment plans. SP5 supported the use of 
other treatment methods to curb pain crisis. SP7 was open but did not deem it not 
applicable to her now because medications her son was taking were working pretty well. 
Maybe in the future when her son gets older and then there is the need to explore other 
options, they will then do so. SP10 also supported that everyone should try and explore 
other options, and HCPs should be encouraged to prescribe or try these new/other 
therapies more due to the belief there are better therapies than what is currently being 
used.  
Theme 2: Participants’ Experiences/Perceptions 
Almost all the participants seemed to have tried some form of alternative 
treatment ranging from homecare/selfcare to religiosity. Most commonly used regimens 
aside from pharmaceuticals were natural products including: (a) diets; (b) drinking more 
water” (c) nutraceuticals; (d) herbal products most unique ones stated were chlorophyll 
and shea butter; (f) homecare/selfcare management like applying hot pads, taking hot 
baths/showers, applying shea butter, and coconut oils; (g) listening to music and watching 




very successful with alternative treatments especially diets, less stress, staying hydrated, 
and rest. SP2 recommended more African foods. SP2 stated, “I always encourage as 
much natural treatment as possible before making opioids an option.” Both SPs5 and 6 
claimed that they have not tried any other regimen. SP5 mentioned not yet trying out any 
other regimen due to not having used nonpharmaceutical medications before. SP11 
admitted to giving chlorophyll to her two sons with SCD, and it has been very effective 
as it helps by increasing blood level and the formation of new hemoglobin cells which 
may reduce or get rid of sickled cells. It was observed that educational level played a 
major role in the participants’ experiences and readiness to explore alternative treatment 
options as most of the participants who were in support of using alternative interventions 
were mostly of higher educational levels (graduates) with most of them confirming that 
they do their own research on alternative therapies that offer better treatment options. It 
was also observed that these participants have better control over their condition.  
Theme 3: Type: Coping Strategies/Other Regimens 
SP1 declared that her daughter takes hot baths especially at the onset of a pain 
crisis which she claimed works well and is very effective. SP1 attributed success to 
saying a lot of prayers, using heating pads, getting a lot of massages, and listening to 
music as a distraction during pain crisis. SP1’s daughter also uses biofreeze during crisis, 
and for prevention she uses hydroxyurea and also takes iron vitamins daily. SP1 also 
talked about praying always for her daughter, which has been very helpful and added 
“prayers have powers.” SP2 stated discussed using massage therapies including breathing 




therapies early before the pain intensifies might help a bit, but if the pain has already 
intensified, they usually do not work or help. SP2 tries to stay hydrated by drinking a lot 
of water and staying warm, eating healthful diets, uses prayers, hot pads therapy, music, 
and acupuncture as well as other pharmaceutical products. SP2 recommended eating 
African food products (which are mainly plant foods). SP2 stated,  
I pray a lot because if not for God, I do not think I will still be here. Praying has 
been very effective for me especially during hospitalizations and when my meds 
are not working, prayers help a lot by helping me to relax and somehow soothe 
the pain. My sister usually prays with me whilst I wait for a doctor and at times 
too I get the opportunity to communicate with the hospital chaplain who may at 
times pay him a visit which is also always helpful. Yes, even at the hospital there 
is always a chaplain to pray and counsel me which helps to release fear. I also 
always try to avoid stress, a major trigger for pain crisis.  
SP3 asserted that staying hydrated is beneficial. SP3’s daughter drinks more 
water, 100% juices, and smoothies which includes adding vegetables without her 
knowing it. SP3’s daughter eats healthy and balanced diet (fruits and veggies) especially 
diets high in iron, takes nutraceuticals/ vitamins such as omega 3 daily, and practices skin 
care by applying skin moisturizers like shea butter, coconut lotions, and creams after 
showering and washing hands and face. SP3 also added, “I do pray. I believe God can 
work through the doctors, but they would have to care about their patients first.” SP4 also 
affirmed using or applying shea-butter on his son’s body daily especially during pain 




chlorophyll liquid daily (purchased from Amazon) because it increases the oxygen level. 
SP4  also always uses an air purifier in the child’s room so to ensure the optimum or 
maximum amount of oxygen. SP4 also believes in prayers which seemed to help a lot.  
SP5 uses massages with hot water and application of hot ointment at the joints 
with pains, drink lots of water, eats hot foods always, and avoids stress and fatigue. SP5 
also takes folic acid, Vitamin B complex, motivite, zincovite, and ibuprofen. Concerning 
employing religiosity however SP5 stated, “I do not believe it…superstitions.” SP6 
claimed they currently do not use any alternative therapies at home but daughter plenty of 
water to ensure hydration. When that does not control her pain, then they head to the 
emergency room. SP6’s daughter also takes hydroxyurea daily to suppress pain crises and 
prevent infections. SP6 stated, “I do think religion and spirituality play an important role 
regarding the impact on managing pains.” They have been using prayers and confiding in 
spiritual/religious leaders. SP7 employs distraction by watching wrestling which helps 
her son to calm down during crisis and incorporates massaging, hot pads, and listening to 
soft music. SP7 also depends on and always call their Pastor and his wife and church 
elders to pray with/and for them during crisis. However, she felt, “Prayers are not 
effective because they do not make the pain go away.” SP8 eats more fruits, vegetables, 
and herbs such as lemon and avocado. SP8 maintains a diet low on peanut and meat 
because of the high oil content. SP8 employs prayers and fasting which due to the claim 
it helps with detoxification of the body. SP8 also drinks mainly alkaline water especially 
when taking medications and uses the Kangen machine that sieve/filter the water which 




years and claimed it has been very effective and believe has contributed a lot to the 
current improvement or good health. SP8’s last pain crisis that resulted in a 
hospitalization and a blood transfusion was in 1994.  
SP9 rests by sleeping more at times, employs massaging with hot ointments like 
Bengay or warm cloths, prays a lot, and engages in some religious activities which 
includes going to church or consulting with a pastor to pray for her daughter. Faith has 
played a major role, including using distractions, and eating healthy. 
SP10 employs rest, drinking water, applying heating pad, and using aromatherapy 
with essential oils with a diffuser as it helps with relaxation and to not think about the 
pain. SP10 also takes multivitamins, folic acid tablets, and uses Epsom salt. SP11 also 
gives chlorophyll liquid to her sons which helps increases the blood level, helps form 
new HgB, and may reduce or get rid of sickled cells. SP11 consults/confides in 
spiritual/religious leaders during crisis and relies on her Christian faith. 
Theme 4: Effectiveness/Efficacy, Safety/Side Effects, Cost/Affordability 
The effectiveness/efficacy, safety/side effects, and cost/affordability are some of 
the factors that participants consider before they employ/explore a regimen. Overall, 
there was no serious side effects reported for any of the other remedies, but the possibility 
of side effects were the main reason most of the participants were skeptical in trying 
other or new treatment options. SP2 declared being open to alternative treatments but 
usually request about side effects. SP3 talked about loving and using a lot of natural 
treatments (produce) but thought they should be used only in extreme cases and if it there 




vital organs like the liver. SP2 maintained that alternative treatment options are effective, 
but they come with a price and side effects. SP5 declared that some of the alternative 
regimens really help because constant intake of them (folic acid, Vitamin B complex, 
motivite, and zincovite) help to boost the immune system that will eventually produce 
good red blood cells in the blood without it being sickled or curved which apparently 
helps in reducing the number of pain crisis. SP9 also asserted that most of the alternative 
regimens can be very effective as they may offer better treatment options such as 
reducing the frequency or intensity of pain crisis. SP10 discussed being open to new 
therapies if they are safe to use in the body and had the perception that they are not very 
effective. 
Research Question 3 
RQ3: What is the stage of readiness for adopting alternative treatment methods 
for members of the SCD patients or parents/caretakers? Almost all of the participants 
were open to exploring alternative regimen but few thought there was no need for change 
or try new treatments if what they are already using (opioid analgesics, etc.) are working. 
Themes developed were:  
• participants’ perceptions 
• resistance to change 
Theme 1: Participants’ Perceptions 
The majority of the participants expressed an interest in trying new therapies and 
contributed diverse views to that effect. SP4 embraces any treatments that are evidence 




stated, “Well, I will promote any new therapy positively if it is approved by food and 
drugs authority and if the aim in which it was used will be achieved. Purposefully!” SP6 
recommended that SCD doctors/nurses should be willing to try new/other therapies so 
there can be many options available for different families and their choices. SP8 
maintained that alternative treatments are very important and must be encouraged as due 
to drastic improvement of his health and overall living conditions since starting to eat 
healthy and drinking alkaline water. SP9 thought SCD HCPs should try other options like 
diets, nutrients, hot pads, massaging, prayers, and others that can also help with managing 
pains and may even possess the potential to reduce the frequencies of pain crisis. SP9 
stated, “Alternative treatment options should be promoted since there is still no cure that 
works for all patients.” 
Theme 2: Resistance to Change 
Some of the participants seemed to be at the contemplation stage of the TTM and 
though claimed to be open to using alternative interventions, they still did not see the 
need to stop or switch from opioid analgesics as it works perfectly for them. SP1 claimed 
being open to other options but expressed hesitation to change when the one you are 
currently on is working. SP7 also claimed to be open to other regimens but did not deem 
them necessary for her son now due to medications or treatment plans (opioid analgesics) 
her son is on are working pretty well. SP7 added, however that may be in the future when 
her son gets older, and there is the need to explore other options they will then do so. SP7 
felt that is a decision that her son needs to make himself so they will continue with the 




preferred regimens to use. SP11 asserted that there is no need to change or stop the 
current treatment regimen due to opioids such as morphine and hydrocodone working. 
SP11 added that blood transfusions are effective because they increase the blood level 
and help patients get better as they may get rid or reduce the production of sickled cells, 
but they have the side effect of iron overload. 
Research Question 4 
By addressing RQ4: How does disease perception among SCD patients/caretakers 
impact their willingness to try alternative treatment methods? Almost all of the 
participants claimed to have a pretty good knowledge of the disease including its 
signs/symptoms and some of the associated comorbidities which influences their choice 
of treatment options. Some of the themes that emerged under RQ4 were: 
• knowledge/awareness/ confidence in managing pains 
• ideal treatment 
• research  
• education/creating awareness 
Theme 1: Knowledge/Awareness/Confidence in Managing Pains 
Most of the participants claimed having an awareness of symptoms, increase in 
self-confidence, and improved knowledge on signs and symptoms as well as the proper 
management of pains. SP1 discussed having a pretty good knowledge about the 
symptoms of SCD. SP1 felt her daughter’s HCPs are also very knowledgeable or 
understand the condition very well. SP1 felt very confident in managing her daughter’s 




which affects his concentration especially during classes and easily causes him to be 
angry at onset of crisis. His HCPs are pretty knowledgeable about SCD and always 
discuss with and prescribe alternative medications although they are also concerned about 
the possibility of polypharmacy with the numerous medications they keep prescribing for 
him to help keep his pain crisis and condition under control. S6 declared that her 
daughter's HCP understands her daughter's condition well and is always researching new 
techniques and treatments. Though she claimed to know her daughter’s symptoms (and 
gave few of them ( pain in her arms, legs, chest, and stomach), she also stated that she 
does not have the confidence to manage her daughter’s pains and uses whatever her HCP 
recommends or prescribes for her. SP7 claimed to be pretty confident with managing her 
son’s pains after joining a support group because she used to feel very lonely and scared 
with no one to relate to. SP7 stated it is now better due to having gained enough 
knowledge about the disease after joining the support group as they are always sharing 
diverse information and resources including effective pain management strategies. 
Theme 2: Ideal Treatment 
Participants offered various views on what an ideal treatment should be which 
included treatments that are safe, capable of preventing or eliminating pain crisis, easy to 
administer or use, less invasive on organs, have no or less side or adverse effects, and are 
affordable. SP1 wished for a medicine that will eliminate pain crises. SP3 wished for a 
treatment that will help save patients’ eyesight, a common complication for SCD patients 
and ways to deal during times of an epidemic and flu season. She added, “Flu shots can 




now as a cure for SCD involved using inactive HIV cells and also ends up wiping out the 
immune system which renders it unsafe and thus wishes if another mechanism can be 
developed that would be less invasive on organs with no or less side or adverse effects. 
SP6 hoped for a treatment that is able to manage pain crisis more effectively at home. 
SP9 wished for a treatment capable of curing or eliminating SCD and its associated 
complications entirely that are affordable and feasible/conducive. SP10 wanted treatment 
that is easy to administer at home and convenient. SP11 hoped for an interdisciplinary 
transitional team including a pediatrician and an adult SCD HCP team for patients as they 
transition to adulthood due to that being the stage most patients encounter most 
complications due to lack of adult SCD HCPs.  
Theme 3: Research 
Participants requested for more research to be conducted about SCD for the 
appropriate treatments to be developed for its management. SP2 suggested that more 
research is really done about the source of the pain so that they can tackle the problem 
from its source and produce medications to that effect. SP5 also proposed that there 
should be more research on other alternatives. 
Education/Creating Awareness 
The majority of participants stated that they do not think their HCPs are that 
knowledgeable about SCD and really understand the caliber of the SCD pains which tend 
to influence their prescribing habits or decisions by often under prescribing for its 
management and may also seem to lack knowledge or awareness on alternative therapies. 




SCD and alternative remedies or interventions. SP2 maintained that most none SCD 
HCPs have little knowledge on SCD and this makes it worse during hospital visits and 
requested for a better communication system between patients’ SCP practitioners during 
hospitalization especially on treatment options. SP3 suggested,  
Schools should have a partnership with SCD treatment centers just in case of a 
crisis at school or for information and that teachers treated my daughter like she 
was diseased for the longest until I told them what it was she has.  
Thus educational personnel also need to be educated on SCD and the necessary 
steps to take when a student is going through pain crisis during school hours. SP4 
claimed HCPs have less awareness about alternative therapies for SCD. SP11 attested to 
this fact and declared that “HCPs tend to prescribe certain type of meds due to lack of 
knowledge in the disease and other meds all because of lack of education.” SP11 thus 
recommended for HCPs to be educated more on the disease and diverse treatment 
options.  
Evidence of Trustworthiness 
Connelly (2016) described trustworthiness or rigor of a study as the degree of 
confidence in data, interpretation, and methods used that guarantees the quality of a 
study. Amankwaa (2016) also asserted that for a study to be considered credible, 
researchers need to establish the protocols and procedures used for the study. Elo et al. 
(2014) inferred that it is “imperative to scrutinize the trustworthiness of every phase of 
the analysis process, including the preparation, organization, and reporting of result 




study” (p. 1). By employing these guidelines, much work and efforts were taken to plan 
or prepare and execute each stage of this study starting from the choice of study 
methodology and analysis plan, recruitment of study participants, data collection, 
compilation and processing, data analysis, and reporting of the study designs. Care was 
taken to guarantee that all the necessary details and relevant data or information gathered 
were reported and presented in a systematic order. According Elo et al., a prerequisite for 
a successful content analysis is that the data can be reduced to concepts that describe the 
research phenomenon by creating categories, concepts, a model, conceptual system, or 
conceptual map. Thus, by following these suggestions the data collected were all 
subjected to a number of steps of coding from which categories and themes were 
developed and finally organized or grouped into the concepts based on the conceptual 
framework, biopsychosocial-spiritual model of chronic pain proposed by Taylor et al. 
(2013) and illustrated in Table 3. The necessary criteria required to guarantee 
trustworthiness which are credibility, dependability, confirmability, transferability and 
authenticity were applied to this study. 
Credibility 
Credibility is considered as the most important criterion and is described as the 
truth of the data or the participant views, the interpretation and representation of them by 
the researcher (Cope, 2014; Polit & Beck, 2012). According to Cope, when a researcher 
describes their experiences and verify the research findings with the participants, the 
credibility of the study gets magnified or better. Several steps were taken to achieve 




virtually, I did not distance myself from the entire process but saw to it that I was 
personally and actively involved in all the stages from the recruitment stage to the 
reporting. I recruited mostly by posting the recruitment flyers in support groups on 
Facebook and sending the flyer to all my contacts through texting and e-mail. I also 
reached out to the leadership of the groups through email mostly establishing a 
relationship and building a rapport with them. Some of them volunteered to be study 
participants themselves and also recommended specific participants based on their 
conditions when I decided to incorporate snowball sampling. When I noticed that my data 
were getting skewed as almost all the participants were basically of the SS-type; I 
reached out to some of the leaders and one gave me information about some of their 
group members who have the SC-type. Though not all the leads provided agreed to 
participate in the study, one of these members became one of my best participants, a 
parent with two SC-type patients who provided so much information that could not be 
obtained from just any literature review. I also created a rapport with the participants who 
responded to the recruitment advertisement. Apart from emailing the consent forms and 
questionnaire to them, I also sent personalized emails which made them feel comfortable 
and made it easy for us to communicate including participants easily reaching out for 
clarification as often as they had questions they needed clarification on. The phone 
interviews were conducted professionally. I saw to it that it was not done rigidly but 
always created this relaxing environment or mood, rendering them more like 
conversations which made the participants more relaxed and enabled me to gain their 




information than I expected. Therefore, almost all of the phone interviews surpassed 1 
hour instead of the 45 minutes averaged interview time allotted to each participant. I 
employed member checking frequently during the interview process especially with 
salient points that I wanted to get right and any new information learned during the 
interview. I often summarized points and restated them as I understood them which gave 
participants the opportunity to make the necessary corrections or additions when needed. 
I also incorporated member checking with the participants who answered the 
questionnaire independently by reaching out to them for more information or clarification 
on any. However, not all of the participants responded to my emails when I reached out 
for more information or clarification of a response which proved to be a major setback of 
the study. 
I also incorporated audit trails into the study. Cohen and Crabtree (2006) defined 
“an audit trail as a transparent description of the research steps taken from the start of a 
research project to the development and reporting of findings and are records that are 
kept regarding what was done in an investigation”(p.1). As proposed by Cope (2014), 
credibility is strengthened by the researcher when reporting a qualitative study by 
demonstrating their engagement, methods of observation, and audit trails.  
Dependability 
Polit and Beck (2012) described dependability as the constancy of the data over 
similar conditions. This can be observed when another researcher concurs with the 
decision trails at each stage of the research process or if the study findings were 




this study by the similarities observed in some of the alternative treatment options like the 
natural regimens and coping strategies participants have used for pain management. 
Confirmability 
According to Cope (2014), confirmability refers to how the researcher is able to 
prove that the data collected is a true representation of participants’ responses and not the 
researcher’s biases or viewpoints and depicts that the findings were derived directly from 
the data which can be portrayed by providing rich quotes from the participants that depict 
each emerging theme. This principle was applied when reporting the study results or 
findings by using significant statements or direct quote from participants based on the 
emerging themes. 
Transferability 
Cope (2014) described transferability as the ability to apply study findings to 
other settings, groups, or individuals not involved in the study to enable readers to 
associate the results with their own experiences. Transferability is portrayed in this study 
by the similarity of the experiences with alternative treatment options among the study 
participants even though the participants were from five different states. This 
demonstrates how readers and individuals from other states not represented can easily 
relate to the experiences of the study participants. However, it was revealed through the 
participants that location plays a major role in the kind of health services that patients 
received as well as the level of knowledge of SCD HCPs which may also influence the 
treatment administered. For instance, SP4 declared that her son’s condition improved 




is handled there in terms of health services and support. SP11 asserted that a support 
group in Virginia advocated for the SCD community to be exempt so that HCPs would be 
able to prescribe as much as opioid analgesics for their patients as they required without 
any restrictions. SP2 who is from Texas also maintained that the kind of treatment or 
health services offered are based on location of the health care facility. Since Houston is 
very good in the level of services as compared to Dallas and may even offer 
psychological services to patient when needed, SP2 relocated from Dallas to Houston. 
SP3 who also relocated from Virginia to South Carolina strongly attested and stated, 
In South Carolina the hospitals do not know sickle cell disorder well and send my 
daughter home with fever and pain. In Virginia it is way better first in and 
recovery time is a lot shorter. Doctors in South Carolina do not treat sickle cell 
well here. They usually do not try to keep her healthy as possible. 
Authenticity 
Cope (2014) declared that “authenticity is the ability and extent to which the 
researcher expresses the feelings and emotions of the participants’ experiences in a 
faithful manner by adopting a descriptive approach through which readers grasp the 
essence of the experience through the participant quotes” (p. 1). Once again, authenticity 
of the study findings was also depicted by using significant statements or direct quotes by 






The purpose of this qualitative study was to explore the experiences and 
perceptions of patients and parents/caretakers on alternative treatment options for SCD 
pain crisis management with the intent of decreasing SCD patients’ dependency on 
opioid-base or related analgesics. Due to COVID-19, data collection was strictly virtual 
with most study participants recruited through social media platforms such as Facebook 
and Whatsapp for some SCD support groups and also through snowball sampling. About 
half of the participants who contacted me expressed their interest to participate after 
seeing the recruitment flyer on social media. The data collection format or process 
occurred in two categories: (a) independent completion of the interview and (b) a phone 
interview. Six participants opted to do the interview independently and requested for the 
questionnaire to be emailed to them while the remaining five participants opted for phone 
interviews. I sent consent forms to the participants via e-mail or text message. Consent 
was required before they were allowed to participate. The interview responses reflected 
the participants’ level of understanding and knowledge on SCD which was also positively 
correlated with participants’ educational level.  
I employed the code and code technique to perform a thorough data analysis of 
the data collected. Overall, about 15 emerging themes were developed under the 
overarching theme alternative treatment options based on participants’ responses. The 
majority of the participants declared that they are aware of alternative treatments or 
interventions and expressed interest in exploring such interventions. However, 




products or options were more influenced by their perceived susceptibility to SCD, 
perceived knowledge on the seriousness of the disease, perceived benefit of the 
alternative remedy, and perceived barriers to that intervention as proposed by the HBM. 
For instance, participants were more concern about effectiveness, side effects, and at 
times cost before they tried an alternative treatment option.  
Though the majority of the participants claimed they were open to alternative 
interventions like self-care management, natural remedies, and other coping mechanisms, 
some of them were still at the contemplation stage as they considered the 
effectiveness/efficacy and safety of these alternative interventions while some resisted to 
change with the claim of their current treatment plan (mainly opioid analgesics) being 
effective. The other group of participants exhibited readiness to change and were even 
already using some form of alternative therapy or intervention (self-care management, 
various forms of coping strategies, and religion). Concepts developed were based on the 
conceptual framework – the BPS-spiritual model by Taylor et al. (2013). A summary of 
participants’ responses based on the themes developed were presented in detail in this 
chapter. In Chapter 5, an interpretation of the study findings, limitations of the study, 





Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
This qualitative case study research was conducted to examine SCD patients’ or 
their parents/caretakers’ experiences and perceptions regarding exploring alternative 
therapies or interventions for pain management aside from opioid analgesics. The utmost 
objective of the study was to learn about some of the alternative treatments that 
participants had used or were using that had been effective in managing their pain, 
including their safety, availability, cost, and transferability, among other concerns. The 
case study approach was employed to help answer the research questions. According to 
Hyett et al. (2014), “Case studies are designed to suit the case and research question” (p. 
2). Content analysis was used in the data analysis”. As Soroko and Dolczewski (2020) 
wrote,  
Content analysis is systematically applied when describing qualitative data with 
the use of rule-bound procedures and human-generated interpretation and may 
include identifying patterns in data and in categories for explanation purposes and 
relational context obtained from reflection on coding as a human process. (p. 1). 
Chronic pain is the hallmark of SCD and a major challenge for SCD patients and 
their families that usually impacts their QOL or living standard. Benjamin (2008) 
asserted that though SCD patients are living longer now, their lives are impacted even 
more by unpredictable intermittent or constant pain that is often poorly managed over a 
lifetime. Benjamin (2008) claimed that pain management poses major public health 




in the past occurred mainly through palliative care, with providers employing mostly 
opioid analgesics to help patients relax as they went through pain episodes. With the 
current opioid crisis, it has become imperative for other treatment options to be 
explored—hence the purpose of this study. There is a need to investigate means or 
interventions that can be employed to help alleviate pain episodes associated with SCD 
and contribute toward improving QOL for patients and their families.  
Benjamin (2008) proposed an interdisciplinary team approach that would bring 
medical professionals together for optimal compassionate care that is coordinated from 
the beginning of life and throughout the patient’s lifespan, adding that the management of 
pain in SCD has not been approached in a straightforward manner by practicing 
hematologists, pain experts, or generalists. Taylor et al. (2013) also asserted that chronic 
pain in adults with SCD is a complex, multidimensional experience that includes 
biological, psychological, sociological, and spiritual factors, thus affirming the need for 
an interdisciplinary team approach for its management. These declarations also align with 
some of the study participants’ propositions for alternative therapies or interventions to 
be incorporated into the orthodox way of managing of SCD pains, which was the goal of 
this study.  
In this chapter, I will interpret the study findings, which I developed after 
transcribing and analyzing participants’ experiences and perceptions regarding alternative 
treatment options. Additionally, I will present the limitations of the study, 




Interpretation of Findings 
The research findings make a unique contribution to the literature through the 
exploration and analysis of SCD community members’ experiences and perceptions 
regarding alternative treatment regimens. Study participants shared their diverse 
experiences and perceptions related to alternative treatment regimens for managing their 
SCD pain or the pain of their charge.  
The study findings also strongly correspond to findings from previous research 
studies. Yoon and Black (2006) conducted a similar study to investigate the prevalence 
and types of both pharmacological and complementary therapies used for SCD pain 
management by caregivers and explore caregivers’ interest in using complementary 
therapies in the future, presented similar findings. In their cross-sectional, descriptive 
study of 63 SCD caregivers, Yoon and Black found that the most frequently used pain 
medications for children with SCD were opioid analgesics such as acetaminophen with 
codeine and acetaminophen with oxycodone. They reported that more than 70% of 
caregivers confirmed using some complementary therapies (coping strategies), including 
prayer, spiritual healing by others, massage, and relaxation, and that most of the 
caregivers were willing to try various types of complementary therapies for pain 
management (Yoon & Black, 2006).  
Most of my study participants shared their experiences with using diverse natural 
products in managing pain, with most of them attesting that these products were effective 




In spite of unprecedented advances in modern system of medicine, people in 
SCD-prone areas have been taking traditional medicinal plants or plant-derived 
products to increase the life span of patients in addition to the numerous clinical 
trials that have been going on for the use of natural products and their effect in 
pure form or characterized phytoconstituents on particularly inhibition of 
hemoglobin polymerization for the symptomatic management of SCD. (p. 1) 
Study participants’ verbatim quotes were transcribed from both audio recorded and 
online interviews and were analyzed individually, with various themes evolving based on 
the theoretical and conceptual frameworks adopted for this study. 
Emerging Themes 
Various important themes emerged when the study participants’ interview 
responses were transcribed and analyzed, depicting the numerous coping mechanisms 
and strategies that they had been employing over the years to manage their pain, as 
previously discussed in Chapter 4. 
Coping Mechanisms 
The study participants described the various strategies that had been working for 
them in managing pain, which included religion, natural products, medicines, and other 
palliative or coping interventions. The majority of the participants had religious beliefs 
and had been using various forms of religious practice, especially prayer, during pain 
crises, which most of them declared to have been very effective and helpful in sustaining 




I pray a lot because if not for God I do not think I will still be here. Praying has 
been very effective for me especially during hospitalizations and when my meds 
are not working, prayers help a lot by helping me to relax and somehow soothe 
the pain.  
According to Bediako et al. (2011), positive religious coping was associated with 
significantly fewer hospital admissions. SP8, the oldest participant/patient (70 years old), 
was a former professor at Harvard University who was doing very well and strongly 
supported using religion as a coping strategy. SP8 went further to suggest that fasting 
helps to detoxify the body. However, SP7, who declared that she always called on her 
pastor and church elders to pray for them whenever her son, the patient, was having a 
pain crisis, insisted that prayer was not effective because “it doesn’t really take the pain 
away.” Cotton et al. (2012) maintained that children used religion to gain control, make 
meaning, and find comfort by praying to get well, to keep from getting sick, and to get 
out of the hospital as they described a functional God who made them take their medicine 
or took them to the hospital and an emotional God who made them happy and comforted 
them when they were sad or scared. Bediako et al. (2011) also asserted that religious 
practices have both psychological and physical benefits for patients, examples being  
prayers, meditations, and consumption of religious media which were found to be 
inversely related to physical health outcomes and patients seemed better adjusted 
psychologically if they were religious. 
Distraction was another major strategy that the majority of the participants 




minds off their pain. Examples of distraction strategies were listening to music and 
watching wrestling.  
According to the participants, one of the major triggers of pain crisis is extreme 
weather conditions, especially cold weather, so most of them had adopted the habit of 
staying warm by wearing warm clothes, avoiding eating very hot or cold foods, and using 
hot pads or taking hot showers, especially at the onset of crisis. Dehydration was also 
recognized as a major pain crisis trigger, so most of the participants declared that they 
drank a lot of water to stay hydrated at all times. Both stress and fatigue were also 
considered triggers for pain crises, so the majority of the participants fought stress and 
stated that they tried to get more rest to avoid developing fatigue.  
The majority of the participants used diverse forms of natural products, including 
nutraceuticals (vitamins, dietary supplements: folic acid, omega-3 fatty acids, etc.), which 
they took on a daily basis as a preventative measure to either mitigate pain crisis or 
reduce its frequency and intensity. Some of the natural products that the study 
participants stated that they had been using were shea butter (because of its anti-
inflammatory properties), chlorophyl, everyday fruits and veggies, and alkaline water. 
According to Ameh et al. (2012), in West Africa where SCD is endemic, the disease has 
long been treated with natural products such as herbs, especially in rural communities. 
Based on the findings of a study that they conducted, Ameh et al. reported three new anti-
sickling herbs: mahogany (Entandrophragma utile), Mexican tea and wormseed 
(Chenopodium ambrosioides), and Guinea henweed (Petiveria alliacea). Mahogany 




affected joints to relieve pain. There is a need for more research on medicinal products 
that are seen as alternative remedies for SCD pain management and prevention in order to 
establish their efficacy and safety, as most of the study participants proposed. As SP3 
asserted, “I love and use a lot of natural treatments, they are effective but they come with 
a price and side effects and must only be use in extreme cases and if necessary.” 
Medications 
It was deduced from the participants’ responses that SCD patients rely on both 
pharmaceutical and nonpharmaceutical treatments, as well as both prescribed and over-
the-counter (OTC) products for either management or prevention of pain crisis. For many 
years, SCD HCPs have been using mostly palliative care to manage pain. Painkillers—
primarily opioid analgesics such as Tylenol with codeine, morphine, and oxycodone—are 
the most common medications that the participants stated that their HCPs usually 
prescribed for pain management. Sadler et al. (2019) maintained that “opioids are the 
main therapy for both chronic “steady state” SCD pain and acute pain that results from 
vaso-occlusive crisis but they are often ineffective at fully alleviating pain, are associated 
with unwanted side effects, and do not target the underlying pain mechanism thus 
supporting the need for new pain therapies to be employed for SCD patients” (p.1). Most 
of the participants in the current study, however, deemed these opioid analgesics to be 
very effective and necessary for SCD pain management and recommended that HCPs 
continue to prescribe them. The participants thought that HCPs choose to prescribe 
opioid analgesics over other potential medications because opioids are effective, are fast 




“SP1 maintained that there is no need to change because the opioids works.” 
However, she thought that alternative regimens are also necessary because patients 
should have a lot of options to choose from to support their well-being. SP2 stated that 
because pain is the mainstay of SCD, pain medications remain necessary. SP7 declared, 
“Opioids are very effective because I have been using it personally for years.” SP11 
asserted that there is no need to change the practice of prescribing opioid painkillers 
because these medications work, especially morphine and hydrocodone. Nonetheless, the 
Office of Disease Prevention and Health Promotion (n.d.) maintained that, 
 Opioid therapy should be delivered in the context of multimodal care and that 
physicians should consider additional treatment options as opioid therapy have some 
minimal benefit that can be augmented or maximized in the context of other therapies, 
stress reduction or emotional or behavioral strategies.  
There were other medications that participants stated that their HCPs had been 
prescribing to control their pain; examples included NSAIDs such as ibuprofen and 
neuropathic pain drugs such as gabapentin and Lyrica, among others. Jadenu was another 
medication that some of the patients were taking to prevent iron overload caused by 
blood transfusion. 
The majority of the patients were taking hydroxyurea to prevent or to reduce the 
frequency of pain crises and attributed the reduction in their pain episodes to the 
medication. However, one patient who claimed to have been using hydroxyurea for 4 
years said that it increases the chance of getting infections. Further, he stated that because 




reducing his appetite. SP11 also confirmed that hydroxyurea causes hair loss. In contrast 
to these claims, another parent claimed that hydroxyurea helps to prevent infections.  
None of the participants indicated using any of the newly approved medications. 
“SP11 stated that several patients complained how most of the new meds (adakveo and 
oxbryta®, etc.) are not effective, especially an infusion drug and that each drug works 
differently for each patient.” She added that the dosage forms for some of the new drugs 
deter patients from taking them. For example, she explained, “Endari is a vitamin in a 
powder form that needs to be dissolved in water so most patients don’t like it.” Finally, 
she stated that the high prices of these new drugs discouraged many parents from seeking 
prescriptions for them, declaring, “We cannot afford new meds, especially Endari she 
declared.”  
The majority of the participants confirmed that they used various OTC 
medications, mostly vitamins. In particular, they claimed that folic acid helped them 
manage and have an upper hand on the disease. Overall, there were no serious side 
effects reported for any of the medications. Nevertheless, the possibility of side effects 
was the main reason that most of the participants were skeptical about trying other or new 
treatment options. 
Concerning whether SCD patients abuse prescription medications, most of the 
participants declared that this perception was simply the result of stigma. The majority of 
the participants did not think that SCD patients abuse prescription medications. SP11 
claimed that it is “a stigma because of race. SCD patients are usually accused of abusing 




Rather, there was a notion among some of the participants that patients may be compelled 
to take more of their prescribed medications because SCD HCPs seem not to understand 
the extent of SCD-related pain and therefore tend to under prescribe for their patients, 
confirming the findings of previous studies by Booker et al. (2006) and others. Labbé et 
al. (2005) asserted that many physicians believe that SCD patients are more likely to 
become addicted to pain medication than are other patient populations and that these 
attitudes affect their pain management practices, potentially leading them to undertreat 
their patients’ pain. 
Support Systems 
As asserted by Telfair and Gardner (1999), not many studies have been done on 
the impact of support groups on the psychological well-being (PWB) of adolescents with 
SCD. In a study with 99 African American adolescent SCD support group members, 
Telfair and Gardner found that PWB was best predicted by fewer physical symptoms and 
greater satisfaction with the group. Their study also revealed that belonging to or having 
a form of support system plays an important role in the management of SCD-related pain.  
Most of the participants in my study belonged to a support group or had a support 
system. Often, their support systems involved family members as well as leaders and 
other members of religious/spiritual communities, on whom they could lean during times 
of crisis and consult for information and resources. One parent stated that she used to feel 
very lonely and unsure of herself, but since she had joined a support group, she did not 
feel like that anymore; she felt more confident, especially in managing her son’s pains 




group also claimed that when it comes to emotional or psychological issues related to 
SCD, most patients prefer to turn to their support group for help instead of their HCP 
team. Telfair and Gardner (1999) detected an interaction effect between pain and group 
satisfaction. These authors claimed that “support groups have the potential to mitigate the 
detrimental effects of living with a chronic disease among adolescents, especially during 
times of acute pain and thus proposed health professionals should be encouraged to 
promote the active involvement in support groups to adolescents with SCD and other 
chronic conditions” (p. 7). 
However, one patient stated that he does not like joining support groups because 
being around other SCD patients negatively impacts him; it usually makes him more 
depressed so he depends solely on his family especially during crisis. His family and at 
times hospital chaplains usually pray with him during hospital visits and when his 
medicines are not working. SP3 stated that her sister, a surgical technician and her 
daughter’s father, who is also a patient, are all she has when it comes to getting the care 
and support she needs as they help her with transportation and advice during a crisis. SP6 
declared that her daughter has “an amazing support system which includes her family, 
friends, school community, and church community and thus they never feel like alone in 
this battle and most of them are learning about the condition but for the most part they're 
pretty knowledgeable.” She added that her family relies on each other when anything is 
needed and that includes childcare for her other child or transportation. SP7 belongs to a 
SCD support group who shares information and provides support, care, and experiences 




wife, and leaders from church who pray with them whenever her son is having a crisis. 
SP11 who is one of the founders of a support group in Virginia stated that they decided to 
start this group because initially there was no support for parents and some of the services 
they offer to members include education, advocacy, and support on a financial level even 
to the extent of paying for rent and groceries when needed, technology, plan of care, 
provide supplemental income, emergency COVID assistance, and many other services. 
The support group operates on grants from Virginia Commonwealth University , and 
there are different organizations that also offer help to the group including the Global 
Blood/Drug Therapeutic (GBT).  
Education/Creating More Awareness 
According to Chakravorty et al. (2018), depending on the findings of a study 
conducted, there is a widespread prevalence of poor knowledge about SCD among 
healthcare providers and the public reported a poorer experience of care in the emergency 
setting compared to planned care, which lacks timely provision of pain relief. According 
to SP2, HCPs who are SCD specialist seem to be knowledgeable about the disease but 
when he is hospitalized, it seems most of the non SCD HCPs are not that knowledgeable 
so they always have to contact his specialist for help. He suggested that every hospital 
should try to establish an effective means to communicate better with their patients’ SCD 
specialists. Thomas and Cohn (2006) agreed that the use of good communication skills by 
healthcare professionals is vital for good healthcare practice and proposed the need for 
training in communication skills and cultural awareness for HCPs in SCD which may 




communicating with patients with SCD. SP3 also declared that SCD HCPs are 
knowledgeable about the condition but because of racial disposition of most patients 
being African American and poor, they are inclined to adopt a certain attitude (not caring 
that much) toward their patents. SP11 also affirmed that HCPs do not show care or 
concern especially the mental health or status are not well addressed on such issues like 
depression. anxiety due to the fear of the disease is the reason most of the patients turn to 
or rely on support groups. Chakravorty et al. (2018) declared that SCD adolescents and 
young patents reported significantly poorer experience of care in several domains 
compared to children or adults according to their study findings. Thomas and Cohn 
(2006) also affirmed that many SCD patients felt that they were negatively labeled by the 
health care system and are skeptical of opening themselves to an unsympathetic system 
and may therefore appear hostile and aggressive when interacting with health care 
professionals, which in turn leads to distortions and misunderstandings between both 
groups. These authors thus maintained that training especially in communication skills 
and cultural awareness for HCPs might be helpful in reducing mistrust and result in 
increasing empathetic responses among health care professionals. Chakravorty et al. 
(2018) asserted that understanding patient views of their care experience is not optional 
but essential to ensure effective delivery of health care and may lead to a better patient 
experience which would be associated with improved treatment adherence, better use of 
preventive services, and healthcare utilization.  
Nevertheless, SP11 strongly believed that SCD HCPs are not well educated on the 




because they do not believe they have the disease. She maintained that HCPs lack 
knowledge about the disease and other medications aside from opioids all because of a 
lack of education. SP11 requested the need for more HCPs to be educated on the disease. 
SP2 rated the level of the knowledge of HCPs in SCD to be about a level of 7 and added 
that HCPs treat all SCD cases the same irrespective of the differences in disease types as 
they do not try to tailor treatments based on the type or conditions of the patient. Smith et 
al. (2005) proposed that the main reason for the poor understanding of pain in SCD is that 
adult SCD is a new "epidemic," that is poorly described epidemiologically. According to 
these authors, in the past, the estimated median survival for patients was 20 years, so 
treating the pain of SCD was primarily left solely to those caring for children 
(pediatricians) but with important advances in treatment options such as prophylactic 
penicillin for children, mortality rates in children have drastically decreased with median 
SCD survival now stretches well into the fourth or fifth decade (Smith et al., 2005). This 
has resulted in the relatively new phenomenon of adults with chronic SCD and adult 
medical professionals treating pain in a disease for which they have limited training and 
experience. SP11 asserted that most SCD patients die during the transition years due to 
lack of qualified SCD HCPs so young adult patients tend to rely on non SCD HCPs. 
Thus, for an ideal treatment, SP11 wished for a transition team including both a 
pediatrician and an SCD HCP adult team that works together. Consequently, Labbé et al. 
(2005) proposed that physicians might benefit from additional education regarding SCD, 
addiction to pain medication, the pharmacology of opioids, and the assessment and 




Limitations of the Study 
There were several limitations encountered during the study partly due to 
COVID-19. First of all, the sample size of only 11 study participants was small even 
though saturation was achieved, and the participants were spread over about five states 
which reinforced the generalizability of the study findings. A larger sample size would 
have been more beneficial as that would have increased the opportunity of gathering 
more diverse experiences and perceptions from a larger spectrum and thus enriched the 
study findings more. Secondly, because of COVID, almost all of the study participants 
(about 65%) were recruited virtually by posting the study recruitment on some of the 
popular social media platforms such as Facebook, and others through snowballing. There 
was no prior relationship with participants which affected the communication or rapport 
with some of them. More time was needed to build a relationship and establish rapport 
with some of the participants which involved communicating with them several times 
through e-mail, text, and phone calls to gain their trust and confidence before they 
committed to participate in the study. Time was also a major constraint due to the 
different time zones because of the different states participants were located created a bit 
of confusion and resulted in missing some interviews, rescheduling, or getting 
participants to commit to another interview time. This also presented with another 
challenge such as participants’ availability for phone interviews and having to resort to 
online interviews which lacked personal touch or rapport with participants.  
About 45% of the participants opted for online interviews which negatively 




interview questions did not respond to any follow up emails or text messages sent to them 
for clarification or verification of their responses. Also, only about 37% of the 
participants were patients while the rest were mostly parents/caretakers so their 
experiences with the SCD pains and hence their management were “secondhand” as 
compared to patients sharing or narrating their own experiences. All SPs were all 
Africans/Africa Americans. no other ethnicity responded which may impact 
generalizability of findings due to cultural differences. Also, all the SPs also have only 
two types of SCD: the SS and SC, none of the other types (like the Beta-thalessemia etc) 
responded so may affect generalizability. 
Recommendations 
Based on the study findings and participants’ responses to the interview questions, 
the following recommendations ensued. It was detected that most of the participants are 
already using some form of alternative treatment or expressed their interest in them. 
Nevertheless, they were skeptical and concerned about their safety and efficacy. Thus, it 
is recommended that more research should be done on these alternative remedies to 
guarantee their efficacy and safety. According to SP3, alternative remedies are effective 
but comes with a price and side effects. She stated, “Lots of treatments have side effects 
and tax vital organs like the liver” and thus was reluctant to recommend them but agreed 
that they should be used in extreme cases if there are no other options. SP2 declared 
being open to alternative remedies but usually requests about side effects while SP5 also 





This study targeted mostly patients and parents/caretakers as the study 
participants and deemed it imperative to allow SCD HCPs which would include 
physicians, nurses, nutritionists/dieticians, pharmacists etcetera to also express or share 
their perceptions and experiences on employing alternative treatments for SCD pain 
management. Also, with this popular notion among the SCD community that the HCPs 
lack knowledge on the caliber of SCD pain and hence its proper management especially 
with other treatment options aside from opioid analgesics, it would be appropriate if a 
similar study can be conducted with HCPs as the target population is geared toward 
creating awareness or educating them. Thus, I highly recommend further studies on 
exploring alternative treatment options for pain management purposely for HCPs. Study 
participants also requested various ideal treatment options and education for other 
stakeholders. For instance, SP3 recommended that schools should have partnerships with 
treatment centers for when SCD patients experience a crisis at school or just for 
information. She stated how teachers used to treat her daughter “like she was diseased for 
a long time until I told them what it was…” thus emphasizing the need to educate 
teachers or educational professionals about SCD. SP7 declared that her son’s school has 
the 504 Plan for his school district so teachers are aware and send his work, and he can 
take makeups of tests when he misses school during crises. Some patients also requested 
for education on how to properly manage pains especially at home. SP6 requested for 
training in order to be able to manage pain more effectively at home. According to 
Dampier et al. (2002), “Recurrent acute pain from SCD can be successfully managed at 




intervention to improve patient outcomes” (p. 1). Also further studies, preferably a 
quantitative study to analyze the effectiveness of these alternative treatments specifically 
in managing and reducing frequency of pain episodes would be in order. Thus, document 
the numerical effects or impacts of such therapies on SCD pain management. 
 
Implications 
Positive Social Change 
One of the main objectives for undertaking this study is that the study participants 
shared their experiences and perceptions would contribute toward improving the health 
status, living standards, and life expectancy (quality of life, QoL) for SCD patients and 
their families. Osunkwo et al. (2020) asserted that “the most common patient treatment 
goal is to improve QoL as SCD places a significant burden on patients, mostly or highly 
impacting patients' QoL, emotional wellbeing, the high prevalence of self‐reported VOCs 
and other symptoms.” (p. 1). Pain crisis in general has a negative impact on SCD patients 
and their parents. During a crisis especially if it results in hospitalization, school-aged 
patients and their parents and adult patients all end up staying away from or losing school 
and working days and even at times lose jobs respectively. This and all the financial 
requirements that ensue due to the crisis can easily lead to financial difficulties for the 
patients and their families.  
Pain crisis is also associated with fear, stress, and distress and negatively impacts 
the emotional and mental health of both patients and their families. SCD patients 




participate in so many normal or everyday activities such as playing outdoors, exercising, 
or engaging in strenuous activities, etc. SP4 stated that her son is not able to go school or 
go out to play during a crisis, and generally has a less social life, etc. Edwards et al. 
(2005) declared that because of the chronic nature of SCD which is associated with 
frequent hospitalizations due to the pains and other medical management, it can 
contribute significantly to impaired psychosocial functioning, altered intra- and 
interpersonal relationships, and reduced quality of life. SP2, a 23year old male patient 
reported how he has never been able to have a job or work and also the challenges he is 
having in staying at school because of the frequency of his crisis and hospitalization. At 
the time of the interview, SP2 now a college student failed some classes because he was 
hospitalized during the school year several times and was in the process of getting a 
deferment from the school but sadly the school authorities were not being cooperative. 
Fortunately, I was able to introduce him to a support group in his state who is now 
helping him with the necessary steps to take to be able to get the deferment from his 
school and also will get the chance to do some volunteer work, etc. According to Fuggle 
et al. (1996), SCD pain can result in over seven times increased risk of not attending 
school and is highly disruptive of social and recreational activities. Barbarin and 
Christian (1999) asserted that “there is a high evidence for claims of social deficits 
among adolescents and depression and work-related problems among the adults” (p.1). 
Barbarin and Christian (1999) also proposed that the “social context of SCD, such as 
issues related to socioeconomic status (SES), urbanicity, ethnicity, cultural values, and 




analyses of the effects of SCD on children and their families” (p. 1). In the nutshell, SCD 
pain crisis affect the socio-economic status of the patient and their families and thus their 
QoL. As depicted by the data collected, majority of the participants (about 73%) 
considered themselves as of the low SES with an average annual household income level 
of about $25, 000 dollars. Henceforth, any alternative treatments, interventions, or coping 
mechanisms which especially have the capabilities of reducing the frequency of pain 
crises, hospitalizations, and associated complications and enhanced the social life and 
mental health would be very welcoming and helpful as it can effect positive social change 
to the SCD community by enhancing QoL. 
It is expected that the results from the study, once published would also aid to 
better inform and educate HCPs about the SCD pains, its proper management, and 
evidence-based alternative regimen or coping mechanisms (both pharmaceutical and non-
pharmaceuticals products; prescribed and non-prescribed medications) with the potential 
to offer better pain relief that participants and other stakeholders are using that they can 
also incorporate into their practice. Alsayegh and Mousa (2020) claimed the new and 
recently approved therapeutic agents for SCD should be used alongside with the available 
therapies with potential antiviral activity and must be considered as part of the 
management and classical treatment of SCD with COVID-19 for better outcomes. These 
authors proposed that this would be of benefit to busy HCPs until evidence-based 
management recommendations become available. The SCD community is considered as 





According to the Healthy People (2020), SCD is an example of a genetic 
determinant of health and described it as a condition that people inherit when both 
parents carry the gene for sickle cell. Barbarin and Christian (1999) asserted that 
“although professionals have failed to reach a consensus about definitions of severity in 
SCD, frequency of pain episodes, hospitalizations, infections, fevers, and swellings are 
primary markers used to gauge the disease severity” (p. 2). These authors maintained that 
“SCD is a well-recognized source of distress in the lives of more than 50,000 African 
Americans and their families that often results in enduring psychosocial dysfunction 
(Barbarin & Christian, 1999, p. 1). Managing the SCD pain has always being a major 
challenge for the SCD community. Thus, any interventions that promises better living 
standards for patients and their families can be deemed as a laudable idea. Consequently, 
this study was undertaken to investigate such interventions or treatments that can be 
better choices for managing pain crisis in lieu of orthodox medicine in order to curb side 
effects and the tendency of addictions usually associated with the use of orthodox pain 
medications. Employing the appropriate pain management strategies for SCD related 
pains is imperative considering the caliber of the pains and all the associated life-
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Appendix A: Demographic Questionnaire 






What is your age / your child’s age? (Optional) 
  0 – 5  
  6 – 12  
  13 – 17  
  18 – 22  
  23 – 49  
 50 or greater  
 




What is your Educational level? (Optional) 
Graduate  
College/Some College  
High School  
None  
 
What is your Race / your child’s Race? (Optional) 
Black/African American  
Hispanic  









I have sickle cell disease  
I am a parent, family member or caretaker of someone 
with sickle disease 
 
 I work for a sickle cell disease patient support or 
advocacy organization 
 
 I am a healthcare professional who works with sickle 














Appendix C: Summary of the Data Collected 
Data source Stakeholder type 
(study participants, 
SP) 
Qualitative data Code 










































































































A sickle-cell treatment 
center with a 
hematologist 
 
Have SS specialist 
 
Not at a sickle cell 
treatment center but with 
a hematologist (they treat 
mostly cancer there, 
maybe a cancer clinic) 
 
A children’s hospital 
with a hematologist 
 
At a sickle cell treatment 
center but with a 
hematologist 
 
At a sickle-cell treatment 
center with a 
hematologist 
 
Not at a sickle cell 
treatment center but with 
a hematologist: Children 
Medical Center with an 
assigned nurse. 
 
A primary care center 
(family medicine, 
internal medicine): Have 















At a sickle cell treatment 
center but with a 
hematologist. 
A 
































































Frequency has decreased; 
occurs quarterly now; 
used to be at least once a 
month; triggered by hot 
and cold weather, rainy 
days; normally in her 
chest, spleen, arms, legs, 
stomach and is also 
having problems with 
spleen, it always prevent 
me from going to work. 
 
Frequency reduced; used 
to be Monthly: Triggers 
by Stress, dehydration, 
less rest. Pain can be 
anywhere, especially 
joints with swelling; 
level above 10. Results 
in a lot of hospitalization, 
lengthy ones at times 
about 2 weeks, has never 
been able to work, 
missing school a lot, has 
to defer now because I 
failed some courses as I 
was sick; school 
authorities are not being 
cooperative. Affects his 
concentration especially 
during classes, get easily 
irritated and causes him 




May occur Quarterly/ 
Occasionally and during 
growth spurts and 
vaccinations. Triggers by 
especially by Extreme 
cold or hot weather is, 
Flu and cold seasons and 
when a virus is going 
around. I look for little 
rashes around the joints 
and watch her speech and 
focus. Her skin is a dead 
giveaway that she is in 
pain or got an infection 
or inflammation flare up. 
Hospitalizations is 1 – 2 
times per year, Gets it 




























































































Occasionally (1 – 2 
times): last 
episode/hospital visit was 
in October last year; son 
is doing very well and 
hardly get pain crisis. 
That was really shocking 
to hear considering the 
fact that he has the 
Hemoglobin SS. But that 
was one observation 
made; that 
patients/parents of higher 
educational levels have 
better control over the 
disease especially 
managing their pains as 
they employ various 
coping strategies and 




my knee and elbow. 
Triggers by exposing my 
body or system to cold 
weather or food; Weather 
changes 
It restricts me of 
embarking on my daily 




experiences pain in her 
arms, legs, chest, and 
stomach most often. 
My daughter is not able 
to participate in many 
activities her friends do 






Quarterly. Eyes draw 
back, loss of 
concentration. Triggers 
by exercise, stress, 
allergies, weather. 
Terrible pains in bones 
and high fever and that is 
the sign to go the ER. 
Usually experience the 
pains in the arms, legs, 
feet. He does not go to 
school. He is on the 504 
Plan for his school 
district so the Teachers 
































and can also take 




decreased; Last crisis 
was in 1994; used to be 
very serious requiring 
blood transfusion; 
Triggers by weather 
changes, exercises such 
as running, or lifting a 
heavy stuff as it affects 
my breathing, at times 
feel like I am about to 
pass out. Usually 
experience the pains in 
the Joints (arms, elbows, 
knees). Crisis were very 
acute resulting in 
hospitalizing and thus 
not going to work. 
 
Occasionally 
Used to be mostly in the 
limbs (joints, arms, legs ) 
but of late more in the 
abdomen. She was 
scheduled to do 
ultrasound if that might 
be gall stones which we 
were told maybe 
accumulation of sickle 
cells in the gall bladder 
but have to cancel 
appointment because of 
COVID-19. 
Is not frequent as it used 
to be when she was 
young, but it used to be 
missed school days and 
not going to work, 
calling in sick. This 
impacted any chances of 
promotions and also 
financial status on hours 
that I and her father too 
at times missed from 
work. It also impacted us 
psychologically as it 
always induces fear, 
depression and also 
sadness or pain to see her 
go through so much pain. 
 
 
Occasionally triggers by 
doing too much exercise 
and not sleeping enough. 
I experience the pain in 
my back and legs mostly 
I am not able to drive or 
engage in physical 




































































Have a pretty good 
knowledge on the 
symptoms on SCD and 
feels HCP are also very 
knowledgeable or 
understands the condition 
very well and feel very 
confident.in managing 
their chronic pains from 
day to day. 
 
 
My specialist seems to be 
knowledgeable but when 
on admission it seems 
most of the HCPs may 
not be that 
knowledgeable unless 
they contact my 
specialist. Thus, have 
experience doubts about 
HCP; Believe the doctors 
do not really understand 
SCD pains very well. 






They know it well but as 
for being African 
American and poor, 
nope. 
In South Carolina, the 
hospitals do not know 
Sickle Cell Disorder well 
and send her home with 
fever and pain. In 
Virginia it is way better. 
Doctors in South 
Carolina do not treat 
Sickle Cell, well here. 
 
Pretty well, Very 
confident 
HCPs knowledge on 
SCD: less awareness and 
misrepresented. 
About a level of 7: they 
treat all cases the same 
way. They do not try to 
tailor treatments based 
on the SCD type or 
conditions of the patient. 
There is also the trust 
issue between patients 
and their HCPs, so 
patients prefer turning to 
support groups for 
especially emotional 
support. 
Yes, very good 












































Very well. They do 
understand the situation 
because they are 
specialized personnel 
who are there purposely 
to take care of sickle cell 
patients at the hospital 
 
I think my HCP 
understands my 
daughter's condition well 
and is always researching 
new techniques and 
treatments 
 
Pretty confident now 
after joining a support 
group. Used to feel very 
lonely and scared with no 
one to relate to. It is now 




Have about 4 Specialists 
now for different 
conditions because of my 





HCPs portrayed to be 
knowledgeable but 
wonders if they really 
understand SCD and 

























At the onset of a pain 
crisis is getting into 
warm water or hot 
bathes, 
takes Tylenol with 
codeine, ibuprofen, Bio 
freeze. 
Patient however takes 
hydroxyurea and iron 
vitamins daily which 
might have contributed 
to the decrease in the 























































































Takes hot baths to 
release or relax his rigid 
bones. 
Uses both prescribed 
pharmaceutical and non-
pharmaceutical as well as 
coping mechanisms to 
manage my pains. Takes 
Lyrica, Oxycodone, 
Tylenol #3; Morphine 
daily q12hours etc. 
Drink a lot water; staying 
warm; folic acid. 
Jadenu 360, 
Hydroxyurea: but 
increases the chances of 
getting infections; being 
a chemotherapy drug, it 
is affecting my hair 
growth; I have been on it 
for 4 years; it also 
reduces my appetite 
 
 
Hydration, balanced diet, 
daily vitamin, and skin 
care. 
Pain killers are last line 
before seeing a doctor. 
Tylenol otherwise 
doctors give her drugs in 
emergency room. I try 
not to use it because I 
know they tax (destroy) 
organs like the liver heart 
and such. 
Omega 3, Daily vitamin, 





I give him Tylenol and 
Motrin; Use or apply 
shea-butter has anti-
inflammatory properties 
and chlorophyll liquid: I 
buy it from Amazon 
because it increases 
Oxygen level. Learn 
about it from online 
group. 
He also uses Air purifier 
always in his room so 
that he gets the optimum 
O2. 
 
I normally take in 
painkiller, drink lots of 
water and apply hot 
ointment at the joints 
where am having that 
pain. 17. Basically, I 















afterwards try as much as 
possible to sleep for a 
while or lie down. 
 
 
Since my daughter is still 
pretty young, I try to ask 
as many questions about 
the pain as I can before 
making any decisions. I 
will then administer over 
the counter pain 
medications and give her 
plenty of water to make 
sure she is hydrated 
when that doesn't control 
her pain, we'll head to 
the emergency room. 
 
We watch wrestling; 
helps to calm him down: 
distraction before we go 




Take Folic acid 
specifically My health 
and overall living 
conditions have 
improved drastically 
since I started eating 
healthy and using 
alkaline water, I hardly 




Tylenol #3 alternating 
with Ibuprofen every 4 
hours, prayers, 
massaging at times with 
hot ointments like 
Bengay, hot pads/towels, 
sleep 
 
First line of defense: 
Drink water, lay down or 
get in bed, take my 
ibuprofen, apply my 








rest, heating pad, water, 
Aromatherapy with 
essential oils with a 




and helps me to not think 























































Takes Tylenol with 
codeine, ibuprofen, Bio 
freeze during crisis and 
for prevention 
hydroxyurea and iron 






Tylenol #3; takes hot 
baths to release or relax 
his rigid bones; 
Morphine daily 




specialist is aware of 
other meds and usually 
prescribe them. 
 
Omega 3, Daily vitamin, 
Tylenol, Pain killers last 
line of treatment before 
seeing a doctor. 
 
 
Tylenol and Motrin; 
Chlorophyll liquid 
 
Paracetamol, folic acid, 





My daughter takes 
hydroxyurea daily and 
Tylenol and Motrin as 
needed. My daughter 
takes hydroxyurea daily 
to suppress crises and 
prevent infection 
Hydrocodone, morphine, 
IV at ER, Tramadol. 
OTC: Tylenol and 
Ibuprofen but they were 
not effective, so we do 
not use them anymore. 
 
 
Enbrel, Eliquix, and 
Prednisone are for 
rheumatoid arthritis 
Tylenol for the eye pains 
Folic acid specifically for 
SC 
 




















Tried Hydroxyurea for 
about a month in 2019 
but interesting her HgB 
level rather dropped so 
she lost interest in it and 
decided to discontinue 
using. When we 
discussed this outcome 
with her new MD later, 
he informed us that 
Hydroxyurea works best 
for SS patients or those 
who gets frequent pain 
crises that results in 
frequent hospitalizations 
as that is one of its main 
purposes; to decrease the 








My HCP provides me 
with refills of 





































Takes hot bathes which 
mother says works well, 
thus is very effective, 
says a lot of prayers, 
heating pads, a lot of 
massages, listening to 
music as a distraction 
 
 
Uses massage therapies 
including breathing 
exercises 
such as Yoga but most of 
them were not very 
effective. But if I do or 
apply them early before 
it intensifies it helps a bit 
but if the pain has 
already intensified, they 
usually do not work or 
help. 
Try to stay hydrated by 
drinking a lot of water 
and staying warm, eating 
healthful diets, prayers, 



































































balanced diet, daily 
vitamin, and skin care. 
Give her a balanced meal 
but she is a picky eater 
being autistic… daily 
vitamin, omega 3 and 
encourage water 100% 
juice and smoothies 
which includes her 
veggies without her 
knowing it. Make sure 
after shower and washing 
hands and face to put on 
shea, coconut lotions and 
creams. Taking Omega 
3, Daily vitamin, skin 




Use or apply shea-butter 
has anti-inflammatory 
properties and 
chlorophyll liquid: I buy 
it from Amazon because 
it increases the Oxygen 
level. He also uses Air 
purifier always in his 
room so that he gets the 
optimum or maximum 
O2. 
 
Massaging with hot 
water and application of 
hot ointment at the joints 
where am having that 
pain., drink lots of water. 
Use painkillers like 
paracetamol, ointment 
massaging, lots of intake 
of water, hot food 




We currently do not use 




Distraction by watching 
wrestling; helps to calm 
him down: massaging, 
hot pads, listening to soft 
music. 
 
Eat more fruits and 
veggies; herbals example 
lemon, avocado; eat diets 
low on peanut and meat 
because of the high oil 
content. Uses the Kangen 
machine to sieve/filter 




increases the pH level 
thus alkaline water. It has 
been very effective and 
believe has contributed a 
lot to why I am doing so 






Rest by sleeping more at 
times massaging with hot 




Rest, applying heating 
pad, drinking water, 
Aromatherapy with 
essential oils with a 
diffuser (It relaxes me 
and helps me to not think 
of my pain). 
Multivitamin, Folic Acid 
tablets, Heating pad, 
Epsom salt 
 
 Patient (SP6)  Side Effects 






































depending on location of 
the healthcare facility, 
some may have 
counselors that patients 
especially Houston is 
very good, they have 
psychologists and social 
workers. Side effects of 
medicine, going to the 
hospital always for every 
treatment, frequent blood 
tests; costs of treatment, 
insurance not ready to 
cover most cost etc.? 
 
Child’s HCPs do not 




associated with SCD etc. 
Doctors in South 
Carolina do not treat 
Sickle Cell well here. 
After an emergency 
room visit most often my 
child’s recovery is way 
longer or not complete so 
I try to treat her on my 
own. That maybe my 
fault somewhat but in 








































hospitals do not know 
Sickle Cell Disorder well 
and send her home with 
fever and pain. In 
Virginia it is way better 
first in and recovery time 
is a lot shorter. 
 
Schools should have a 
partnership with 
treatment center just in 
case of a crisis at school 
or for information. 
Teachers treated her like 
she was diseased for the 
longest until I told them 
what it was. 
 
There is also the trust 
issue between patients 
and their HCPs, so 
patients prefer turning to 




My concern is about 
stigmatization and 
support system to help 
sickle cell patients. 
 
 
I do not think my 
daughter's current 
treatment regimen is as 
effective as I would like 
it to be. I wish we were 
able to get the same 
medication she does at 
the hospital at home to 










and sociological impact 
of SCD on my daughter 












Great, can easily discuss 
daughter’s treatment plan 




Very good; can easily 



















































and express concerns 
with Dr. I think every 
hospital should try to 
communicate better with 
their patients SCD 
specialists. 
 
Not good since we 
moved to South Carolina. 
It is not easy to discuss 
concerns with them. 
They ask but you can tell 
they do not care. I just do 
not believe in my state 
and the care they have 
for their patients. If I can 
get them to care they 
would not have such a 
hard job. 
 
Yes, very good 
relationship and rapport 
 
 
Well, I only have access 
to them only on my visit 
to the hospital for 
checkups. if am being 
attended to by the health 
personnel on the day of 
visit for checkups, I do 
discuss my concerns and 
treatment plans with 
them and at times other 
alternatives will be 
advised by them. 
 
 
The relationship between 
my family and my HCPs 
is great and I do not have 
many complaints. I am 
confident I can 
communicate with my 
HCPs at any time. We 
discuss treatment options 




Good and can easily 
discuss treatment plans 
and other concerns with 









It is very good, he always 







about my health; Very 
easy to communicate 
with, I can message them 
online 




























































1 – 2 times/yr; She use to 
be sick at least once a 
month but now it is 
quarterly, Missing work 
 
More than 10 times per 
year. Can be 
unpredictable. A lot of 
hospitalization, 
Last admission was on 
July 7- 20 
Usually affects my 
parent’s ability to work. 
Very stressful for my 
parents. has never been 
able to work 
 
1 – 2 times/yr. 
 
1 – 2 times/yr.; last 
episode in October last 
year; Not able to go 
school, go out to play, 
less social life etc. in the 
past when he used to be 
sick often when young 
 
3-5 times/year; In my 
period of pain crisis, it 
restricts me of embarking 
on my daily activities 
like working at the office 
 
1 – 2 times/yr. 
my daughter is not able 
to participate in many 
activities her friends do 
such as swim or run for 
long distances 
 
1 – 2 times/yr. He can go 
to school but He is on the 
504 Plan for his school 
district so Teachers are 
aware and send his work 




None in the past year. 
Hardly. The last one was 
about 2 years ago Was 
admitted at the hospital 
for pneumonia and then 
diagnosed with 
rheumatoid arthritis 
which was triggered by a 
very cold weather. The 
last crisis related one was 

























and required blood 
transfusion. 
. 
No times in the past year. 
Last ER visit was 








































































Was not specific but 
stated how taking hot 
baths have been an 
effective first line 




Yes, being very 
successful with 
alternative treatments 
especially diets, less 
stress, staying hydrated 
and rest. Recommend 
more African foods. 
I always encourage as 
much natural treatment 
as possible before 




(Hydration): body and 
skin. Dry skin allows 
infection to get in… I 
also try to give her a 
balanced meal, but she is 
a picky eater being 
autistic…, uses daily 
vitamin, omega 3 and 
encourage water 100% 
juice and smoothies 
which includes her 
veggies without her 
knowing it. Make sure 
after shower and washing 
hands and face to put on 
her on shea, coconut 




Uses or apply shea-butter 
on spots of pains because 
it has anti-inflammatory 
properties and I give him 
chlorophyll liquid 
because it enhances the 
intake of oxygen. Uses 
an air purifier in his 
room so that he gets the 




That is what am yet to try 
out because I have not 
used non-pharmaceutical 
medication before. Well I 
will promote it positively 
if it is approved by food 
and drugs authority and 









































None, never tried new 
medicines 
My HCPs/NP have 
discussed some of the 
new meds but preferred 
to stick with the meds we 
are using now which are 
working for him. 
 
Take Folic acid daily, 
have been eating more 
fruits and veggies; herbs 
example lemon, avocado 
etc., eat diets 
low on peanuts and meat 
because of the high oil 
content and sugar and 
drinking manly alkaline 
water for the past 15 
years which I think has 
contributed a lot to 




Healthy eating, Prayers 
and faith in God, resting, 
massaging, distraction 
must be also be tried 
along with any 
pharmaceuticals the 
patient but this depend 
mostly on the type of 
SCD a patient has will 
determine what regimen 




They are not as effective 
as ibuprofen for me, they 












I will like my daughter to 
try them to see which 
one helps better. I am 
open to other options but 
why change when the 
one you are currently on 





































































alternative regimens are 
also necessary 
So that way patients 
would have a lot of 
options to choose from 
for their wellbeing. 
 
Think more research is 
really required about the 
source of the pains so 
that they can tackle the 
problem from its source 
and produces meds to 
that combat it. 
Lack of adequate 





I love and use a lot of 
natural treatments. Think 
they must be used only in 
extreme cases and if it is 
no other options. Lots of 
treatments have side 
effects and tax vital 
organs like the liver. 
Thus, must only be used 
in extreme case and if 
necessary, also thinks I 
am sure they would way 





Open to any evidence- 
based treatments. I think 






I support the use of using 
other treatment methods 
to curb pain crisis. There 
should be more research 




I do think SCD 
doctors/nurses should be 
willing to try new/other 
therapies more so there 
can be many options 
available for different 
families and their choices 
 
Open but don’t deem it 
not applicable to her now 













son are working pretty 
well, maybe in the future 
when her son gets older 
and then there is the need 
to explore other options 
they will then do so. 
 
It is very important and 
must be encouraged as 
my health and overall 
living conditions since I 
started eating healthy and 




I think our HCPs should 
try other options like 
diets, nutrients, hot pads, 
massaging, prayers and 
others that can also help 
in managing pains. Yes, 
they should be promoted 
since still no cure that 
works for all patients. 
 
I am open to new things 
if they are safe to use on 
my body. I feel like 
everyone should give it a 
try and explore other 
options and HCPs should 
be encouraged to 
prescribe or try these 
new/other therapies 
more because I know 
there are better therapies. 
My HCP only introduces 
me to new medication of 
it will be beneficial in 
significant ways to my 
sickle cell (such as 
oxybryta) , which he 
prescribe to me about 6 
months ago. 
 


















Hot bathes work is well 
 
They are very effective; 
the pain killers that are 
usually prescribed for the 
pain only serves as a 
backing to these 
regimens 
 
They are effective but 
they come with a price 





It really helps because 


































above drugs helps to 
boost the immune system 
that will eventually 
produce good red blood 
cells in the blood without 
it being sickled or curve 
which will apparently 
help in the number of 
pain crisis. Its effective 
like I said, I ensure that I 
take in my drugs daily 
and not exposing my 
body or system to cold 






Current treatment plans 
are effective; Prayers 
however is not effective 
because it does not make 






Most can be very 
effective as these opioids 
are mainly for soothing 
the pains it run its cause; 
some of these may offer 
better treatment options 
such as reducing the 




























Of a low-income status. 
Has an insurance that 
covers about 95% of all 
medical expenses 
 
Low SES; have a good 
insurance but looking for 
Medicaid because even 
though it fully covers 
most of my medical 
expenses/treatments, 
however, it restrict my 
hospital length of stay 
even though I may not be 
fully recovered and thus 
results in being forced to 
be discharged early from 
hospitals 
 
Very low SES have no 
insurance but on 












































High SES have a good 
insurance which covers a 
lot of the treatments. 
Have had no bad 
experiences so far. 
 
Very low SES, Insurance 
do not cover prescribed 
drugs from the doctor or 
specialist, it does not 
cover most of my 
expenses on drugs. 
However, it reduces the 
lab text fee on both urine 
and blood and few drugs 
which are not costly. 
Financially they are not 
helping in that aspect. I 
do not get any assistance. 
 
Middle; good insurance; 
I have not incurred any 
out of pocket expenses 
related to my daughter's 
condition. 
 
Very low SES. Have an 
insurance but not good 
though it covers 
everything 
 
Of a low-SES status. 
Has an insurance. 
Probably Medicaid 







companies are not ready 
to cover cost of some 
treatments; even restrict 
some of the health 
facilities we are allowed 
to go to 
 
Low SES status. 
Have an insurance that 
covers everything. 












Lack of adequate 

































Lack of research and not 
ready to work with out 
 
 
Lack of support system 












How the society treats 
SCD patients makes 
most patients don’t want 
to go public about their 
condition due to lack of 
education/knowledge and 
awareness so it is time 
for the public to be 
educated and more 
publicity to create on 
SCD. 






































My family: do not really 
like being part of support 
groups because being 
around them always 
makes me very 
depressed. 
They are very 
knowledgeable about 
SCD and provide both 
emotional and physical 
support especially during 
crisis like praying with 
me. 
 
My sister and her father 
are all I have really when 
it comes getting the care 
and support, she needs. 
Her father knows it well, 
he has Sickle Cell and 
my sister use to work as 




Yes. Actively involved in 
a support group; one of 
the leaderships …. 
Because of trust issues 
between patients and 
HCPs. Most patients 
prefer turning to support 
















































I do not have any support 
system, though I receive 
newsletters and others 
from online groups 
purposely to educate 
myself more and to know 
what is going on around 






My daughter has an 
amazing support system 
which includes her 
family, friends, school 
community, and church 
community and we never 
feel like we are alone in 
this battle. Our family 
relies on each other when 
anything is needed 
whether that is childcare 




An SCD support group in 
Dallas/TX; have prayers 
section on every Sunday. 
Leaders from church. 
Sharing information and 
provide support and care 
and share experiences. 
Pastor and wife Pray 




Part of a Ghanaian-US-
based support group. 
Provides information and 
resources but have to pay 
membership fees etc. 




friends, member of an 




Family members and 
sickle cell support group. 
They do their best to stay 
informed about my 
condition. 
My family helps me to 
do any task I need done, 

























































Treat or helps with the 
pain faster that is why 
HCPs prefer to prescribe 
it 
 
Because of the caliber of 
the pains that needs to be 
curbed causes HCPs 
continue to prescribe 
them but based on the 
type of disease it 
determines the type of 
med that may need to be 
prescribed too. Pain 
killers serves as a 
backing to the other 
regimens so it may still 
be necessary for the 
HCPs to continue to 
prescribe them. 
 
Give her pain killers 
before we go to the 
hospital. Tylenol and 
other doctors give her 
drugs in emergency 
room. I try not to use it 
because I know they tax 
organs like the liver heart 
and such. 
 
HCPs are more into the 
opioids; prescribes them 
more 
 
Well they do prescribe 
that medication based on 
the condition the patient 
is going through and I 
believe they do employ 
different medications too 
with that effect. 
 
HCPS chooses to 
prescribe opioids 
analgesics instead of 
other non-opioid 
medications as I think 
this is because they know 
how quick the opioids 




Opioids are very 
effective because I have 
been using it personally 
for years. 
 
Not very sure as my 
condition is not that bad I 
















Prescribe mainly opioids 
analgesics and nothing 
else. Because most HCPs 
lack knowledge on the 
effectiveness of these 
other medications as 
most of these are pretty 
new and was recently 
approved by the FDA. 
 
 
Very effective, it always 
treats my pain. 
. I think my HCP chose 
to prescribe these things 
because he may receive 
additional money from 
the drug maker to 
promote the medicine 
versus other therapies. 
 









































Not sure if SCD patients 
abuses prescription 
medicine At least not my 
daughter, she only takes 
her pain medicines when 
she is having crises. 
 
Very false and is sad that 
the patients are treated 
with such contempt 
considering all the 
challenges they deal with 
and even the side effects 
associated with these 
meds. Because most of 
these meds do not work 
or help instantly, some 
patients may feel 
compelled to take more. 
Most of the meds are not 
instant relief so it may 
seem they do not work 
and thus a patient may 
end up taking more to be 
able to curb the pains. 
However, my HCPs 
expressed concern about 
the threat of 
polypharmacy because of 
the numerous med I take 
but just keeping 
switching to new meds. 
 
Yes. She has a family 
history of addiction on 
both sides so, I always 
encourage as much 
natural treatment as 
possible before making 
















































I do not think so, because 
the scale of the pain is 
not well understood 
 
 
I think SCD abuses drugs 
to curb or relief pain; 
perhaps there will be 
different issue pertaining 
to the pain which might 
need different medication 
to stop that but due to the 
situation of managing 
pain they take in drugs at 
their own discretion to 
minimize the pain 
 
 
I do not think SCD 
patients abuse medical 
prescription drugs 
because I honestly think 
they need a high level of 
medication to alleviate 




I do not believe is true. 
 
 
Not very sure as my 
condition is not that bad I 




Not my daughter but it 
can be possible as it 
seems HCPs don’t 
actually understand the 
caliber of the SCD pains, 
they tend to under-
prescribe for their 
patients. Also, these pain 
killers they usually 
prescribe are not that 
potent enough to really 
handle the pains, they 
wear out easily after 
some few hours so the 
patient may be forced to 
take more than 
prescribed by the HCP to 
completely control or 
stop the pains, and also 
they are mainly for 
maintenance, purposely 
to soothe the pains, help 
the patient feel 
comfortable during a 
crisis but doesn’t really 
stop or shortened the 






No, I don’t think we feel 
as if it is the only thing 
that will help. My HCP 
prescribe me extra pain 
medicine unless I ask for 
it. 










































SCD have not received 
attention as other 
diseases like the cancers. 
My organization (a 
support group) lobbied 
for SCD patients in the 
state of Virginia to be 






HCPs treat cancer way 




Lack of specialized 
healthcare facilities that 
are specifically for SCD 




































Problems with spleen 
 
Multiple infections: used 
to be very common 
especially when under 
unsanitized conditions, 
Strokes: mild, Growth 
problems or delay in 
reaching puberty, Iron 
overload, difficulty 
concentrating, Problems 
with spleen, difficulty 
with breathings, affects 
his concentration 
especially during classes 
easily causes him to be 
angry at onset of crisis. 
 
Chronic daily pain, such 



































Problems with eyesight 
(from sickle cell disease), 




Chronic daily pain, such 
as joint pain or hip pain, 
Acute chest syndrome 
 
Joint pains and at times 
headache. In my teens I 
experienced priapism but 








Problems with eyesight 
(from sickle cell 
disease); Acute chest 
syndrome; he has 
Asthma too, so it makes 
it difficult for him. He 
gets tired easily 
especially because of the 
Asthma medicine he 
uses. 
 
Problems with eyesight 
Breathing Difficulties 





pains; hematuria when 
young, breathing issues, 
Asthma, allergies. 
 
Chronic daily pain, such 
as joint pain or hip pain. 



















Yes prayers: I pray 
always for my daughter, 




Yes, even at the hospital 
there is always a chaplain 
to pray and counsel me 
which helps to release 
any fear I may be having. 
Prays a lot because if not 
for God I do not think I 
will still be here. Praying 
has been very effective 
for me especially during 
hospitalizations and 
when my meds are not 






















































lot by helping me to 
relax and somehow 
soothe the pain 
 
I do pray. I believe God 
can work through the 
doctor’s, but they would 




Prayers: I think it helps a 
lot 
 




I do think religion and 
spirituality play an 
important role regarding 
the impact on managing 
pains. Have been using 





Prayers but, it is not 
effective because it does 




Prayers and fasting 
which helps with 






leaders, use of some 
spiritual/religious 
artifacts and they have 
been very effective and 
have contributed a lot 
towards her current 
status with SCD. 
 
 
Prayers to God, I think 
prayer can help your 
perspective on the pain 
you’re having. 
Somewhat effective, but 
I don’t think about my 
pains too much after I 
pray. 
. 



















































































Treatment that will help 
save their eyesight and 
ways to deal during times 
of an epidemic and flu 
season. Flu shot can 
sometimes make them 
sick. 
 
Bone marrow: the Gene 
therapy currently being 
employed uses inactive 
HIV cells and also wipes 
all the immune system 
which renders it unsafe 
so if something else can 
be developed that would 
be less invasive on 
organs with no or less 
side or adverse effects. 
 
Adhering to basic 
strategies like good diet, 
enough fluids to avoid 
dehydration, not 
exposing body or system 
to cold weather or foods, 
visiting the clinic 
regularly etc. 
 
Being able to manage 







Prayers and fasting 
which even helps with 





A treatment capable of 
curing or eliminating 
SCD and its associated 
complications entirely. 




Easy to administer, 
convenient, can be 























Appendix D: Significant or Unique Statements and Their Implications 
Compilation of significant or unique statements by participants Implications 
At least not my daughter, she only takes her pain medicines 
when she is having crises. Very false and is sad that 
the patients are treated with such contempt. There is 
a family history of addiction on both sides so, I 
always encourage as much natural treatment as 
possible before making opioids an option. 
Participants responses on if SCD patients abuses prescription 
medications 
Takes daily medication of Hydroxyurea, folate and iron 
vitamins 
Preventative strategies 
Participant thinks opioid analgesics helps with the pain faster 
that is why HCPs prefer to prescribe it. The type of 
disease determines the type of med that HCPs 
prescribed. Pain killers serves as a backing to other 
regimens. I try not to use it because I know they tax 
organs like the liver heart etc. (side effects). HCPs 
treat all SCD cases the same way. They don’t try to 
tailor treatment based on the type or conditions of 
the patient 
Participants perceptions on opioid analgesics and why HCPs 
prescribes them over others /HCP prescribing habits 
I have being very successful with alternative treatments 
especially diets, less stress, staying hydrated and 
rest 
Participants experiences with alternative treatments 
Hot bathes work’s really well. Prayers have powers, are very 
helpful. Prayers and counselling help to release my 
fears. They are effective but with a price and side 
effects. I just do not want anything habit forming 
and will have awful side effects 
Participants perceptions of the effectiveness of coping strategies 
That way patients have a lot of options in their well-being. I 
am open to other options “but why change when the 
one you currently on is working. I will like my 
daughter to try them to see which one helps out 
better. Should only be used in extreme cases and if 
it is no other options. Lots of treatments have side 
effects and tax vital organs like the liver 
Participants perceptions/responses to exploring alternative 
treatment options 
I pray always for my daughter. Prays a lot because if not for 
God I don’t think I will still be here. Prayers help a 
lot to soothe the pain. I love and use a lot of natural 
treatments. Apply shea-butter because it has anti-
inflammatory properties and chlorophyll liquid. Air 
purifier to gets the optimum amount of O2. 
Coping Strategies 
I was forced to defer by failing a class awaiting medical 
withdrawal for deferral. A lot of hospitalization, has 
never been able to work, missing work. Gets easily 
angry or upset at the onset of crisis. 
Impact of pain crisis. 
I have doubts about HCP; believe the doctors don’t really 
understand SCD pains very well. In South Carolina 
the hospitals/HCPs do not know or treat SCD well 
and always send my daughter home with fever and 
pain. In Virginia it is way better first in and 
recovery time is a lot shorter. they treat cancer way 
more better than they do with SCD. 
Participants perceptions about HCPs knowledge on SCD. 
I don’t really like being part of support groups because being 
around them always makes me very depressed. 
Emotional and physical support. Schools should 
have a partnership with treatment center just in case 
of a crisis at school or for information. 
Participants perceptions on Support Systems 
Have a full insurance coverage but it restrict my hospital 
length of stay even though I may not be fully 
recovered but I will be forced to be discharged early 
from hospitals stays. 
Participants financial challenges 
They just do not care, no one trying to discuss nothing. Participants responses on relationship with HCPs and their 
attitude 
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